<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Eli Lilly and Company - Wikipedia</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"XpoL@wpAMNcAA61QXvYAAABN","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Eli_Lilly_and_Company","wgTitle":"Eli Lilly and Company","wgCurRevisionId":949908777,"wgRevisionId":949908777,"wgArticleId":758905,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Eli_Lilly_and_Company","wgRelevantArticleId":758905,"wgIsProbablyEditable":!0,"wgRelevantPageIsProbablyEditable":!0,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgRedirectedFrom":"Lilly_(Eli)_\u0026_Co.",
"wgMediaViewerOnClick":!0,"wgMediaViewerEnabledByDefault":!0,"wgPopupsReferencePreviews":!1,"wgPopupsConflictsWithNavPopupGadget":!1,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFMode":"stable","wgMFAmc":!1,"wgMFAmcOutreachActive":!1,"wgMFAmcOutreachUserEligible":!1,"wgMFLazyLoadImages":!0,"wgMFDisplayWikibaseDescriptions":{"search":!0,"nearby":!0,"watchlist":!0,"tagline":!1},"wgMFIsPageContentModelEditable":!0,"wgWMESchemaEditAttemptStepOversample":!1,"wgULSCurrentAutonym":"English","wgNoticeProject":"wikipedia","wgInternalRedirectTargetUrl":"/wiki/Eli_Lilly_and_Company","wgWikibaseItemId":"Q632240","wgCentralAuthMobileDomain":!0,"wgEditSubmitButtonLabelPublish":!0,"wgMinervaPermissions":{"watch":!0,"talk":!1},"wgMinervaFeatures":{"beta":!1,"mobileOptionsLink":!0,"categories":!1,"pageIssues":!0,"talkAtTop":!1,"historyInPageActions":!1,"overflowSubmenu":!1,
"tabsOnSpecials":!1,"personalMenu":!1,"mainMenuExpanded":!1,"simplifiedTalk":!0},"wgMinervaDownloadNamespaces":[0]};RLSTATE={"site.styles":"ready","noscript":"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","skins.minerva.base.styles":"ready","skins.minerva.content.styles":"ready","skins.minerva.content.styles.images":"ready","mediawiki.hlist":"ready","mediawiki.ui.icon":"ready","mediawiki.ui.button":"ready","skins.minerva.icons.wikimedia":"ready","skins.minerva.mainMenu.icons":"ready","skins.minerva.mainMenu.styles":"ready","mobile.init.styles":"ready","ext.wikimediaBadges":"ready"};RLPAGEMODULES=["mediawiki.action.view.redirect","site","mediawiki.page.startup","skins.minerva.options","skins.minerva.scripts","ext.gadget.switcher","ext.centralauth.centralautologin","ext.popups","mobile.init","ext.relatedArticles.readMore.bootstrap","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","mw.externalguidance.init",
"ext.quicksurveys.init","ext.centralNotice.geoIP","ext.centralNotice.startUp"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.cite.styles%7Cext.wikimediaBadges%7Cmediawiki.hlist%7Cmediawiki.ui.button%2Cicon%7Cmobile.init.styles%7Cskins.minerva.base.styles%7Cskins.minerva.content.styles%7Cskins.minerva.content.styles.images%7Cskins.minerva.icons.wikimedia%7Cskins.minerva.mainMenu.icons%2Cstyles&amp;only=styles&amp;skin=minerva"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=minerva&amp;target=mobile"></script>
<meta name="generator" content="MediaWiki 1.35.0-wmf.28"/>
<meta name="referrer" content="origin"/>
<meta name="referrer" content="origin-when-crossorigin"/>
<meta name="referrer" content="origin-when-cross-origin"/>
<meta name="theme-color" content="#eaecf0"/>
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/2/2b/Eli_Lilly_and_Company.svg/1200px-Eli_Lilly_and_Company.svg.png"/>
<meta name="viewport" content="initial-scale=1.0, user-scalable=yes, minimum-scale=0.25, maximum-scale=5.0, width=device-width"/>
<link rel="manifest" href="/w/api.php?action=webapp-manifest"/>
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit"/>
<link rel="edit" title="Edit this page" href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit"/>
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png"/>
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd"/>
<link rel="license" href="//creativecommons.org/licenses/by-sa/3.0/"/>
<link rel="canonical" href="https://en.wikipedia.org/wiki/Eli_Lilly_and_Company"/>
<link rel="dns-prefetch" href="//login.wikimedia.org"/>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Eli_Lilly_and_Company rootpage-Eli_Lilly_and_Company stable issues-group-B skin-minerva action-view">
<div id="mw-mf-viewport">
	<div id="mw-mf-page-center">
		<a class="mw-mf-page-center__mask" href="#"></a>
		<header class="header-container header-chrome">
			<form class="header" action="/w/index.php" method="get">
				<nav class="navigation-drawer toggle-list view-border-box">
					<input type="checkbox" id="main-menu-input" class="toggle-list__checkbox" role="button" aria-labelledby="mw-mf-main-menu-button">
					<label for="main-menu-input" id="mw-mf-main-menu-button"
						class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-menu-base20 mw-ui-icon-flush-left toggle-list__toggle"
						title="Open main menu" data-event-name="ui.mainmenu">Open main menu</label>
					<div id="mw-mf-page-left" class="menu toggle-list__list view-border-box">
	<ul id="p-navigation">
			<li class="">
			    <a href="/wiki/Main_Page" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-home" data-event-name="menu.home"><span>Home</span></a>
			</li>
			<li class="">
			    <a href="/wiki/Special:Random#/random" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-die " data-event-name="menu.random"><span>Random</span></a>
			</li>
			<li class="jsonly">
			    <a href="/wiki/Special:Nearby" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-mapPin nearby" data-event-name="menu.nearby"><span>Nearby</span></a>
			</li>
	</ul>
	<ul id="p-personal">
			<li class="">
			    <a href="/w/index.php?title=Special:UserLogin&amp;returnto=Eli+Lilly+and+Company" class="menu__item--login mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-logIn " data-event-name="menu.login"><span>Log in</span></a>
			</li>
	</ul>
	<ul id="pt-preferences">
			<li class="jsonly">
			    <a href="/w/index.php?title=Special:MobileOptions&amp;returnto=Eli+Lilly+and+Company" class="menu__item--settings mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-settings " data-event-name="menu.settings"><span>Settings</span></a>
			</li>
	</ul>
	<ul class="hlist">
			<li class="">
			    <a href="/wiki/Wikipedia:About" class="" data-event-name=""><span>About Wikipedia</span></a>
			</li>
			<li class="">
			    <a href="/wiki/Wikipedia:General_disclaimer" class="" data-event-name=""><span>Disclaimers</span></a>
			</li>
	</ul>
</div>

					<label class="main-menu-mask" for="main-menu-input"></label>
				</nav>
				<div class="branding-box">
					<a href="/wiki/Main_Page">
						<span><img src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" width="116" height="18" alt="Wikipedia"/></span>
						
					</a>
				</div>
				<div class="search-box">
					<input class="search mw-ui-background-icon-search skin-minerva-search-trigger" type="search" name="search" id="searchInput"
						autocomplete="off" placeholder="Search Wikipedia" aria-label="Search Wikipedia"
						value="">
				</div>
				<nav class="minerva-user-navigation" aria-label="User navigation">
					<div><button id="searchIcon" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-search-base20 skin-minerva-search-trigger" type="submit">Search</button></div>
					
				</nav>
			</form>
		</header>
		<main id="content" class="mw-body">
			<div class="banner-container">
			<div id="siteNotice"></div>
			</div>
			
			<div class="pre-content heading-holder">
				<div class="page-heading">
					<h1 id="section_0">Eli Lilly and Company</h1>
					<div class="tagline"></div>
				</div>
				<nav class="page-actions-menu">
	<ul id="page-actions" class="page-actions-menu__list">
		<li id="language-selector" class="page-actions-menu__list-item">
				<a id="" href="/wiki/Special:MobileLanguages/Eli_Lilly_and_Company" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-language-base20 mw-ui-icon-with-label-desktop language-selector"
					data-mw="interface"
					data-event-name="menu.languages" role="button" title="Language">Language</a>
		</li>
		<li id="page-actions-watch" class="page-actions-menu__list-item">
				<a id="ca-watch" href="/w/index.php?title=Special:UserLogin&amp;returnto=Eli+Lilly+and+Company" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-star-base20 mw-ui-icon-with-label-desktop watch-this-article mw-watchlink menu__item--page-actions-watch"
					data-mw="interface"
					data-event-name="menu.watch" role="button" title="Watch">Watch</a>
		</li>
		<li id="page-actions-edit" class="page-actions-menu__list-item">
				<a id="ca-edit" href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=0" class="edit-page menu__item--page-actions-edit mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 mw-ui-icon-with-label-desktop"
					data-mw="interface"
					data-event-name="menu.edit" role="button" title="Edit the lead section of this page">Edit</a>
		</li>
	</ul>
</nav>
<!-- version 1.0.2 (change every time you update a partial) -->

				
				
				<div class="minerva__subtitle"><span class="mw-redirectedfrom">&#160;&#160;(Redirected from <a href="/w/index.php?title=Lilly_(Eli)_%26_Co.&amp;redirect=no" class="mw-redirect" title="Lilly (Eli) &amp; Co.">Lilly (Eli) &amp; Co.</a>)</span></div>
			</div>
			
			<div id="bodyContent" class="content"><div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><script>function mfTempOpenSection(id){var block=document.getElementById("mf-section-"+id);block.className+=" open-block";block.previousSibling.className+=" open-block";}</script><div class="mw-parser-output"><section class="mf-section-0" id="mf-section-0"><div role="note" class="hatnote navigation-not-searchable">For other uses, see <a href="/wiki/Eli_Lilly_(disambiguation)" class="mw-disambig" title="Eli Lilly (disambiguation)">Eli Lilly (disambiguation)</a>.</div>

<p class="mw-empty-elt">
</p>
<p><b>Eli Lilly and Company</b> is an American <a href="/wiki/Pharmaceutical" class="mw-redirect" title="Pharmaceutical">pharmaceutical</a> company headquartered in <a href="/wiki/Indianapolis,_Indiana" class="mw-redirect" title="Indianapolis, Indiana">Indianapolis, Indiana</a>, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Col. <a href="/wiki/Eli_Lilly" title="Eli Lilly">Eli Lilly</a>, a pharmaceutical <a href="/wiki/Chemist" title="Chemist">chemist</a> and veteran of the <a href="/wiki/American_Civil_War" title="American Civil War">American Civil War</a>.
</p><table class="infobox vcard" style="width:22em"><caption class="fn org">Eli Lilly and Company</caption><tbody><tr><td colspan="2" class="logo" style="text-align:center"><a href="/wiki/File:Eli_Lilly_and_Company.svg" class="image"><img alt="Eli Lilly and Company.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/2b/Eli_Lilly_and_Company.svg/220px-Eli_Lilly_and_Company.svg.png" decoding="async" width="220" height="120" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/2b/Eli_Lilly_and_Company.svg/330px-Eli_Lilly_and_Company.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2b/Eli_Lilly_and_Company.svg/440px-Eli_Lilly_and_Company.svg.png 2x" data-file-width="53" data-file-height="29"></a></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/List_of_legal_entity_types_by_country" title="List of legal entity types by country">Type</a></div></th><td class="category" style="line-height: 1.35em;"><a href="/wiki/Public_company" title="Public company">Public</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><a href="/wiki/Ticker_symbol" title="Ticker symbol">Traded as</a></th><td style="line-height: 1.35em;"><div class="plainlist"><ul><li><a href="/wiki/New_York_Stock_Exchange" title="New York Stock Exchange">NYSE</a>: <a rel="nofollow" class="external text" href="https://www.nyse.com/quote/XNYS:LLY">LLY</a></li><li><a href="/wiki/S%26P_100" title="S&amp;P 100">S&amp;P 100</a> component</li><li><a href="/wiki/S%26P_500" class="mw-redirect" title="S&amp;P 500">S&amp;P 500</a> component</li></ul></div></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><a href="/wiki/International_Securities_Identification_Number" title="International Securities Identification Number">ISIN</a></th><td style="line-height: 1.35em;"><span class="plainlinks nourlexpansion"><a class="external text" href="https://tools.wmflabs.org/isin/?language=en&amp;isin=US5324571083">US5324571083 </a><a href="https://www.wikidata.org/wiki/Q632240?uselang=en#P946" title="Edit this on Wikidata"><img alt="Edit this on Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" style="vertical-align: text-top" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20"></a></span></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Industry</th><td class="category" style="line-height: 1.35em;"><a href="/wiki/Pharmaceutical_industry" title="Pharmaceutical industry">Pharmaceutical</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Founded</th><td style="line-height: 1.35em;">1876<span class="noprint">; 144 years ago</span><span style="display:none"> (<span class="bday dtstart published updated">1876</span>)</span></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Founder</th><td class="agent" style="line-height: 1.35em;"><a href="/wiki/Eli_Lilly" title="Eli Lilly">Eli Lilly</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Headquarters</th><td class="label" style="line-height: 1.35em;"><a href="/wiki/Indianapolis,_Indiana" class="mw-redirect" title="Indianapolis, Indiana">Indianapolis, Indiana</a>, U.S.</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Key people</div></th><td class="agent" style="line-height: 1.35em;">David A. Ricks <span style="font-size:85%;">(<a href="/wiki/Chairperson#Public_corporations" title="Chairperson">Chairman</a>, <a href="/wiki/President_(corporate_title)" title="President (corporate title)">President</a>, &amp; <a href="/wiki/Chief_Executive_Officer" class="mw-redirect" title="Chief Executive Officer">CEO</a>)</span><br>
Joshua Smiley <span style="font-size:85%;">(<a href="/wiki/Vice_president#In_business" title="Vice president">Senior Vice President</a> &amp; <a href="/wiki/CFO" class="mw-redirect" title="CFO">CFO</a>)</span><sup id="cite_ref-10K_1-0" class="reference"><a href="#cite_note-10K-1">[1]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Products</th><td style="line-height: 1.35em;"><a href="/wiki/Medication" title="Medication">Pharmaceutical drugs</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Revenue</th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> <span style="white-space: nowrap"><a href="/wiki/United_States_dollar" title="United States dollar">US$</a>24.556 billion</span> <span style="font-size:85%;">(2018)</span></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Earnings_before_interest_and_taxes" title="Earnings before interest and taxes">Operating income</a></div></th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> <span style="white-space: nowrap">US$3.721 billion</span> <span style="font-size:85%;">(2018)</span></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Net_income" title="Net income">Net income</a></div></th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> <span style="white-space: nowrap">US$3.232 billion</span> <span style="font-size:85%;">(2018)</span></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><span class="nowrap"><a href="/wiki/Asset" title="Asset">Total assets</a></span></th><td style="line-height: 1.35em;"><img alt="Decrease" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/11px-Decrease2.svg.png" decoding="async" title="Decrease" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/17px-Decrease2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/22px-Decrease2.svg.png 2x" data-file-width="300" data-file-height="300"> <span style="white-space: nowrap">US$43.908 billion</span> <span style="font-size:85%;">(2018)</span></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><span class="nowrap"><a href="/wiki/Equity_(finance)" title="Equity (finance)">Total equity</a></span></th><td style="line-height: 1.35em;"><img alt="Decrease" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/11px-Decrease2.svg.png" decoding="async" title="Decrease" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/17px-Decrease2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/22px-Decrease2.svg.png 2x" data-file-width="300" data-file-height="300"> <span style="white-space: nowrap">US$10.909 billion</span> <span style="font-size:85%;">(2018)</span></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Number of employees</div></th><td style="line-height: 1.35em;">33,815 <span style="font-size:85%;">(June 2019)</span></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Website</th><td style="line-height: 1.35em;"><span class="url"><a rel="nofollow" class="external text" href="http://lilly.com">lilly<wbr></wbr>.com</a></span></td></tr><tr><td colspan="2" style="text-align:center;line-height: 1.35em;"><b>Footnotes / references</b><br><sup id="cite_ref-2" class="reference"><a href="#cite_note-2">[2]</a></sup></td></tr></tbody></table><p>Lilly's notable achievements include being the first company to mass-produce the <a href="/wiki/Polio_vaccine" title="Polio vaccine">polio vaccine</a> developed by <a href="/wiki/Jonas_Salk" title="Jonas Salk">Jonas Salk</a>, and <a href="/wiki/Insulin" title="Insulin">insulin</a>. It was one of the first <a href="/wiki/Pharmaceutical" class="mw-redirect" title="Pharmaceutical">pharmaceutical</a> companies to produce human <a href="/wiki/Insulin" title="Insulin">insulin</a> using <a href="/wiki/Recombinant_DNA" title="Recombinant DNA">recombinant DNA</a> including Humulin (<a href="/wiki/Insulin_(medication)" title="Insulin (medication)">insulin medication</a>), Humalog (<a href="/wiki/Insulin_lispro" title="Insulin lispro">insulin lispro</a>), and the first approved <a href="/wiki/Biosimilar" title="Biosimilar">biosimilar</a> insulin product in the US, Basaglar (<a href="/wiki/Insulin_glargine" title="Insulin glargine">insulin glargine</a>).<sup id="cite_ref-3" class="reference"><a href="#cite_note-3">[3]</a></sup></p><p>Lilly is currently the largest manufacturer of <a href="/wiki/Psychiatry" title="Psychiatry">psychiatric</a> medications and produces Prozac (<a href="/wiki/Fluoxetine" title="Fluoxetine">fluoxetine</a>), Dolophine (<a href="/wiki/Methadone" title="Methadone">methadone</a>), Cymbalta (<a href="/wiki/Duloxetine" title="Duloxetine">duloxetine</a>), and Zyprexa (<a href="/wiki/Olanzapine" title="Olanzapine">olanzapine</a>). According to John Marks, the author of The Search For The Manchurian Candidate, Lilly also produced LSD for the CIA’s <a href="/wiki/Project_MKUltra" title="Project MKUltra">MKultra</a> mind control program.
</p><p>The company is ranked 123rd on the 2019 <a href="/wiki/Fortune_500" title="Fortune 500">Fortune 500</a>.<sup id="cite_ref-4" class="reference"><a href="#cite_note-4">[4]</a></sup> It is ranked 221st on the <a href="/wiki/Forbes_Global_2000" title="Forbes Global 2000">Forbes Global 2000</a> list of the largest public companies in the world<sup id="cite_ref-5" class="reference"><a href="#cite_note-5">[5]</a></sup> and 252nd on the Forbes list of America's Best Employers.<sup id="cite_ref-6" class="reference"><a href="#cite_note-6">[6]</a></sup></p><p>Eli Lilly is a full member of the <a href="/wiki/Pharmaceutical_Research_and_Manufacturers_of_America" title="Pharmaceutical Research and Manufacturers of America">Pharmaceutical Research and Manufacturers of America</a><sup id="cite_ref-7" class="reference"><a href="#cite_note-7">[7]</a></sup> and the <a href="/wiki/European_Federation_of_Pharmaceutical_Industries_and_Associations" title="European Federation of Pharmaceutical Industries and Associations">European Federation of Pharmaceutical Industries and Associations</a> (EFPIA).<sup id="cite_ref-8" class="reference"><a href="#cite_note-8">[8]</a></sup></p><p>As of 1997, it was the largest corporation and the largest charitable benefactor in Indiana.<sup id="cite_ref-p58_9-0" class="reference"><a href="#cite_note-p58-9">[9]</a></sup></p>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none"><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul><li class="toclevel-1 tocsection-1"><a href="#History"><span class="tocnumber">1</span> <span class="toctext">History</span></a>
<ul><li class="toclevel-2 tocsection-2"><a href="#Company_founder"><span class="tocnumber">1.1</span> <span class="toctext">Company founder</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Early_days:_1870%E2%80%931900"><span class="tocnumber">1.2</span> <span class="toctext">Early days: 1870–1900</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Modernization:1900%E2%80%931940"><span class="tocnumber">1.3</span> <span class="toctext">Modernization:1900–1940</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#Expansion:_1940%E2%80%931970"><span class="tocnumber">1.4</span> <span class="toctext">Expansion: 1940–1970</span></a></li>
<li class="toclevel-2 tocsection-6"><a href="#1970%E2%80%93present"><span class="tocnumber">1.5</span> <span class="toctext">1970–present</span></a></li>
<li class="toclevel-2 tocsection-7"><a href="#Acquisition_history"><span class="tocnumber">1.6</span> <span class="toctext">Acquisition history</span></a></li>
</ul></li>
<li class="toclevel-1 tocsection-8"><a href="#Acquisition_history_2"><span class="tocnumber">2</span> <span class="toctext">Acquisition history</span></a></li>
<li class="toclevel-1 tocsection-9"><a href="#Collaborative_research"><span class="tocnumber">3</span> <span class="toctext">Collaborative research</span></a>
<ul><li class="toclevel-2 tocsection-10"><a href="#Publicly_funded_research"><span class="tocnumber">3.1</span> <span class="toctext">Publicly funded research</span></a></li>
</ul></li>
<li class="toclevel-1 tocsection-11"><a href="#Pharmaceutical_brands"><span class="tocnumber">4</span> <span class="toctext">Pharmaceutical brands</span></a>
<ul><li class="toclevel-2 tocsection-12"><a href="#Historical"><span class="tocnumber">4.1</span> <span class="toctext">Historical</span></a>
<ul><li class="toclevel-3 tocsection-13"><a href="#Cialis"><span class="tocnumber">4.1.1</span> <span class="toctext">Cialis</span></a></li>
<li class="toclevel-3 tocsection-14"><a href="#Cymbalta"><span class="tocnumber">4.1.2</span> <span class="toctext">Cymbalta</span></a></li>
<li class="toclevel-3 tocsection-15"><a href="#Gemzar"><span class="tocnumber">4.1.3</span> <span class="toctext">Gemzar</span></a></li>
<li class="toclevel-3 tocsection-16"><a href="#Methadone"><span class="tocnumber">4.1.4</span> <span class="toctext">Methadone</span></a></li>
<li class="toclevel-3 tocsection-17"><a href="#Prozac"><span class="tocnumber">4.1.5</span> <span class="toctext">Prozac</span></a></li>
<li class="toclevel-3 tocsection-18"><a href="#Secobarbital"><span class="tocnumber">4.1.6</span> <span class="toctext">Secobarbital</span></a>
<ul><li class="toclevel-4 tocsection-19"><a href="#Secobarbital_overdoses"><span class="tocnumber">4.1.6.1</span> <span class="toctext">Secobarbital overdoses</span></a></li>
</ul></li>
<li class="toclevel-3 tocsection-20"><a href="#Thimerosal"><span class="tocnumber">4.1.7</span> <span class="toctext">Thimerosal</span></a></li>
<li class="toclevel-3 tocsection-21"><a href="#Zyprexa"><span class="tocnumber">4.1.8</span> <span class="toctext">Zyprexa</span></a></li>
</ul></li>
</ul></li>
<li class="toclevel-1 tocsection-22"><a href="#Leadership"><span class="tocnumber">5</span> <span class="toctext">Leadership</span></a></li>
<li class="toclevel-1 tocsection-23"><a href="#Accolades"><span class="tocnumber">6</span> <span class="toctext">Accolades</span></a>
<ul><li class="toclevel-2 tocsection-24"><a href="#Community_service"><span class="tocnumber">6.1</span> <span class="toctext">Community service</span></a></li>
<li class="toclevel-2 tocsection-25"><a href="#Lilly_Endowment"><span class="tocnumber">6.2</span> <span class="toctext">Lilly Endowment</span></a></li>
<li class="toclevel-2 tocsection-26"><a href="#Eli_Lilly_and_Company_Foundation"><span class="tocnumber">6.3</span> <span class="toctext">Eli Lilly and Company Foundation</span></a></li>
</ul></li>
<li class="toclevel-1 tocsection-27"><a href="#Controversy"><span class="tocnumber">7</span> <span class="toctext">Controversy</span></a>
<ul><li class="toclevel-2 tocsection-28"><a href="#Prozac_2"><span class="tocnumber">7.1</span> <span class="toctext">Prozac</span></a></li>
<li class="toclevel-2 tocsection-29"><a href="#NAFTA_Suit"><span class="tocnumber">7.2</span> <span class="toctext">NAFTA Suit</span></a></li>
<li class="toclevel-2 tocsection-30"><a href="#Criminal_prosecution"><span class="tocnumber">7.3</span> <span class="toctext">Criminal prosecution</span></a></li>
<li class="toclevel-2 tocsection-31"><a href="#Insulin_pricing"><span class="tocnumber">7.4</span> <span class="toctext">Insulin pricing</span></a></li>
</ul></li>
<li class="toclevel-1 tocsection-32"><a href="#References"><span class="tocnumber">8</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-33"><a href="#Bibliography"><span class="tocnumber">9</span> <span class="toctext">Bibliography</span></a></li>
<li class="toclevel-1 tocsection-34"><a href="#External_links"><span class="tocnumber">10</span> <span class="toctext">External links</span></a></li>
</ul></div>

</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(1)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="History">History</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=1" title="Edit section: History" data-section="1" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-1 collapsible-block" id="mf-section-1">
<h3 class="in-block"><span class="mw-headline" id="Company_founder">Company founder</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=2" title="Edit section: Company founder" data-section="2" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Eli_Lilly" title="Eli Lilly">Eli Lilly</a></div>
<p>The company's founder was Colonel <a href="/wiki/Eli_Lilly" title="Eli Lilly">Eli Lilly</a>, a <a href="/wiki/Pharmacist" title="Pharmacist">pharmaceutical chemist</a> and <a href="/wiki/Union_Army" title="Union Army">Union army</a> veteran of the <a href="/wiki/American_Civil_War" title="American Civil War">American Civil War</a>. Lilly served as the company president until his death in 1898.<sup id="cite_ref-IHSHBR1_10-0" class="reference"><a href="#cite_note-IHSHBR1-10">[10]</a></sup><sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (April 2020)">citation needed</span></a></i>]</sup></p><p>In 1869, after working for drugstores in Indiana, Lilly became a partner in a <a href="/wiki/Paris,_Illinois" title="Paris, Illinois">Paris, Illinois</a>, drugstore with James W. Binford.<sup id="cite_ref-b911_11-0" class="reference"><a href="#cite_note-b911-11">[11]</a></sup> In 1873, Lilly left the partnership with Binford and returned to Indianapolis. In 1874, Lilly partnered with John F. Johnston and opened a drug manufacturing operation called Johnston and Lilly, but dissolved the partnership in 1876. Lilly used his share of the assets to open his own pharmaceutical manufacturing business in Indianapolis in May 1876. His new business venture became Eli Lilly and Company.<sup id="cite_ref-LillyBio_12-0" class="reference"><a href="#cite_note-LillyBio-12">[12]</a></sup><sup id="cite_ref-m6_13-0" class="reference"><a href="#cite_note-m6-13">[13]</a></sup></p>
<div class="thumb tleft"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Colonel_eli_lilly_in_1885.JPG" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/07/Colonel_eli_lilly_in_1885.JPG/220px-Colonel_eli_lilly_in_1885.JPG" decoding="async" width="220" height="219" class="thumbimage" data-file-width="246" data-file-height="245"></noscript><span class="lazy-image-placeholder" style="width: 220px;height: 219px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/0/07/Colonel_eli_lilly_in_1885.JPG/220px-Colonel_eli_lilly_in_1885.JPG" data-alt="" data-width="220" data-height="219" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Colonel_eli_lilly_in_1885.JPG" class="internal" title="Enlarge"></a></div>Colonel <a href="/wiki/Eli_Lilly" title="Eli Lilly">Eli Lilly</a> (1838–1898), founder</div></div></div>
<h3 class="in-block"><span id="Early_days:_1870.E2.80.931900"></span><span class="mw-headline" id="Early_days:_1870–1900">Early days: 1870–1900</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=3" title="Edit section: Early days: 1870–1900" data-section="3" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>On May 10, 1876, Lilly opened his own laboratory in Indianapolis, where he began to manufacture medicinal drugs. The sign outside, above the shop's door, read: "Eli Lilly, Chemist."<sup id="cite_ref-IHSHBR1_10-1" class="reference"><a href="#cite_note-IHSHBR1-10">[10]</a></sup><sup id="cite_ref-b540_14-0" class="reference"><a href="#cite_note-b540-14">[14]</a></sup><sup id="cite_ref-15" class="reference"><a href="#cite_note-15">[15]</a></sup> Lilly began his manufacturing venture with three employees including Lilly's son, <a href="/wiki/Josiah_K._Lilly_Sr." title="Josiah K. Lilly Sr.">Josiah</a> (J. K.).<sup id="cite_ref-p59_16-0" class="reference"><a href="#cite_note-p59-16">[16]</a></sup><sup id="cite_ref-m6_13-1" class="reference"><a href="#cite_note-m6-13">[13]</a></sup></p><p>One of the first medicines that Lilly produced was <a href="/wiki/Quinine" title="Quinine">quinine</a>, a drug used to treat <a href="/wiki/Malaria" title="Malaria">malaria</a>.<sup id="cite_ref-p57_17-0" class="reference"><a href="#cite_note-p57-17">[17]</a></sup> By the end of 1876, sales reached $4,470.<sup id="cite_ref-p57_17-1" class="reference"><a href="#cite_note-p57-17">[17]</a></sup> By 1879, the company had grown to $48,000.<sup id="cite_ref-p57_17-2" class="reference"><a href="#cite_note-p57-17">[17]</a></sup> In 1878, Lilly hired his brother, James, as his first full-time salesman and the subsequent sales team marketed the company's drugs nationally.<sup id="cite_ref-Kahn23_18-0" class="reference"><a href="#cite_note-Kahn23-18">[18]</a></sup></p><p>The company moved from Pearl Street to larger quarters at 36 South Meridian Street. In 1881, the company moved to its headquarters in Indianapolis's south-side industrial area. Lilly later purchased additional facilities for research and production.<sup id="cite_ref-IHSHBR14_19-0" class="reference"><a href="#cite_note-IHSHBR14-19">[19]</a></sup><sup id="cite_ref-m27_20-0" class="reference"><a href="#cite_note-m27-20">[20]</a></sup></p><p>Lilly's first innovation was gelatin-coating for pills and capsules. The company's other early innovations included fruit flavorings and sugarcoated pills, which made the medicines easier to swallow.<sup id="cite_ref-p59_16-1" class="reference"><a href="#cite_note-p59-16">[16]</a></sup></p><p>In 1881, Lilly formally incorporated the business as Eli Lilly and Company, elected a board of directors, and issued stock to family members and close associates.<sup id="cite_ref-Kahn23_18-1" class="reference"><a href="#cite_note-Kahn23-18">[18]</a></sup> Colonel Lilly's only son, Josiah (J. K.), a pharmaceutical chemist, graduated from the <a href="/wiki/Philadelphia_College_of_Pharmacy_and_Science" class="mw-redirect" title="Philadelphia College of Pharmacy and Science">Philadelphia College of Pharmacy</a> in 1882, and joined the family business as a superintendent of its laboratory after college. J. K. became company president in 1898.<sup id="cite_ref-b913_21-0" class="reference"><a href="#cite_note-b913-21">[21]</a></sup> In 1883 the company contracted to mix and sell Succus Alteran, its first widely successful product and one its best sellers. The product was marketed as a "blood purifier" and as a treatment for <a href="/wiki/Syphilis" title="Syphilis">syphilis</a>, some types of rheumatism, and skin diseases such as <a href="/wiki/Eczema" class="mw-redirect" title="Eczema">eczema</a> and <a href="/wiki/Psoriasis" title="Psoriasis">psoriasis</a>.<sup id="cite_ref-m27_20-1" class="reference"><a href="#cite_note-m27-20">[20]</a></sup><sup id="cite_ref-MadisonM72_22-0" class="reference"><a href="#cite_note-MadisonM72-22">[22]</a></sup> Sales from this product provided funds for Lilly to expand its manufacturing and research facilities.<sup id="cite_ref-IHSHBR2_23-0" class="reference"><a href="#cite_note-IHSHBR2-23">[23]</a></sup> By the late 1880s Colonel Lilly was one of the Indianapolis area's leading businessmen, whose company had more than one-hundred employees and had $200,000 ($5,276,296 in 2015 chained dollars) in annual sales.<sup id="cite_ref-b911_11-1" class="reference"><a href="#cite_note-b911-11">[11]</a></sup></p><p>As the Lilly company grew, other businesses set up operations near the plant on Indianapolis's near south side. The area developed into one of the city's major business and industrial hubs. Lilly's production, manufacturing, research, and administrative operations in Indianapolis eventually occupied a complex of more than two dozen buildings covering a fifteen-block area, as well as production plants along Kentucky Avenue.<sup id="cite_ref-24" class="reference"><a href="#cite_note-24">[24]</a></sup></p>
<div class="thumb tleft"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Eli_Lilly_Medicines,_1906.jpg" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ea/Eli_Lilly_Medicines%2C_1906.jpg/220px-Eli_Lilly_Medicines%2C_1906.jpg" decoding="async" width="220" height="253" class="thumbimage" data-file-width="500" data-file-height="574"></noscript><span class="lazy-image-placeholder" style="width: 220px;height: 253px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ea/Eli_Lilly_Medicines%2C_1906.jpg/220px-Eli_Lilly_Medicines%2C_1906.jpg" data-alt="" data-width="220" data-height="253" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Eli_Lilly_Medicines,_1906.jpg" class="internal" title="Enlarge"></a></div>An assortment of Lilly's <a href="/wiki/Throat_lozenge" title="Throat lozenge">throat lozenges</a> from a 1906 sales book.</div></div></div>
<p>Around 1890, Colonel Lilly turned over the day-to-day management of the business to his son, J. K., who ran the company for thirty-four years. Although the 1890s were a tumultuous decade economically, the company flourished and came out stronger than ever.<sup id="cite_ref-b911_11-2" class="reference"><a href="#cite_note-b911-11">[11]</a></sup><sup id="cite_ref-p60_25-0" class="reference"><a href="#cite_note-p60-25">[25]</a></sup> In 1894 Lilly purchased a manufacturing plant to be used solely for creating capsules. The company also made several technological advances in the manufacturing process, including automating its capsule production. Over the next few years the company annually created tens of millions of capsules and pills.<sup id="cite_ref-PodczekJones_26-0" class="reference"><a href="#cite_note-PodczekJones-26">[26]</a></sup></p><p>Until the turn of the century Lilly operated in Indianapolis and the surrounding area as many other pharmaceutical businesses did—manufacturing and selling "sugar-coated pills, fluid extracts, elixirs, and syrups".<sup id="cite_ref-MadisonM72_22-1" class="reference"><a href="#cite_note-MadisonM72-22">[22]</a></sup> The company used plants for its raw materials and produced its products by hand. One historian noted, "Although the Indianapolis firm was more careful in making and promoting drugs than the patent medicine men of the era, the company remained ambivalent about scientific research."<sup id="cite_ref-MadisonM72_22-2" class="reference"><a href="#cite_note-MadisonM72-22">[22]</a></sup></p><p>In addition to Colonel Lilly, his brother, James, and son, Josiah (J. K.), the growing company employed other Lilly family. Colonel Lilly's cousin, Evan Lilly, was hired as a bookkeeper.<sup id="cite_ref-p60_25-1" class="reference"><a href="#cite_note-p60-25">[25]</a></sup> As young boys, Lilly's grandsons, <a href="/wiki/Eli_Lilly_(industrialist)" title="Eli Lilly (industrialist)">Eli</a> and <a href="/wiki/Josiah_K._Lilly,_Jr." class="mw-redirect" title="Josiah K. Lilly, Jr.">Josiah Jr.</a> (Joe), ran errands and performed other odd jobs. Eli and Joe joined the family business after college. Eventually, each grandson served as company president and chairman of the board.<sup id="cite_ref-IHSHBR256_27-0" class="reference"><a href="#cite_note-IHSHBR256-27">[27]</a></sup></p><p>Josiah (J. K.), Colonel Lilly's son and Eli and Joe's father, inherited the company after Colonel Lilly died and became its president in 1898.<sup id="cite_ref-IHSHBR3_28-0" class="reference"><a href="#cite_note-IHSHBR3-28">[28]</a></sup> At the time of Colonel Lilly's death the company had a product line of 2,005 items and annual sales of more than $300,000 ($8,547,600 in 2015 chained dollars).<sup id="cite_ref-bb912_29-0" class="reference"><a href="#cite_note-bb912-29">[29]</a></sup> Colonel Lilly was a pioneer in the modern pharmaceutical industry, with many of his early innovations later becoming standard practice. His ethical reforms in a trade that was marked by outlandish claims of miracle medicines began a period of rapid advancement in the development of medicinal drugs.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30">[30]</a></sup> J. K. Lilly continued to advocate for federal regulation on medicines.<sup id="cite_ref-31" class="reference"><a href="#cite_note-31">[31]</a></sup> Under J. K.'s leadership, the company introduced scientific management concepts, organized the company's research department, increased its sales force, and began international distribution of its products.<sup id="cite_ref-IHSindustry3_32-0" class="reference"><a href="#cite_note-IHSindustry3-32">[32]</a></sup> In addition J. K. oversaw a large expansion of the company. By 1905 the company reached sales of $1 million ($26,381,481 in 2015 chained dollars).<sup id="cite_ref-IHSHBR3_28-1" class="reference"><a href="#cite_note-IHSHBR3-28">[28]</a></sup></p>
<div class="thumb tleft"><div class="thumbinner" style="width:204px;"><a href="/wiki/File:Josiah_K._Lilly.jpg" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/4/42/Josiah_K._Lilly.jpg" decoding="async" width="202" height="315" class="thumbimage" data-file-width="202" data-file-height="315"></noscript><span class="lazy-image-placeholder" style="width: 202px;height: 315px;" data-src="//upload.wikimedia.org/wikipedia/commons/4/42/Josiah_K._Lilly.jpg" data-alt="" data-width="202" data-height="315" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Josiah_K._Lilly.jpg" class="internal" title="Enlarge"></a></div><a href="/wiki/Josiah_K._Lilly,_Sr." class="mw-redirect" title="Josiah K. Lilly, Sr.">Josiah K. Lilly, Sr.</a> (1861–1948), second company president.</div></div></div>
<h3 class="in-block"><span id="Modernization:1900.E2.80.931940"></span><span class="mw-headline" id="Modernization:1900–1940">Modernization:1900–1940</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=4" title="Edit section: Modernization:1900–1940" data-section="4" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Eli_Lilly_and_Company_Headquarters_ca1919_b1007511_003_tif_zs25x9459.png" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/9c/Eli_Lilly_and_Company_Headquarters_ca1919_b1007511_003_tif_zs25x9459.png/220px-Eli_Lilly_and_Company_Headquarters_ca1919_b1007511_003_tif_zs25x9459.png" decoding="async" width="220" height="141" class="thumbimage" data-file-width="4850" data-file-height="3112"></noscript><span class="lazy-image-placeholder" style="width: 220px;height: 141px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/9/9c/Eli_Lilly_and_Company_Headquarters_ca1919_b1007511_003_tif_zs25x9459.png/220px-Eli_Lilly_and_Company_Headquarters_ca1919_b1007511_003_tif_zs25x9459.png" data-alt="" data-width="220" data-height="141" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Eli_Lilly_and_Company_Headquarters_ca1919_b1007511_003_tif_zs25x9459.png" class="internal" title="Enlarge"></a></div>Eli Lilly and Company Headquarters, Indianapolis, ca.1919</div></div></div>
<p>Just before and after World War I, the Lilly company experienced rapid change.<sup id="cite_ref-MadisonM72_22-3" class="reference"><a href="#cite_note-MadisonM72-22">[22]</a></sup> Expansion of Lilly's manufacturing facilities at the McCarty Street plant improved production capacity with a new Science Building (Building 14), opened in 1911, and a new capsule plant (Building 15) in 1913.<sup id="cite_ref-33" class="reference"><a href="#cite_note-33">[33]</a></sup> The company also began constructions of the <a href="/wiki/Lilly_Biological_Laboratories" title="Lilly Biological Laboratories">Lilly Biological Laboratories</a>, a research and manufacturing plant on 150 acres near Greenfield, Indiana, in 1913.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34">[34]</a></sup><sup id="cite_ref-SHAARD_35-0" class="reference"><a href="#cite_note-SHAARD-35">[35]</a></sup></p><p>In addition to development of new medicines, the company achieved several technological advances, including automation of its production facilities. Lilly was also an innovator in pill capsule manufacturing. It was among the first manufacturers to insert medications into empty gelatin capsules, which provided a more exact dosage.<sup id="cite_ref-IHSHBR1_10-2" class="reference"><a href="#cite_note-IHSHBR1-10">[10]</a></sup> Lilly manufactured capsules for its own needs and sold its excess capacity to others.<sup id="cite_ref-MadisonM73_36-0" class="reference"><a href="#cite_note-MadisonM73-36">[36]</a></sup> A 1917 <i>Scientific American</i> article claimed the Lilly operation in Indianapolis was "the largest capsule factory in the world" and was "capable of producing 2.5 million capsules a day".<sup id="cite_ref-MadisonM73_36-1" class="reference"><a href="#cite_note-MadisonM73-36">[36]</a></sup> One of Lilly's innovations was fruit flavoring for medicines and sugar-coated pills to make their medicines easier to swallow.<sup id="cite_ref-p59_16-2" class="reference"><a href="#cite_note-p59-16">[16]</a></sup> Over the next few years the company began to create tens of millions of capsules and pills annually.<sup id="cite_ref-PodczekJones_26-1" class="reference"><a href="#cite_note-PodczekJones-26">[26]</a></sup></p>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Belladonna_cultivation_Hand_book_of_pharmacy_and_therapeutics_b1007511_005_tif_5x21tg304.tiff" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/ab/Belladonna_cultivation_Hand_book_of_pharmacy_and_therapeutics_b1007511_005_tif_5x21tg304.tiff/lossless-page1-220px-Belladonna_cultivation_Hand_book_of_pharmacy_and_therapeutics_b1007511_005_tif_5x21tg304.tiff.png" decoding="async" width="220" height="341" class="thumbimage" data-file-width="3704" data-file-height="5737"></noscript><span class="lazy-image-placeholder" style="width: 220px;height: 341px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/a/ab/Belladonna_cultivation_Hand_book_of_pharmacy_and_therapeutics_b1007511_005_tif_5x21tg304.tiff/lossless-page1-220px-Belladonna_cultivation_Hand_book_of_pharmacy_and_therapeutics_b1007511_005_tif_5x21tg304.tiff.png" data-alt="" data-width="220" data-height="341" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Belladonna_cultivation_Hand_book_of_pharmacy_and_therapeutics_b1007511_005_tif_5x21tg304.tiff" class="internal" title="Enlarge"></a></div>Belladonna cultivation, Eli Lilly and Company, 1919</div></div></div>
<p>Other advances improved plant efficiency and eliminated production errors. Eli Lilly, grandson of the company founder, introduced a method for blueprinting manufacturing tickets in 1909.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37">[37]</a></sup> This process, which created multiples copies of a drug formula, helped eliminate manufacturing and transcription errors.<sup id="cite_ref-MadisonM73_36-2" class="reference"><a href="#cite_note-MadisonM73-36">[36]</a></sup> In the 1920s Eli introduced the new concept of straight-line production, where raw materials entered at one end of the facility and the finished product came out the other end, in the company's manufacturing process. Under Eli's supervision, the design for Building 22, a new 5-floor plant that opened in Indianapolis in 1926, implemented the straight-line concept to improve production efficiency and lower production costs.<sup id="cite_ref-38" class="reference"><a href="#cite_note-38">[38]</a></sup><sup id="cite_ref-MadisonM74_39-0" class="reference"><a href="#cite_note-MadisonM74-39">[39]</a></sup> One historian noted, "It was probably the most sophisticated production system in the American pharmaceutical industry."<sup id="cite_ref-MadisonM74_39-1" class="reference"><a href="#cite_note-MadisonM74-39">[39]</a></sup> This more efficient manufacturing process also allowed the company to hire a regular workforce. Instead of recalling workers at peak times and laying them off when production demand fell, Lilly's regular workforce produced less-costly medicines in off-peak times using the same manufacturing facilities.<sup id="cite_ref-IHSHBR256_27-1" class="reference"><a href="#cite_note-IHSHBR256-27">[27]</a></sup></p>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Views_in_Elastic_Filled_Capsule_Department_b1007511_008_tif_bn999778q.tiff" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e5/Views_in_Elastic_Filled_Capsule_Department_b1007511_008_tif_bn999778q.tiff/lossless-page1-220px-Views_in_Elastic_Filled_Capsule_Department_b1007511_008_tif_bn999778q.tiff.png" decoding="async" width="220" height="362" class="thumbimage" data-file-width="2946" data-file-height="4849"></noscript><span class="lazy-image-placeholder" style="width: 220px;height: 362px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e5/Views_in_Elastic_Filled_Capsule_Department_b1007511_008_tif_bn999778q.tiff/lossless-page1-220px-Views_in_Elastic_Filled_Capsule_Department_b1007511_008_tif_bn999778q.tiff.png" data-alt="" data-width="220" data-height="362" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Views_in_Elastic_Filled_Capsule_Department_b1007511_008_tif_bn999778q.tiff" class="internal" title="Enlarge"></a></div>Men and women workers preparing drug capsules, Eli Lilly and Company, 1919</div></div></div>
<p>During the 1920s the introduction of new products also brought the company financial success.<sup id="cite_ref-MadisonM72_22-4" class="reference"><a href="#cite_note-MadisonM72-22">[22]</a></sup> In 1919 Josiah hired biochemist <a href="/wiki/George_Henry_Alexander_Clowes" title="George Henry Alexander Clowes">George Henry Alexander Clowes</a> as director of biochemical research. In 1921 three <a href="/wiki/University_of_Toronto" title="University of Toronto">University of Toronto</a> scientists, <a href="/wiki/J._J._R._Macleod" class="mw-redirect" title="J. J. R. Macleod">J. J. R. Macleod</a>, <a href="/wiki/Frederick_G._Banting" class="mw-redirect" title="Frederick G. Banting">Frederick G. Banting</a>, and <a href="/wiki/Charles_H._Best" class="mw-redirect" title="Charles H. Best">Charles H. Best</a>, were working on the development of <a href="/wiki/Insulin" title="Insulin">insulin</a> for treatment of diabetes.<sup id="cite_ref-MadisonM76_40-0" class="reference"><a href="#cite_note-MadisonM76-40">[40]</a></sup> Clowes proposed a collaboration with the researchers in December 1921, then again March and May 1922. The researchers were hesitant to work with a commercial drug firm, particularly since they had the <a href="/wiki/Connaught_Laboratories" title="Connaught Laboratories">Connaught Laboratories</a>' non-commercial facilities at hand. Nonetheless, as limits were reached at the scale to which Connaught could produce insulin, Clowes and Eli Lilly met with the researchers in 1922 to negotiate an agreement with the <a href="/wiki/University_of_Toronto" title="University of Toronto">University of Toronto</a> scientists to mass-produce insulin.<sup id="cite_ref-41" class="reference"><a href="#cite_note-41">[41]</a></sup><sup id="cite_ref-42" class="reference"><a href="#cite_note-42">[42]</a></sup><sup id="cite_ref-43" class="reference"><a href="#cite_note-43">[43]</a></sup> The collaboration greatly accelerated the large-scale production of the extract.<sup id="cite_ref-Roberts_44-0" class="reference"><a href="#cite_note-Roberts-44">[44]</a></sup> In 1923, Lilly began selling Iletin (Insulin, Lilly), their tradename for the first commercially available insulin product in the U.S for the treatment of diabetes.<sup id="cite_ref-MLilly61_45-0" class="reference"><a href="#cite_note-MLilly61-45">[45]</a></sup> Numerous objections were registered by the Insulin Committee of the University of Toronto in regard to Lilly's use of the term "Iletin", although production continued under this name and the objection was later dropped "as a concession".<sup id="cite_ref-46" class="reference"><a href="#cite_note-46">[46]</a></sup><sup id="cite_ref-47" class="reference"><a href="#cite_note-47">[47]</a></sup></p><p>Banting and Macleod won a Nobel Prize in 1923 for their research, which they subsequently shared with co-discoverers <a href="/wiki/Charles_Best_(medical_scientist)" title="Charles Best (medical scientist)">Charles Best</a> and <a href="/wiki/James_Collip" title="James Collip">James Collip</a>.<sup id="cite_ref-48" class="reference"><a href="#cite_note-48">[48]</a></sup><sup id="cite_ref-49" class="reference"><a href="#cite_note-49">[49]</a></sup> Insulin, "the most important drug" in the company's history, did "more than any other" to make Lilly "one of the major pharmaceutical manufacturers in the world."<sup id="cite_ref-MadisonM76_40-1" class="reference"><a href="#cite_note-MadisonM76-40">[40]</a></sup> Eli Lilly enjoyed effective monopoly on the sale of insulin in the U.S. for almost two years, until the first of the new American licensees, Frederick Stearns &amp; Co., entered the market in June 1924.<sup id="cite_ref-50" class="reference"><a href="#cite_note-50">[50]</a></sup></p><p>The success of insulin enabled the company to attract well-respected scientists and, with them, make more medical advances. By its fiftieth anniversary in 1926 sales reached $9 million and the company produced more than 2,800 different items.<sup id="cite_ref-IHSHBR256_27-2" class="reference"><a href="#cite_note-IHSHBR256-27">[27]</a></sup> In 1928 Lilly introduced Liver Extract 343 for the treatment of pernicious anemia, a blood disorder, in a joint venture with two <a href="/wiki/Harvard_University" title="Harvard University">Harvard University</a> scientists, <a href="/wiki/George_R._Minot" class="mw-redirect" title="George R. Minot">George R. Minot</a> and <a href="/wiki/William_P._Murphy" title="William P. Murphy">William P. Murphy</a>. In 1930 Lilly introduced Liver Extract No. 55 in collaboration with <a href="/wiki/George_Whipple" title="George Whipple">George Whipple</a>, a <a href="/wiki/University_of_Rochester" title="University of Rochester">University of Rochester</a> scientist.<sup id="cite_ref-51" class="reference"><a href="#cite_note-51">[51]</a></sup> Minot, Murphy, and Whipple won the 1934 Nobel Prize in medicine for their research.<sup id="cite_ref-MLilly67_52-0" class="reference"><a href="#cite_note-MLilly67-52">[52]</a></sup></p><p>Despite the economic challenges of the Great Depression, Lilly's sales rose to $13 million in 1932.<sup id="cite_ref-IHSHBR5_53-0" class="reference"><a href="#cite_note-IHSHBR5-53">[53]</a></sup> That same year <a href="/wiki/Eli_Lilly_(industrialist)" title="Eli Lilly (industrialist)">Eli Lilly</a>, the eldest grandson of Col. Lilly, was named as the company's president to succeed his father, who remained as chairman of the board until 1948. Eli joined the family business in 1909.<sup id="cite_ref-IHSHBR3_28-2" class="reference"><a href="#cite_note-IHSHBR3-28">[28]</a></sup> In his early years at the company Eli was especially interested in improving production efficiency and introduced a number of labor-saving devices. He also introduced scientific management principles and implemented cost-savings measures that modernized the company.<sup id="cite_ref-54" class="reference"><a href="#cite_note-54">[54]</a></sup> In addition Eli was involved in expanding the company's research efforts and collaborations with university researchers.<sup id="cite_ref-55" class="reference"><a href="#cite_note-55">[55]</a></sup></p><p>In 1934, the firm opened two new facilities on the McCarty Street complex: a replica of Lilly's 1876 laboratory and the new <a href="/wiki/Lilly_Research_Laboratories" class="mw-redirect" title="Lilly Research Laboratories">Lilly Research Laboratories</a>, "one of the most fully equipped facilities in the world."<sup id="cite_ref-56" class="reference"><a href="#cite_note-56">[56]</a></sup> In the 1930s the company also continued expansion overseas.<sup id="cite_ref-MLilly111_57-0" class="reference"><a href="#cite_note-MLilly111-57">[57]</a></sup> In 1934, Eli Lilly and Company Limited, the company's first overseas subsidiary was established in <a href="/wiki/England" title="England">England</a>, with headquarters in <a href="/wiki/London" title="London">London</a> and a manufacturing plant in <a href="/wiki/Basingstoke,_England" class="mw-redirect" title="Basingstoke, England">Basingstoke</a>.<sup id="cite_ref-IHSHBR5_53-1" class="reference"><a href="#cite_note-IHSHBR5-53">[53]</a></sup><sup id="cite_ref-MLilly111_57-1" class="reference"><a href="#cite_note-MLilly111-57">[57]</a></sup></p>
<h3 class="in-block"><span id="Expansion:_1940.E2.80.931970"></span><span class="mw-headline" id="Expansion:_1940–1970">Expansion: 1940–1970</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=5" title="Edit section: Expansion: 1940–1970" data-section="5" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p><a href="/wiki/World_War_II" title="World War II">World War II</a> brought production at Lilly to a new high with the manufacturing of <a href="/wiki/Thiomersal" title="Thiomersal">Merthiolate</a> and penicillin. During the war Lilly also cooperated with the <a href="/wiki/American_Red_Cross" title="American Red Cross">American Red Cross</a> to process blood plasma and by war's end the company had dried over two million pints of blood, "about 20 percent of the United States' total".<sup id="cite_ref-Madison,_Eli_Lilly,_p._105_58-0" class="reference"><a href="#cite_note-Madison,_Eli_Lilly,_p._105-58">[58]</a></sup> Merthiolate, first introduced in 1930, was an "anticeptic and germicide" that became a U.S. army "standard issue" during World War II.<sup id="cite_ref-59" class="reference"><a href="#cite_note-59">[59]</a></sup><sup id="cite_ref-MLilly65_60-0" class="reference"><a href="#cite_note-MLilly65-60">[60]</a></sup> In the early 1940s Lilly became one of the companies mass-producing <a href="/wiki/Penicillin" title="Penicillin">penicillin</a>.<sup id="cite_ref-61" class="reference"><a href="#cite_note-61">[61]</a></sup></p><p>International operations expanded even further during World War II.<sup id="cite_ref-MLilly111_57-2" class="reference"><a href="#cite_note-MLilly111-57">[57]</a></sup> Eli Lilly International Corp. was formed in 1943 as a subsidiary to encourage business trade abroad. By 1948 Lilly employees worked in thirty-five countries, most of them as sales representatives in Latin America, Asia, and Africa.<sup id="cite_ref-MLilly111_57-3" class="reference"><a href="#cite_note-MLilly111-57">[57]</a></sup></p><p>At the end of World War II the company continued to grow. In 1945 Lilly began a major expansion effort that would include two manufacturing operations in Indianapolis. The company purchased the massive Curtiss-Wright propeller plant on South Kentucky Avenue, west of the company's McCarty Street operation. When renovation was completed in mid-1947, the Kentucky Avenue location manufactured antibiotics and capsules and housed the company's shipping department.<sup id="cite_ref-62" class="reference"><a href="#cite_note-62">[62]</a></sup> By 1948 Lilly employed nearly 7,000 people.<sup id="cite_ref-b540_14-1" class="reference"><a href="#cite_note-b540-14">[14]</a></sup></p><p>Eli Lilly, who had served as the company's president since 1932, retired from active management of the company in 1948, became chairman of the board, and relinquished the presidency to his brother, <a href="/wiki/Josiah_K._Lilly,_Jr." class="mw-redirect" title="Josiah K. Lilly, Jr.">Josiah K. Lilly, Jr.</a> (Joe).<sup id="cite_ref-63" class="reference"><a href="#cite_note-63">[63]</a></sup> During Eli's sixteen-year presidency sales rose from $13 million in 1932 to $117 million in 1948. Joe joined the company in 1914 and concentrated on the company's personnel and marketing efforts.<sup id="cite_ref-bb912_29-1" class="reference"><a href="#cite_note-bb912-29">[29]</a></sup> He served as company president from 1948 to 1953, then became chairman of the board and remained in that capacity until his death in 1966.<sup id="cite_ref-64" class="reference"><a href="#cite_note-64">[64]</a></sup> In 1952 the company offered its first public shares of stock.<sup id="cite_ref-65" class="reference"><a href="#cite_note-65">[65]</a></sup> In 1953 Eugene N. Beesley was named the company's new president, the first non-family member to run the company.
</p><p>Over the next several decades Lilly continued to develop and introduce new drugs to the marketplace. In the 1950s Lilly introduced two new antibiotics: vancomycin and erythromycin. In addition Lilly was heavily involved in production and distribution of <a href="/wiki/Jonas_Salk" title="Jonas Salk">Jonas Salk</a>'s <a href="/wiki/Polio_vaccine" title="Polio vaccine">poliomyelitis (polio) vaccine</a>. In 1954 the National Foundation for Infantile Paralysis (NFIP) contracted with five pharmaceutical companies to produce Salk's polio vaccine for clinical trials. These included Lilly as well as Parke, Davis and Company, Cutter Laboratories, Wyeth Laboratories, and Pitman-Moore Company.<sup id="cite_ref-IHSpolio5_66-0" class="reference"><a href="#cite_note-IHSpolio5-66">[66]</a></sup> Lilly's selection to produce the vaccine was, in part, due to its previous experience in collaborations with university researchers.<sup id="cite_ref-IHSpolio6_67-0" class="reference"><a href="#cite_note-IHSpolio6-67">[67]</a></sup> Lilly manufactured 60 percent of the Salk vaccine in 1955.
</p><p>During the mid-twentieth century Lilly continued to expand its production facilities outside of Indianapolis. In 1950 Lilly began Tippecanoe Laboratories in <a href="/wiki/Lafayette,_Indiana" title="Lafayette, Indiana">Lafayette, Indiana</a>,<sup id="cite_ref-b541_68-0" class="reference"><a href="#cite_note-b541-68">[68]</a></sup> and increased <a href="/wiki/Antibiotic" title="Antibiotic">antibiotic</a> production with its patent on <a href="/wiki/Erythromycin" title="Erythromycin">erythromycin</a>. In 1954 Lilly formed <a href="/w/index.php?title=Elanco_Animal_Health&amp;action=edit&amp;redlink=1" class="new" title="Elanco Animal Health (page does not exist)">Elanco Products Company</a> for the production of <a href="/wiki/Veterinary" class="mw-redirect" title="Veterinary">veterinary</a> pharmaceuticals. In 1969, the company opened a new plant in <a href="/wiki/Clinton,_Indiana" title="Clinton, Indiana">Clinton, Indiana</a>.<sup id="cite_ref-b541_68-1" class="reference"><a href="#cite_note-b541-68">[68]</a></sup></p><p>After a company reorganization and transition to non-family management in 1953, Lilly continued to expand its global presence. In the 1960s Lilly operated thirteen affiliate companies outside the United States.<sup id="cite_ref-IHSHBR6_69-0" class="reference"><a href="#cite_note-IHSHBR6-69">[69]</a></sup> In 1962, with an acquisition from Distillers Company, the company established a major factory in <a href="/wiki/Liverpool" title="Liverpool">Liverpool</a>, England. In 1968, Lilly built its first research facility, the <a href="/wiki/Lilly_Research_Centre" title="Lilly Research Centre">Lilly Research Centre</a> Limited, outside the United States near <a href="/wiki/London" title="London">London, England</a> in <a href="/wiki/Surrey" title="Surrey">Surrey</a>.
</p>
<h3 class="in-block"><span id="1970.E2.80.93present"></span><span class="mw-headline" id="1970–present">1970–present</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=6" title="Edit section: 1970–present" data-section="6" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Eli_Lilly_Corporate_Center,_Indianapolis,_Indiana,_USA.jpg" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/05/Eli_Lilly_Corporate_Center%2C_Indianapolis%2C_Indiana%2C_USA.jpg/220px-Eli_Lilly_Corporate_Center%2C_Indianapolis%2C_Indiana%2C_USA.jpg" decoding="async" width="220" height="165" class="thumbimage" data-file-width="4032" data-file-height="3024"></noscript><span class="lazy-image-placeholder" style="width: 220px;height: 165px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/0/05/Eli_Lilly_Corporate_Center%2C_Indianapolis%2C_Indiana%2C_USA.jpg/220px-Eli_Lilly_Corporate_Center%2C_Indianapolis%2C_Indiana%2C_USA.jpg" data-alt="" data-width="220" data-height="165" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Eli_Lilly_Corporate_Center,_Indianapolis,_Indiana,_USA.jpg" class="internal" title="Enlarge"></a></div>Eli Lilly and Company's Corporate Center in <a href="/wiki/Indianapolis" title="Indianapolis">Indianapolis</a>, <a href="/wiki/Indiana" title="Indiana">Indiana</a> in 2019.</div></div></div>
<p>During the 1970s and 1980s, Eli Lilly and Company saw a flurry of drug production: an antibiotic, <a href="/wiki/Cefalexin" title="Cefalexin">Keflex</a>, in 1971; a heart drug, <a href="/wiki/Dobutamine" title="Dobutamine">Dobutrex</a>, in 1977; Ceclor, which would become the world's top selling oral antibiotic, in 1979; a <a href="/wiki/Leukemia" title="Leukemia">leukemia</a> drug, Eldisine; an antiarthritic, <a href="/wiki/Benoxaprofen" title="Benoxaprofen">Oraflex</a>; and an analgesic, <a href="/wiki/Dextropropoxyphene" title="Dextropropoxyphene">Darvon</a>. When generic drugs flooded the marketplace after the expiration of patents for drugs discovered in the 1950s and 1960s, Lilly diversified into other areas, most notably agricultural chemicals, animal-health products, cosmetics, and medical instruments.
</p><p>In 1971, the company became a component of the <a href="/wiki/S%26P_500_Index" title="S&amp;P 500 Index">S&amp;P 500 Index</a>.
</p><p>To further diversify its product line, Lilly made an uncharacteristic, but ultimately profitable move in 1971, when it bought cosmetic manufacturer <a href="/wiki/Elizabeth_Arden,_Inc." title="Elizabeth Arden, Inc.">Elizabeth Arden, Inc.</a> for $38 million. Although the subsidiary continued to lose money for five years after Lilly acquired it, executive management changes at Arden helped turn it into a financial success. By 1982 the subsidiary's "sales were up 90 percent from 1978, with profits doubling to nearly $30 million." Sixteen years after its acquisition, Lilly sold Arden to <a href="/wiki/Faberg%C3%A9_(cosmetics)" title="Fabergé (cosmetics)">Fabergé</a> in 1987 for $657 million.<sup id="cite_ref-IHSHBR7_70-0" class="reference"><a href="#cite_note-IHSHBR7-70">[70]</a></sup></p><p>In 1977, Lilly ventured into medical instruments with the acquisition of IVAC Corporation, which manufactures vital signs and <a href="/wiki/Intravenous" class="mw-redirect" title="Intravenous">intravenous</a> fluid infusion monitoring systems.<sup id="cite_ref-71" class="reference"><a href="#cite_note-71">[71]</a></sup> Lilly also purchased Cardiac Pacemakers Incorporated, a manufacturer of <a href="/wiki/Artificial_pacemaker" class="mw-redirect" title="Artificial pacemaker">heart pacemakers</a> in 1977. In 1980, Lilly acquired Physio-Control Corporation. Other acquisitions included Advance Cardiovasular Systems Incorporated in 1984, Hybritech in 1986, and Devices for Vascular Intervention, Incorporated in 1989. Lilly acquired Pacific Biotech in 1990 and Origin Medsystems and Heart Rhythm Technologies, Incorporated in 1992. In the early 1990s, Lilly combined these medical equipment companies into a Medical Devices and Diagnostics Division that "contributed about 20 percent" of Lilly's annual revenues.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (July 2018)">citation needed</span></a></i>]</sup></p><p>In 1989, a joint agri-chemical venture between Elanco Products Company and <a href="/wiki/Dow_Chemical" class="mw-redirect" title="Dow Chemical">Dow Chemical</a> created DowElanco. In 1997, Lilly sold its 40% share in the company to Dow Chemical for $1.2 billion and the name was changed to <a href="/wiki/Dow_AgroSciences" title="Dow AgroSciences">Dow AgroSciences</a>.<sup id="cite_ref-72" class="reference"><a href="#cite_note-72">[72]</a></sup></p><p>In 1994, Lilly acquired PCS Systems, a drug delivery business for Health Maintenance Organizations, and later added two similar organizations to its holdings.<sup id="cite_ref-IHSHBR8_73-0" class="reference"><a href="#cite_note-IHSHBR8-73">[73]</a></sup> Lilly purchased PCS, which was the largest U.S. prescription drug benefits manager at the time, for $4 billion.<sup id="cite_ref-Kokomo73194_74-0" class="reference"><a href="#cite_note-Kokomo73194-74">[74]</a></sup></p><p>In 1991, Vaughn Bryson was named <a href="/wiki/Chief_executive_officer" title="Chief executive officer">CEO</a> of Eli Lilly. During his 20-month tenure, the company reported its first quarterly loss as a publicly traded company.<sup id="cite_ref-KokomoTrib62893_75-0" class="reference"><a href="#cite_note-KokomoTrib62893-75">[75]</a></sup> In 1993 <a href="/wiki/Randall_L._Tobias" title="Randall L. Tobias">Randall L. Tobias</a>, a vice-chairman of <a href="/wiki/AT%26T_Corporation" title="AT&amp;T Corporation">AT&amp;T Corporation</a> and Lilly board member, was named Lilly's chairman, president, and CEO after "product and competitive pressures" had "steadily eroded Lilly's stock price since early 1992."<sup id="cite_ref-KokomoTrib62693_76-0" class="reference"><a href="#cite_note-KokomoTrib62693-76">[76]</a></sup> Tobias was the first president and CEO recruited from outside of the company. Under Tobias's leadership the company "cut costs and narrowed its mission".<sup id="cite_ref-IHSHBR89_77-0" class="reference"><a href="#cite_note-IHSHBR89-77">[77]</a></sup> Lilly sold companies in its Medical Device and Diagnostics Division, expanded international sales, made new acquisitions, and funded additional research and product development. <a href="/wiki/Sidney_Taurel" title="Sidney Taurel">Sidney Taurel</a>, former chief operating officer of Lilly, was named CEO in 1998, replacing Tobias. Taurel was named chairman in January 1999. In 2000 Lilly reported $10.86 billion in net sales.
</p>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Eli_Lilly_global_manufacturing_plants.png" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/79/Eli_Lilly_global_manufacturing_plants.png/220px-Eli_Lilly_global_manufacturing_plants.png" decoding="async" width="220" height="96" class="thumbimage" data-file-width="1425" data-file-height="625"></noscript><span class="lazy-image-placeholder" style="width: 220px;height: 96px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/7/79/Eli_Lilly_global_manufacturing_plants.png/220px-Eli_Lilly_global_manufacturing_plants.png" data-alt="" data-width="220" data-height="96" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Eli_Lilly_global_manufacturing_plants.png" class="internal" title="Enlarge"></a></div>Eli Lilly's present day global manufacturing plants.</div></div></div>
<p>In 1998, Eli Lilly formed a joint venture with <a href="/wiki/Icos" title="Icos">Icos Corporation</a> (ICOS), a <a href="/wiki/Bothell,_Washington" title="Bothell, Washington">Bothell, Washington</a>-based biotechnology company, to develop and commercialize <a href="/wiki/Tadalafil" title="Tadalafil">Cialis</a>, a product for the treatment of <a href="/wiki/Erectile_dysfunction" title="Erectile dysfunction">erectile dysfunction</a>. In October 2006, Lilly announced its intention to acquire Icos for $2.1 billion, or $32 per share.<sup id="cite_ref-78" class="reference"><a href="#cite_note-78">[78]</a></sup> After its initial attempt to acquire Icos failed under pressure from large institutional shareholders, Lilly revised its offer to $34 per share. Institutional Shareholder Services (ISS), a proxy advisory firm, advised Icos shareholders to reject the proposal as undervalued,<sup id="cite_ref-79" class="reference"><a href="#cite_note-79">[79]</a></sup><sup id="cite_ref-TimmermanProposed_80-0" class="reference"><a href="#cite_note-TimmermanProposed-80">[80]</a></sup> but the buyout was approved by Icos shareholders and Lilly completed its acquisition of the company on January 29, 2007.<sup id="cite_ref-81" class="reference"><a href="#cite_note-81">[81]</a></sup><sup id="cite_ref-82" class="reference"><a href="#cite_note-82">[82]</a></sup> Lilly closed Icos manufacturing operations, terminated nearly 500 Icos employees, and left 127 employees working at the biologics facility.<sup id="cite_ref-Tartakoff_83-0" class="reference"><a href="#cite_note-Tartakoff-83">[83]</a></sup> In December 2007, CMC Biopharmaceuticals A/S (CMC), a <a href="/wiki/Copenhagen" title="Copenhagen">Copenhagen</a>, <a href="/wiki/Denmark" title="Denmark">Denmark</a>-based provider of contract biomanufacturing services, bought the Bothell-based biologics facility from Lilly and retained the existing 127 employees.<sup id="cite_ref-TimmermanProposed_80-1" class="reference"><a href="#cite_note-TimmermanProposed-80">[80]</a></sup><sup id="cite_ref-Tartakoff_83-1" class="reference"><a href="#cite_note-Tartakoff-83">[83]</a></sup><sup id="cite_ref-84" class="reference"><a href="#cite_note-84">[84]</a></sup></p><p>In January 2009, the largest criminal <a href="/wiki/Fine_(penalty)" title="Fine (penalty)">fine</a> in U.S. history, totaling $1.415 billion was imposed on Lilly for illegal marketing of its best-selling product, the <a href="/wiki/Atypical_antipsychotic" title="Atypical antipsychotic">atypical antipsychotic</a> medication, <a href="/wiki/Olanzapine" title="Olanzapine">Zyprexa</a>.<sup id="cite_ref-85" class="reference"><a href="#cite_note-85">[85]</a></sup></p><p>In January 2011, <a href="/wiki/Boehringer_Ingelheim" title="Boehringer Ingelheim">Boehringer Ingelheim</a> and Eli Lilly and Company announced their global agreement for the joint development and marketing of new APIs for diabetes therapy. Lilly could receive more than one billion dollars for their work on the project, while Boehringer Ingelheim could receive more than $800 million from development of the new drugs.<sup id="cite_ref-86" class="reference"><a href="#cite_note-86">[86]</a></sup> Oral anti-diabetic of Boehringer Ingelheim–<a href="/wiki/Linagliptin" title="Linagliptin">Linagliptin</a> and BI 10773–and two <a href="/wiki/Insulin_analog" title="Insulin analog">insulin analogs</a> of Lilly–LY2605541 and LY2963016–were in phase II and III of clinical developmentat that time.<sup id="cite_ref-87" class="reference"><a href="#cite_note-87">[87]</a></sup></p><p>In April 2014, Lilly announced plans to buy <a href="/wiki/Switzerland" title="Switzerland">Swiss</a> drugmaker <a href="/wiki/Novartis_AG" class="mw-redirect" title="Novartis AG">Novartis AG</a>'s animal health business for $5.4 billion in cash to strengthen and diversify its Elanco unit. Lilly said it planned to fund the deal with about $3.4 billion of cash on hand and $2 billion of loans.<sup id="cite_ref-88" class="reference"><a href="#cite_note-88">[88]</a></sup> As a condition of the acquisition, the <a href="/wiki/Milbemycin_oxime/lufenuron" title="Milbemycin oxime/lufenuron">Sentinel heartworm treatment</a> would be divested to <a href="/wiki/Virbac" title="Virbac">Virbac</a> in order to avoid a monopoly in a subsector of the heartworm (<a href="/wiki/Dirofilaria_immitis" title="Dirofilaria immitis">Dirofilaria immitis</a>) treatment market.<sup id="cite_ref-89" class="reference"><a href="#cite_note-89">[89]</a></sup></p><p>In March 2015, the company announced it would join <a href="/wiki/Hanmi_Pharmaceutical" title="Hanmi Pharmaceutical">Hanmi Pharmaceutical</a> in developing and commercialising Hanmi's phase I <a href="/wiki/Bruton%27s_tyrosine_kinase" title="Bruton's tyrosine kinase">Bruton's tyrosine kinase</a> inhibitor <a href="/wiki/HM71224" class="mw-redirect" title="HM71224">HM71224</a> in a deal which could yield $690 million.<sup id="cite_ref-90" class="reference"><a href="#cite_note-90">[90]</a></sup> A day later the company announced another deal with Innovent Biologics to co-develop and commercialise at least three of Innovents treatments over the next decade, in a deal which could generate up to $456 million. As part of the deal the company will contribute its c-Met monoclonal antibody whilst Innovent will contribute a monoclonal antibody which targets <a href="/w/index.php?title=CD-20&amp;action=edit&amp;redlink=1" class="new" title="CD-20 (page does not exist)">CD-20</a>. The second compound from Innovent is a preclinical immuno-oncology molecule.<sup id="cite_ref-91" class="reference"><a href="#cite_note-91">[91]</a></sup> The following week the company announced it would restart its collaboration with <a href="/wiki/Pfizer" title="Pfizer">Pfizer</a> surrounding the Phase III trial of <a href="/wiki/Tanezumab" title="Tanezumab">Tanezumab</a>. Pfizer is expected to receive an upfront sum of $200 million from the company.<sup id="cite_ref-92" class="reference"><a href="#cite_note-92">[92]</a></sup> In April 2015, the company engaged <a href="/wiki/CBRE_Group" title="CBRE Group">CBRE Group</a> to sell its <a href="/wiki/Biomanufacturing" title="Biomanufacturing">biomanufacturing</a> facility in <a href="/wiki/Vacaville,_California" title="Vacaville, California">Vacaville, California</a>.<sup id="cite_ref-plantsale2015_93-0" class="reference"><a href="#cite_note-plantsale2015-93">[93]</a></sup>  The facility resides on a 52 acres (0.21 km<sup>2</sup>) campus and is one of the largest biopharmaceutical manufacturing centers in the United States.<sup id="cite_ref-plantsale2015_93-1" class="reference"><a href="#cite_note-plantsale2015-93">[93]</a></sup></p><p>In January 2017, Elanco Animal Health, a subsidiary of the company completed the acquisition of Boehringer Ingelheim Vetmedica, Inc's (a subsidiary of <a href="/wiki/Boehringer_Ingelheim" title="Boehringer Ingelheim">Boehringer Ingelheim</a>) US feline, canine and rabies vaccines portfolio.<sup id="cite_ref-94" class="reference"><a href="#cite_note-94">[94]</a></sup></p><p>In March 2017, the company acquired CoLucid Pharmaceuticals for $960 million, specifically gaining the late clinical-stage migraine therapy candidate, <a href="/wiki/Lasmiditan" title="Lasmiditan">lasmiditan</a>.<sup id="cite_ref-95" class="reference"><a href="#cite_note-95">[95]</a></sup><sup id="cite_ref-96" class="reference"><a href="#cite_note-96">[96]</a></sup></p><p>In May 2018, the company acquired <a href="/wiki/Armo_Biosciences" class="mw-redirect" title="Armo Biosciences">Armo Biosciences</a> for $1.6 billion.<sup id="cite_ref-97" class="reference"><a href="#cite_note-97">[97]</a></sup> Days later the company announced it would acquire <a href="/wiki/Aurora_kinase_A" class="mw-redirect" title="Aurora kinase A">Aurora kinase A</a> inhibitor developer - AurKa Pharma - and control over the lead compound, <a href="/w/index.php?title=AK-01&amp;action=edit&amp;redlink=1" class="new" title="AK-01 (page does not exist)">AK-01</a>, for up to $575 million.<sup id="cite_ref-98" class="reference"><a href="#cite_note-98">[98]</a></sup><sup id="cite_ref-99" class="reference"><a href="#cite_note-99">[99]</a></sup></p><p>In January 2019, Eli Lilly announced it would acquire Loxo Oncology for $235 per share - valuing the business at around $8 billion - significantly expanding the business' oncology offerings. The deal will give Eli Lilly Loxo's oral <a href="/wiki/Trk_receptor" title="Trk receptor">TRK</a> inhibitor, <a href="/wiki/Vitrakvi" class="mw-redirect" title="Vitrakvi">Vitrakvi</a> (larotrectinib), LOXO-292, an oral proto-<a href="/wiki/Oncogene" title="Oncogene">oncogene</a> <a href="/wiki/Receptor_tyrosine_kinase" title="Receptor tyrosine kinase">receptor tyrosine kinase</a> rearranged during transfection (RET) inhibitor, LOXO-305, an oral <a href="/wiki/Bruton%27s_tyrosine_kinase" title="Bruton's tyrosine kinase">Bruton's tyrosine kinase</a> (BTK) inhibitor and LOXO-195, a follow-on TRK inhibitor.<sup id="cite_ref-100" class="reference"><a href="#cite_note-100">[100]</a></sup><sup id="cite_ref-101" class="reference"><a href="#cite_note-101">[101]</a></sup> In August 2019, Elanco acquired the Bayer animal health business for $7.6 billion.<sup id="cite_ref-102" class="reference"><a href="#cite_note-102">[102]</a></sup><sup id="cite_ref-103" class="reference"><a href="#cite_note-103">[103]</a></sup></p><p>In January 2020, the company announced its acquisition of Dermira for $1.1 billion, gaining control of two key assets, among others; <a href="/wiki/Lebrikizumab" title="Lebrikizumab">lebrikizumab</a> and <a href="/wiki/Glycopyrronium" class="mw-redirect" title="Glycopyrronium">glycopyrronium</a> cloth used to treat <a href="/wiki/Hyperhidrosis" title="Hyperhidrosis">hyperhidrosis</a>.<sup id="cite_ref-104" class="reference"><a href="#cite_note-104">[104]</a></sup><sup id="cite_ref-105" class="reference"><a href="#cite_note-105">[105]</a></sup><sup id="cite_ref-106" class="reference"><a href="#cite_note-106">[106]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Acquisition_history">Acquisition history</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=7" title="Edit section: Acquisition history" data-section="7" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(2)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Acquisition_history_2">Acquisition history</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=8" title="Edit section: Acquisition history" data-section="8" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-2 collapsible-block" id="mf-section-2">
<div class="mw-collapsible mw-collapsed" style="box-sizing:border-box;width:100%;font-size:95%;padding:4px;border:1px #aaa solid;"><div style="font-size:100%;line-height:1.6;font-weight:bold;background:transparent;text-align:center;;">Eli Lilly and Company Acquisitions</div><div class="mw-collapsible-content" style="background:transparent;text-align:left;;">
<style data-mw-deduplicate="TemplateStyles:r886050385">.mw-parser-output .treeview ul{padding:0;margin:0}.mw-parser-output .treeview li{padding:0;margin:0;list-style-type:none;list-style-image:none}.mw-parser-output .treeview li li{background:url("//upload.wikimedia.org/wikipedia/commons/f/f2/Treeview-grey-line.png")no-repeat 0 -2981px;padding-left:21px;text-indent:0.3em}.mw-parser-output .treeview li li:last-child{background-position:0 -5971px}.mw-parser-output .treeview li.emptyline>ul>.mw-empty-elt:first-child+.emptyline,.mw-parser-output .treeview li.emptyline>ul>li:first-child{background-position:0 9px}</style><div class="treeview">
<ul><li><b>Eli Lilly and Company</b> <small>(Founded 1876)</small>
<ul><li>Eli Lilly and Company
<ul><li>Distillers Company <small>(Acq 1962)</small></li>
<li><a href="/wiki/Elizabeth_Arden,_Inc." title="Elizabeth Arden, Inc.">Elizabeth Arden, Inc.</a> <small>(Acq 1971, Sold <a href="/wiki/Faberg%C3%A9_(cosmetics)" title="Fabergé (cosmetics)">Fabergé</a> in 1987)</small></li>
<li>IVAC Corporation <small>(Acq 1977)</small></li>
<li>Cardiac Pacemakers Inc. <small>(Acq 1977)</small></li>
<li>Physio-Control Inc <small>(Acq 1980)</small></li>
<li>Advance Cardiovasular Systems Inc. <small>(Acq 1984)</small></li>
<li>Hybritech <small>(Acq 1986)</small></li>
<li>Devices for Vascular Intervention Inc. <small>(Acq 1986)</small></li>
<li>Pacific Biotech <small>(Acq 1990)</small></li>
<li>Origin Medsystems <small>(Acq 1992)</small></li>
<li>Heart Rhythm Technologies, Inc. <small>(Acq 1992)</small></li>
<li>PCS System <small>(Acq 1994)</small></li>
<li><a href="/wiki/Icos_Corporation" class="mw-redirect" title="Icos Corporation">Icos Corporation</a> <small>(Acq 2007)</small></li>
<li>Hypnion, Inc<sup id="cite_ref-107" class="reference"><a href="#cite_note-107">[107]</a></sup> <small>(Acq 2007)</small></li>
<li><a href="/wiki/ImClone_Systems" title="ImClone Systems">ImClone Systems</a><sup id="cite_ref-108" class="reference"><a href="#cite_note-108">[108]</a></sup> <small>(Acq 2008)</small></li>
<li>SGX Pharmaceuticals, Inc<sup id="cite_ref-109" class="reference"><a href="#cite_note-109">[109]</a></sup> <small>(Acq 2008)</small></li>
<li>Avid Radiopharmaceuticals<sup id="cite_ref-110" class="reference"><a href="#cite_note-110">[110]</a></sup> <small>(Acq 2010)</small></li>
<li>Alnara Pharmaceuticals<sup id="cite_ref-111" class="reference"><a href="#cite_note-111">[111]</a></sup> <small>(Acq 2010)</small></li>
<li>CoLucid Pharmaceuticals <small>(Acq 2017)</small></li>
<li>Armo Biosciences <small>(Acq 2018)</small></li>
<li>AurKa Pharma <small>(Acq 2018)</small></li>
<li>Loxo Oncology <small>(Acq 2019)</small></li></ul></li>
<li>Elanco Products Company <small>(Established 1954 as a division of Eli Lilly and Company)</small>
<ul><li><a href="/wiki/Dow_AgroSciences" title="Dow AgroSciences">DowElanco</a> <small>(Established 1989 as joint venture with <a href="/wiki/Dow_Chemical" class="mw-redirect" title="Dow Chemical">Dow Chemical</a>, Sold stake 1999 to Dow)</small></li>
<li>Ivy Animal Health<sup id="cite_ref-112" class="reference"><a href="#cite_note-112">[112]</a></sup> <small>(Acq 2007)</small></li>
<li><a href="/wiki/Pfizer" title="Pfizer">Pfizer Animal Health</a><sup id="cite_ref-113" class="reference"><a href="#cite_note-113">[113]</a></sup> <small>(Acq 2010)</small></li>
<li><a href="/wiki/Janssen_Pharmaceutica" title="Janssen Pharmaceutica">Janssen Pharmaceutica Animal Health</a><sup id="cite_ref-114" class="reference"><a href="#cite_note-114">[114]</a></sup> <small>(Acq 2011)</small></li>
<li>ChemGen Corp<sup id="cite_ref-115" class="reference"><a href="#cite_note-115">[115]</a></sup> <small>(Acq 2012)</small></li>
<li>Lohmann SE<sup id="cite_ref-116" class="reference"><a href="#cite_note-116">[116]</a></sup> <small>(Acq 2014)</small></li>
<li><a href="/wiki/Novartis" title="Novartis">Novartis Animal Health</a> <small>(Acq 2014)</small></li>
<li><a href="/wiki/Bayer" title="Bayer">Bayer Animal Health</a> <small>(Acq 2019)</small></li></ul></li></ul></li></ul></div>
</div></div>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(3)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Collaborative_research">Collaborative research</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=9" title="Edit section: Collaborative research" data-section="9" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-3 collapsible-block" id="mf-section-3">
<p>Eli Lilly and Company has a long history of collaboration with research scientists. In 1886 Ernest G. Eberhardt, a chemist, joined the company as its first full-time research scientist.<sup id="cite_ref-IHSHBR12_117-0" class="reference"><a href="#cite_note-IHSHBR12-117">[117]</a></sup> Lilly also hired two botanists, Walter H. Evans and John S. Wright, to join its early research efforts.<sup id="cite_ref-IHSHBR2_23-1" class="reference"><a href="#cite_note-IHSHBR2-23">[23]</a></sup><sup id="cite_ref-118" class="reference"><a href="#cite_note-118">[118]</a></sup> After World War I the company's expanded production facilities and introduction of new management methods set the stage for Lilly's next crucial phase—its "aggressive entry into scientific research and development."<sup id="cite_ref-b540_14-2" class="reference"><a href="#cite_note-b540-14">[14]</a></sup> The first big step came in 1919 when Josiah Lilly hired biochemist George Henry Alexander Clowes as director of biochemical research.<sup id="cite_ref-119" class="reference"><a href="#cite_note-119">[119]</a></sup> Clowes had extensive medical research expertise and links to the scientific research community, which led to the company's collaborations with researchers in the U.S. and elsewhere.<sup id="cite_ref-MLilly55_120-0" class="reference"><a href="#cite_note-MLilly55-120">[120]</a></sup> Clowes's first major collaboration with researchers who developed <a href="/wiki/Insulin" title="Insulin">insulin</a> at the <a href="/wiki/University_of_Toronto" title="University of Toronto">University of Toronto</a> significantly impacted the company's future.<sup id="cite_ref-MLilly55_120-1" class="reference"><a href="#cite_note-MLilly55-120">[120]</a></sup> Lilly's success with insulin production secured the company's position as a leading research-based pharmaceutical manufacturer, allowing it to attract and hire more research scientists and to collaborate with other universities in additional medical research.<sup id="cite_ref-121" class="reference"><a href="#cite_note-121">[121]</a></sup> In 1934 the company built a new research laboratory in Indianapolis.<sup id="cite_ref-MadisonM76_40-2" class="reference"><a href="#cite_note-MadisonM76-40">[40]</a></sup> As part of its research and product development process Lilly also conducted clinical studies at Indianapolis City Hospital (Wishard Memorial Hospital). Lilly continues to conduct clinical studies to test medications before their introduction to the market.<sup id="cite_ref-IHSHBR4_122-0" class="reference"><a href="#cite_note-IHSHBR4-122">[122]</a></sup> In 1949 Eli Lilly actually went into partnership with the United States Army Reserve setting up a local Strategic Intelligence Research and Analysis (SIRA)Unit to allow employees to research company data for the Scientific Logistics and Eurasian fields of study (source: declassified Defense Intelligence Agency document MDR -0191-2008 dated 17 Sep 2012). In 1998 the company dedicated new laboratories for clinical research at the Indiana University Medical Center in Indianapolis.
</p>
<h3 class="in-block"><span class="mw-headline" id="Publicly_funded_research">Publicly funded research</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=10" title="Edit section: Publicly funded research" data-section="10" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In addition to internal research and development activities, Lilly is also involved in publicly funded research projects with other industrial and academic partners. One example in the area of <a href="/wiki/Pre-clinical_development" class="mw-redirect" title="Pre-clinical development">non-clinical</a> safety assessment is the InnoMed PredTox, a collaboration with pharmaceutical companies, research organizations, and the <a href="/wiki/European_Commission" title="European Commission">European Commission</a> to improve the safety of drugs.<sup id="cite_ref-123" class="reference"><a href="#cite_note-123">[123]</a></sup><sup id="cite_ref-Consortium_124-0" class="reference"><a href="#cite_note-Consortium-124">[124]</a></sup> In 2008 this consortium, which included Lilly S.A. (Switzerland), secured a €8 million budget for a 40-month project that was coordinated by the European Federation of Pharmaceutical Industries and Associations (<a href="/wiki/EFPIA" class="mw-redirect" title="EFPIA">EFPIA</a>), an organization who represents the research-based pharmaceutical industry and biotech companies operating in Europe.<sup id="cite_ref-Consortium_124-1" class="reference"><a href="#cite_note-Consortium-124">[124]</a></sup><sup id="cite_ref-125" class="reference"><a href="#cite_note-125">[125]</a></sup><sup id="cite_ref-InnoMed_PredTox_official_project_website_126-0" class="reference"><a href="#cite_note-InnoMed_PredTox_official_project_website-126">[126]</a></sup> In 2008 Lilly's activities included research projects within the framework of the <a href="/wiki/Innovative_Medicines_Initiative" title="Innovative Medicines Initiative">Innovative Medicines Initiative</a>, a public-private research initiative in Europe that is a joint effort of the <a href="/wiki/EFPIA" class="mw-redirect" title="EFPIA">EFPIA</a> and the <a href="/wiki/European_Commission" title="European Commission">European Commission</a>.<sup id="cite_ref-127" class="reference"><a href="#cite_note-127">[127]</a></sup><sup id="cite_ref-128" class="reference"><a href="#cite_note-128">[128]</a></sup><sup id="cite_ref-IMI_Call_Topics_2008_129-0" class="reference"><a href="#cite_note-IMI_Call_Topics_2008-129">[129]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(4)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Pharmaceutical_brands">Pharmaceutical brands</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=11" title="Edit section: Pharmaceutical brands" data-section="11" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-4 collapsible-block" id="mf-section-4">
<p>The company's most important products introduced prior to World War II included <a href="/wiki/Insulin" title="Insulin">insulin</a>, which Lilly marketed as Iletin (Insulin, Lilly), Amytal, Merthiolate, ephedrine, and liver extracts.<sup id="cite_ref-MLilly65_60-1" class="reference"><a href="#cite_note-MLilly65-60">[60]</a></sup> Introduced in 1923, Iletin (Insulin, Lilly) was Lilly's first commercial insulin product. In 2002 the company was the leading producer of products for those with diabetes.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (July 2018)">citation needed</span></a></i>]</sup></p><p>During World War II Lilly produced penicillins and other antibiotics. In addition to penicillin, other wartime production included "antimalarials," blood plasma, encephalitis vaccine, typhus and influenza vaccine, gas gangrene antitoxin, Merthiolate, and Iletin (Insulin, Lilly).<sup id="cite_ref-130" class="reference"><a href="#cite_note-130">[130]</a></sup></p><p>Among the company's more recent pharmaceutical developments are <a href="/wiki/Cephalosporin" title="Cephalosporin">cephalosporin</a>, <a href="/wiki/Erythromycin" title="Erythromycin">erythromycin</a>, and <a href="/wiki/Prozac" class="mw-redirect" title="Prozac">Prozac</a> (fluoxetine), a <a href="/wiki/Selective_serotonin_reuptake_inhibitor" title="Selective serotonin reuptake inhibitor">selective serotonin reuptake inhibitor</a> (SSRI) for the treatment of <a href="/wiki/Clinical_depression" class="mw-redirect" title="Clinical depression">clinical depression</a>. Ceclor, introduced in the 1970s, was an oral cephalosporin antibiotic. Prozac, introduced in the 1980s, quickly became the company's best-selling product for treatment of depression, but Lilly lost its U.S. patent protection for this product in 2001. Among other distinctions, Lilly is the world's largest manufacturer and distributor of medications used in a broad range of <a href="/wiki/Psychiatry" title="Psychiatry">psychiatric</a> and <a href="/wiki/Mental_health" title="Mental health">mental health</a>-related conditions, including <a href="/wiki/Clinical_depression" class="mw-redirect" title="Clinical depression">clinical depression</a>, <a href="/wiki/Generalized_anxiety_disorder" title="Generalized anxiety disorder">generalized anxiety disorder</a>, <a href="/wiki/Narcotic" title="Narcotic">narcotic</a> addiction, <a href="/wiki/Insomnia" title="Insomnia">insomnia</a>, <a href="/wiki/Bipolar_disorder" title="Bipolar disorder">bipolar disorder</a>, <a href="/wiki/Schizophrenia" title="Schizophrenia">schizophrenia</a>, and others.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (July 2018)">citation needed</span></a></i>]</sup></p>
<h3 class="in-block"><span class="mw-headline" id="Historical">Historical</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=12" title="Edit section: Historical" data-section="12" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>Eli Lilly has focused on patent-protected medicines, with generic manufacturers taking over production of earlier drugs whose patents have expired.
</p>
<h4 class="in-block"><span class="mw-headline" id="Cialis">Cialis</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=13" title="Edit section: Cialis" data-section="13" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<div role="note" class="hatnote navigation-not-searchable">Further information: <a href="/wiki/Tadalafil" title="Tadalafil">Tadalafil</a></div>
<p>In 2003, Eli Lilly introduced <a href="/wiki/Tadalafil" title="Tadalafil">Cialis</a> (tadalafil), a competitor to <a href="/wiki/Pfizer" title="Pfizer">Pfizer</a>'s blockbuster <a href="/wiki/Viagra" class="mw-redirect" title="Viagra">Viagra</a> for <a href="/wiki/Erectile_dysfunction" title="Erectile dysfunction">erectile dysfunction</a>. Cialis maintains an active period of 36 hours, causing it sometimes to be dubbed the "weekend pill". Cialis was developed in a partnership with <a href="/wiki/Biotechnology" title="Biotechnology">biotechnology</a> company Icos Corporation. On December 18, 2006, Lilly bought Icos in order to gain full control of the product.<sup id="cite_ref-131" class="reference"><a href="#cite_note-131">[131]</a></sup></p>
<h4 class="in-block"><span class="mw-headline" id="Cymbalta">Cymbalta</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=14" title="Edit section: Cymbalta" data-section="14" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<div role="note" class="hatnote navigation-not-searchable">Further information: <a href="/wiki/Duloxetine" title="Duloxetine">Duloxetine</a></div>
<p>Another Lilly manufactured anti-depressant, <a href="/wiki/Duloxetine" title="Duloxetine">Cymbalta</a>, a <a href="/wiki/Serotonin-norepinephrine_reuptake_inhibitor" class="mw-redirect" title="Serotonin-norepinephrine reuptake inhibitor">serotonin-norepinephrine reuptake inhibitor</a> used predominantly in the treatment of major depressive disorders and generalized anxiety disorder, ranks with Prozac as one of the most financially successful pharmaceuticals in industry history.  It is also used in the treatment of <a href="/wiki/Fibromyalgia" title="Fibromyalgia">fibromyalgia</a>, <a href="/wiki/Neuropathy" class="mw-redirect" title="Neuropathy">neuropathy</a>, <a href="/wiki/Chronic_pain" title="Chronic pain">chronic pain</a> and <a href="/wiki/Osteoarthritis" title="Osteoarthritis">osteoarthritis</a>.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (July 2018)">citation needed</span></a></i>]</sup></p>
<h4 class="in-block"><span class="mw-headline" id="Gemzar">Gemzar</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=15" title="Edit section: Gemzar" data-section="15" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<div role="note" class="hatnote navigation-not-searchable">Further information: <a href="/wiki/Gemcitabine" title="Gemcitabine">Gemcitabine</a></div>
<p>In 1996, the <a href="/wiki/Food_and_Drug_Administration_(United_States)" class="mw-redirect" title="Food and Drug Administration (United States)">U.S. Food and Drug Administration</a> approved <a href="/wiki/Gemcitabine" title="Gemcitabine">Gemzar</a> for the treatment of <a href="/wiki/Pancreatic_cancer" title="Pancreatic cancer">pancreatic cancer</a>. Gemzar is commonly used in the treatment of pancreatic cancer, usually in coordination with 5-FU <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a> and radiology. Gemzar also is routinely used in the treatment of non-small cell <a href="/wiki/Lung_cancer" title="Lung cancer">lung cancer</a>.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (July 2018)">citation needed</span></a></i>]</sup></p>
<h4 class="in-block"><span class="mw-headline" id="Methadone">Methadone</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=16" title="Edit section: Methadone" data-section="16" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<div role="note" class="hatnote navigation-not-searchable">Further information: <a href="/wiki/Methadone" title="Methadone">Methadone</a></div>
<p>Eli Lilly was the first distributor of <a href="/wiki/Methadone" title="Methadone">methadone</a> in the United States, an <a href="/wiki/Analgesic" title="Analgesic">analgesic</a> used frequently in the treatment of <a href="/wiki/Heroin" title="Heroin">heroin</a>, <a href="/wiki/Opium" title="Opium">opium</a> and other <a href="/wiki/Opioid" title="Opioid">opioid</a> and <a href="/wiki/Narcotic" title="Narcotic">narcotic</a> <a href="/wiki/Drug_addiction" class="mw-redirect" title="Drug addiction">drug addictions</a>.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (July 2018)">citation needed</span></a></i>]</sup> Eli Lily was able to acquire the right to produce the drug commercially for just $1 because the patent rights of the original patent holders, <a href="/wiki/IG_Farben" title="IG Farben">IG Farben</a> and <a href="/wiki/Farbwerke_Hoechst" class="mw-redirect" title="Farbwerke Hoechst">Farbwerke Hoechst</a>, were not protected after the <a href="/wiki/Allies_of_World_War_II" title="Allies of World War II">Allies of World War II</a> seized all German patents, research records and trade names. Eli Lily introduced the drug to the United States in 1947, marketed under the trade name "Dolophine".<sup id="cite_ref-132" class="reference"><a href="#cite_note-132">[132]</a></sup></p>
<h4 class="in-block"><span class="mw-headline" id="Prozac">Prozac</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=17" title="Edit section: Prozac" data-section="17" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<div role="note" class="hatnote navigation-not-searchable">Further information: <a href="/wiki/Fluoxetine" title="Fluoxetine">Fluoxetine</a></div>
<p>Prozac was one of the first therapies in its class to treat clinical depression by blocking the uptake of <a href="/wiki/Serotonin" title="Serotonin">serotonin</a> within the <a href="/wiki/Human_brain" title="Human brain">human brain</a>. Prozac was approved by the U.S. FDA in 1987 for use in treating depression, with generic versions appearing after 2002.
</p>
<h4 class="in-block"><span class="mw-headline" id="Secobarbital">Secobarbital</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=18" title="Edit section: Secobarbital" data-section="18" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<div role="note" class="hatnote navigation-not-searchable">Further information: <a href="/wiki/Secobarbital" title="Secobarbital">Secobarbital</a></div>
<p>Eli Lilly has manufactured <a href="/wiki/Secobarbital" title="Secobarbital">Secobarbital</a>, a <a href="/wiki/Barbiturate" title="Barbiturate">barbiturate</a> derivative with <a href="/wiki/Anaesthetic" class="mw-redirect" title="Anaesthetic">anaesthetic</a>, <a href="/wiki/Anticonvulsant" title="Anticonvulsant">anticonvulsant</a>, <a href="/wiki/Sedative" title="Sedative">sedative</a> and <a href="/wiki/Hypnosis" title="Hypnosis">hypnotic</a> properties. Lilly marketed Secobarbital under the brand name Seconal. Secobarbital is indicated for the treatment of <a href="/wiki/Epilepsy" title="Epilepsy">epilepsy</a>, temporary <a href="/wiki/Insomnia" title="Insomnia">insomnia</a> and as a pre-operative medication to produce anaesthesia and <a href="/wiki/Anxiolysis" class="mw-redirect" title="Anxiolysis">anxiolysis</a> in short surgical, diagnostic, or therapeutic procedures which are minimally painful. With the onset of new therapies for the treatment of these conditions, Secobarbital has been less utilized, and Lilly ceased manufacturing it in 1999.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (July 2018)">citation needed</span></a></i>]</sup></p>
<h5 class="in-block"><span class="mw-headline" id="Secobarbital_overdoses">Secobarbital overdoses</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=19" title="Edit section: Secobarbital overdoses" data-section="19" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h5>
<p>Secobarbital gained considerable attention during the 1970s, when it gained wide popularity as a <a href="/wiki/Recreational_drug_use" title="Recreational drug use">recreational drug</a>. On September 18, 1970, <a href="/wiki/Rock_music" title="Rock music">rock</a> guitarist legend <a href="/wiki/Jimi_Hendrix" title="Jimi Hendrix">Jimi Hendrix</a> died from a secobarbital overdose. On June 22, 1969, secobarbital overdose was the cause of death of actress <a href="/wiki/Judy_Garland" title="Judy Garland">Judy Garland</a>. The drug was a central part of the plot of the hugely popular novel <i><a href="/wiki/Valley_of_the_Dolls" title="Valley of the Dolls">Valley of the Dolls</a></i> (1966) by <a href="/wiki/Jacqueline_Susann" title="Jacqueline Susann">Jacqueline Susann</a> in which three highly successful <a href="/wiki/Hollywood,_California" class="mw-redirect" title="Hollywood, California">Hollywood</a> women each fall victim, in various ways, to the drug. The novel was later released as a film by the same name.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (July 2018)">citation needed</span></a></i>]</sup></p>
<h4 class="in-block"><span class="mw-headline" id="Thimerosal">Thimerosal</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=20" title="Edit section: Thimerosal" data-section="20" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<div role="note" class="hatnote navigation-not-searchable">Further information: <a href="/wiki/Thiomersal" title="Thiomersal">Thiomersal</a></div>
<p>Eli Lilly has developed the <a href="/wiki/Vaccine" title="Vaccine">vaccine</a> preservative <a href="/wiki/Thiomersal" title="Thiomersal">thiomersal</a> (also called merthiolate and thimerosal). Thiomersal is effective by causing susceptible bacteria to <a href="/wiki/Autolysis_(biology)" title="Autolysis (biology)">autolyze</a>. Launched in 1930, merthiolate was a mercury-based antiseptic and germicide that "had been formulated at the <a href="/wiki/University_of_Maryland" class="mw-redirect" title="University of Maryland">University of Maryland</a> with support of a Lilly research fellowship."<sup id="cite_ref-MLilly65_60-2" class="reference"><a href="#cite_note-MLilly65-60">[60]</a></sup></p>
<h4 class="in-block"><span class="mw-headline" id="Zyprexa">Zyprexa</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=21" title="Edit section: Zyprexa" data-section="21" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<p>Zyprexa (<a href="/wiki/Olanzapine" title="Olanzapine">Olanzapine</a>) (for <a href="/wiki/Schizophrenia" title="Schizophrenia">schizophrenia</a> and <a href="/wiki/Bipolar_disorder" title="Bipolar disorder">bipolar disorder</a>, as well as <a href="/wiki/Off-label" class="mw-redirect" title="Off-label">off-label</a> uses) Released in 1996, (see criminal prosecution section) it was the company's best selling drug through 2010, when the <a href="/wiki/Patent" title="Patent">patent</a> expired.<sup id="cite_ref-133" class="reference"><a href="#cite_note-133">[133]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(5)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Leadership">Leadership</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=22" title="Edit section: Leadership" data-section="22" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-5 collapsible-block" id="mf-section-5">
<p>After three generations of Lilly family leadership under company founder, Col. Eli Lilly, his son, Josiah K. Lilly Sr., and two grandsons, Eli Lilly Jr. and Josiah K. Lilly Jr., the company announced a reorganization in 1944 that prepared the way for future expansion and the eventual separation of company management from its ownership.<sup id="cite_ref-MLilly112_134-0" class="reference"><a href="#cite_note-MLilly112-134">[134]</a></sup> The large, complex corporation was divided into smaller groups headed by vice presidents and in 1953 Eugene N. Beesley was named the first non-family member to become the company's president.<sup id="cite_ref-IHSHBR6_69-1" class="reference"><a href="#cite_note-IHSHBR6-69">[69]</a></sup></p><p>Although Lilly family members continued to serve as chairman of the board until 1969, Beesley's appointment began the transition to non-family management.<sup id="cite_ref-IHSHBR6_69-2" class="reference"><a href="#cite_note-IHSHBR6-69">[69]</a></sup> In 1972 Richard D. Wood became Lilly's president and CEO after the retirement of Burton E. Beck.<sup id="cite_ref-135" class="reference"><a href="#cite_note-135">[135]</a></sup> In 1991 Vaughn Bryson became president and Wood became board chairman.<sup id="cite_ref-136" class="reference"><a href="#cite_note-136">[136]</a></sup> During Bryson's 20-month tenure as Lilly's president and CEO, the company reported its first quarterly loss as a publicly traded company.<sup id="cite_ref-KokomoTrib62893_75-1" class="reference"><a href="#cite_note-KokomoTrib62893-75">[75]</a></sup></p><p><a href="/wiki/Randall_L._Tobias" title="Randall L. Tobias">Randall L. Tobias</a>, a vice chairman of <a href="/wiki/AT%26T_Corporation" title="AT&amp;T Corporation">AT&amp;T Corporation</a>, was named chairman, president, and CEO in June 1993. Tobias, a Lilly board member since 1986, was recruited from outside the company's executive ranks to replace Lilly's president, Vaughn Bryson, and board chairman, Richard Wood.<sup id="cite_ref-KokomoTrib62893_75-2" class="reference"><a href="#cite_note-KokomoTrib62893-75">[75]</a></sup> Tobias later became the U.S. director of Foreign Assistance and administrator of the <a href="/wiki/U.S._Agency_for_International_Development" class="mw-redirect" title="U.S. Agency for International Development">U.S. Agency for International Development</a> (USAID), with the rank of ambassador.<sup id="cite_ref-137" class="reference"><a href="#cite_note-137">[137]</a></sup></p><p><a href="/wiki/Sidney_Taurel" title="Sidney Taurel">Sidney Taurel</a>, former chief operating officer of Lilly, was named CEO in July 1998 to replace Tobias, who retired. Taurel became chairman of the board in January 1999.<sup id="cite_ref-IHSHBR9_138-0" class="reference"><a href="#cite_note-IHSHBR9-138">[138]</a></sup> Taurel retired as CEO on March 31, 2008, but remained as chairman of the board until December 31, 2008. <a href="/wiki/John_C._Lechleiter" title="John C. Lechleiter">John C. Lechleiter</a> was elected as Lilly's CEO and president, effective April 1, 2008. Lechleiter had served as Lilly's president and chief operating officer since October 2005.<sup id="cite_ref-TaurelRetires_139-0" class="reference"><a href="#cite_note-TaurelRetires-139">[139]</a></sup>  In July 2016 Dave Ricks, who also had a long career at Lilly, was appointed CEO.<sup id="cite_ref-140" class="reference"><a href="#cite_note-140">[140]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(6)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Accolades">Accolades</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=23" title="Edit section: Accolades" data-section="23" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-6 collapsible-block" id="mf-section-6">
<p>In 2006, <i><a href="/wiki/Fortune_(magazine)" title="Fortune (magazine)">Fortune</a></i> magazine named Eli Lilly and Company one of the top 100 companies in the United States for which to work. Also in 2006, <i><a href="/wiki/Barron%27s_Magazine" class="mw-redirect" title="Barron's Magazine">Barron's Magazine</a></i> named the company among the top 500 best managed companies in the U.S.
</p><p>In 2012, <i>Working Mothers</i> magazine named Lilly one of the "100 Best Companies for Working Mothers" for the eighteenth consecutive year. <i>Working Mother</i> reported that in 2012 forty-eight percent of Lilly's U.S. employees and thirty-four percent of its U.S. managers and executives were women.<sup id="cite_ref-WorkingMother_141-0" class="reference"><a href="#cite_note-WorkingMother-141">[141]</a></sup><sup id="cite_ref-142" class="reference"><a href="#cite_note-142">[142]</a></sup></p><p>In 2018, Eli Lilly and Company was recognized as one of the Ethisphere Institute's World's Most Ethical Companies, the second year in a row.<sup id="cite_ref-143" class="reference"><a href="#cite_note-143">[143]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Community_service">Community service</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=24" title="Edit section: Community service" data-section="24" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>The Lilly family as well as Eli Lilly and Company has a long history of community service. Around 1890 Col. Lilly turned over operation of the family business to his son, Josiah, who ran the company for the next several decades.<sup id="cite_ref-IHSHBR2_23-2" class="reference"><a href="#cite_note-IHSHBR2-23">[23]</a></sup> Col. Lilly remained active in civic affairs and assisted a number of local organizations, including the Commercial Club of Indianapolis, which later became the Indianapolis Chamber of Commerce,<sup id="cite_ref-b399_144-0" class="reference"><a href="#cite_note-b399-144">[144]</a></sup> and the <a href="/wiki/Charity_Organization_Society" title="Charity Organization Society">Charity Organization Society</a>, a forerunner to the Family Services Association of Central Indiana, an organization supported by <a href="/wiki/United_Way_of_America" title="United Way of America">United Way</a>.<sup id="cite_ref-IHSHBR2_23-3" class="reference"><a href="#cite_note-IHSHBR2-23">[23]</a></sup><sup id="cite_ref-145" class="reference"><a href="#cite_note-145">[145]</a></sup> Josiah's sons, Eli and Joe, were also philanthropists who supported numerous cultural and educational organizations.<sup id="cite_ref-b91012_146-0" class="reference"><a href="#cite_note-b91012-146">[146]</a></sup></p><p>It was Josiah Sr. who continued his father's civic mindedness and began the company tradition of sending aid to disaster victims.<sup id="cite_ref-IHSHBR3_28-3" class="reference"><a href="#cite_note-IHSHBR3-28">[28]</a></sup> Following the <a href="/wiki/1906_San_Francisco_earthquake" title="1906 San Francisco earthquake">1906 San Francisco earthquake</a>, the company sent much needed medicine to support recovery efforts and provided relief after the 1936 <a href="/wiki/Johnstown_Flood" title="Johnstown Flood">Johnstown Flood</a>.<sup id="cite_ref-IHSHBR3_28-4" class="reference"><a href="#cite_note-IHSHBR3-28">[28]</a></sup></p><p>In 1917, Lilly Field Hospital 32, named in Josiah's honor, was equipped in Indianapolis and moved overseas to Contrexville, France, during World War I, where it remained in operation until 1919.<sup id="cite_ref-IHSHBR3_28-5" class="reference"><a href="#cite_note-IHSHBR3-28">[28]</a></sup> Throughout World War II, Lilly manufactured more than two hundred products for military use, including aviator survival kits and seasickness medications for the D-Day invasion.<sup id="cite_ref-IHSHBR5_53-2" class="reference"><a href="#cite_note-IHSHBR5-53">[53]</a></sup> In addition Lilly dried more than two million pints of blood plasma by the war's end.<sup id="cite_ref-Madison,_Eli_Lilly,_p._105_58-1" class="reference"><a href="#cite_note-Madison,_Eli_Lilly,_p._105-58">[58]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Lilly_Endowment">Lilly Endowment</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=25" title="Edit section: Lilly Endowment" data-section="25" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Lilly_Endowment" title="Lilly Endowment">Lilly Endowment</a></div>
<p>In 1937, Josiah K. Lilly Sr. and his two sons, Eli and Joe, founded the <a href="/wiki/Lilly_Endowment" title="Lilly Endowment">Lilly Endowment</a>, a private charitable foundation, with gifts of Lilly stock.<sup id="cite_ref-MLilly20506_147-0" class="reference"><a href="#cite_note-MLilly20506-147">[147]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Eli_Lilly_and_Company_Foundation">Eli Lilly and Company Foundation</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=26" title="Edit section: Eli Lilly and Company Foundation" data-section="26" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>The Eli Lilly and Company Foundation, which is separate from the Lilly Endowment, operates as a tax-exempt private charitable foundation that the company established in 1968. The Foundation is funded through Lilly's corporate profits.<sup id="cite_ref-148" class="reference"><a href="#cite_note-148">[148]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(7)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Controversy">Controversy</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=27" title="Edit section: Controversy" data-section="27" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-7 collapsible-block" id="mf-section-7">
<div role="note" class="hatnote navigation-not-searchable">See also: <a href="/wiki/List_of_largest_pharmaceutical_settlements" title="List of largest pharmaceutical settlements">List of largest pharmaceutical settlements</a></div>
<p>Eli Lilly has been involved in several controversies, including political and medical ethics controversies.  Eli Lilly is now the sole manufacturer of <a href="/wiki/Bovine_somatotropin" title="Bovine somatotropin">BGH</a> having purchased the rights to manufacture the drug from <a href="/wiki/Monsanto" title="Monsanto">Monsanto</a>.
</p>
<h3 class="in-block"><span class="mw-headline" id="Prozac_2">Prozac</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=28" title="Edit section: Prozac" data-section="28" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>A landmark study found that <a href="/wiki/Fluoxetine" title="Fluoxetine">fluoxetine</a> (Prozac) was more likely to increase overall suicidal behavior. 14.7% of the patients (n = 44) on fluoxetine had suicidal events, compared to 6.3% in the psychotherapy group and 8.4% from the combined treatment group.<sup id="cite_ref-149" class="reference"><a href="#cite_note-149">[149]</a></sup> Eli Lilly, the manufacturer, and the lead researcher did not make these findings obvious.<sup id="cite_ref-150" class="reference"><a href="#cite_note-150">[150]</a></sup> Several internal documents, which were released by the <a href="/wiki/British_Medical_Journal" class="mw-redirect" title="British Medical Journal">British Medical Journal</a>, indicated a link between use of Prozac and suicidal or violent behavior. The FDA has warned that Prozac and similar antidepressants could cause agitation, panic attacks and aggression.<sup id="cite_ref-151" class="reference"><a href="#cite_note-151">[151]</a></sup> These documents revealed that Eli Lilly knew about this as early as 1984, years before the drug was FDA-approved.<sup id="cite_ref-152" class="reference"><a href="#cite_note-152">[152]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="NAFTA_Suit">NAFTA Suit</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=29" title="Edit section: NAFTA Suit" data-section="29" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In September 2013, Eli Lilly sued Canada for violating its obligations to foreign investors under the <a href="/wiki/North_American_Free_Trade_Agreement" title="North American Free Trade Agreement">North American Free Trade Agreement</a> by allowing its courts to invalidate patents for two of its drugs.  The company sought damages in the amount of $500 million for lost potential profits.<sup id="cite_ref-153" class="reference"><a href="#cite_note-153">[153]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Criminal_prosecution">Criminal prosecution</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=30" title="Edit section: Criminal prosecution" data-section="30" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<div role="note" class="hatnote navigation-not-searchable">See also: <a href="/wiki/Olanzapine#Controversy,_lawsuits_and_settlements" title="Olanzapine">Olanzapine § Controversy, lawsuits and settlements</a>; and <a href="/wiki/James_Gottstein#Eli_Lilly_memos" title="James Gottstein">James Gottstein § Eli Lilly memos</a></div>
<p>In 2009, four sales representatives for Eli Lilly filed separate <a href="/wiki/Qui_tam" title="Qui tam">qui tam</a> lawsuits against the company for illegally marketing olanzapine (branded Zyprexa), an <a href="/wiki/Antipsychotic" title="Antipsychotic">antipsychotic</a> medication, for uses not approved by the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a>. Eli Lilly pleaded guilty to actively promoting Zyprexa for <a href="/wiki/Off-label" class="mw-redirect" title="Off-label">off-label</a> uses, particularly for the treatment of dementia in the elderly. The $1.415 billion penalty included an $800 million civil settlement and a $515 million criminal fine. The <a href="/wiki/US_Justice_Department" class="mw-redirect" title="US Justice Department">US Justice Department</a> said the criminal fine of $515 million was the largest ever in a healthcare case and the largest criminal fine for an individual corporation ever imposed in a US criminal prosecution of any kind.<sup id="cite_ref-usdoj-2009_154-0" class="reference"><a href="#cite_note-usdoj-2009-154">[154]</a></sup><sup id="cite_ref-155" class="reference"><a href="#cite_note-155">[155]</a></sup> "That was a blemish for us," <a href="/wiki/John_C._Lechleiter" title="John C. Lechleiter">John C. Lechleiter</a>, CEO of Lilly, told <i>The New York Times</i>. "We don't ever want that to happen again. We put measures in place to assure that not only do we have the right intentions in integrity and compliance, but we have systems in place to support that."<sup id="cite_ref-156" class="reference"><a href="#cite_note-156">[156]</a></sup> In an internal email, Lechleiter had stated "we must seize the opportunity to expand our work with Zyprexa in this same child-adolescent population" for <a href="/wiki/Off-label" class="mw-redirect" title="Off-label">off-label</a> use.<sup id="cite_ref-Berenson_157-0" class="reference"><a href="#cite_note-Berenson-157">[157]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Insulin_pricing">Insulin pricing</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=31" title="Edit section: Insulin pricing" data-section="31" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In January 2019, lawmakers from the <a href="/wiki/United_States_House_of_Representatives" title="United States House of Representatives">United States House of Representatives</a> sent letters to Eli Lilly and other insulin manufacturers asking for explanations for their rapidly raising insulin prices. The annual cost of insulin for people with type 1 diabetes in the U.S. almost doubled from $2,900 to $5,700 over the period from 2012 to 2016.<sup id="cite_ref-158" class="reference"><a href="#cite_note-158">[158]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(8)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="References">References</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=32" title="Edit section: References" data-section="32" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-8 collapsible-block" id="mf-section-8">
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="references"><li id="cite_note-10K-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-10K_1-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.sec.gov/Archives/edgar/data/59478/000005947818000089/lly-20171231x10xk.htm">"Eli Lilly and Company 2017 Form 10-K Annual Report"</a>. <i>sec.gov</i>. <a href="/wiki/U.S._Securities_and_Exchange_Commission" title="U.S. Securities and Exchange Commission">U.S. Securities and Exchange Commission</a>. January 2018.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=sec.gov&amp;rft.atitle=Eli+Lilly+and+Company+2017+Form+10-K+Annual+Report&amp;rft.date=2018-01&amp;rft_id=https%3A%2F%2Fwww.sec.gov%2FArchives%2Fedgar%2Fdata%2F59478%2F000005947818000089%2Flly-20171231x10xk.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><style data-mw-deduplicate="TemplateStyles:r935243608">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}</style></span>
</li>
<li id="cite_note-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-2">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://last10k.com/sec-filings/lly#link_fullReport">"Eli Lilly and Company Annual Report (Form 10-K)"</a>. <i>last10k.com</i>. <a href="/wiki/U.S._Securities_and_Exchange_Commission" title="U.S. Securities and Exchange Commission">U.S. Securities and Exchange Commission</a>. February 2019.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=last10k.com&amp;rft.atitle=Eli+Lilly+and+Company+Annual+Report+%28Form+10-K%29&amp;rft.date=2019-02&amp;rft_id=https%3A%2F%2Flast10k.com%2Fsec-filings%2Flly%23link_fullReport&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-3">^</a></b></span> <span class="reference-text"><cite class="citation news">Swiatek, Jeff (28 December 2015). <a rel="nofollow" class="external text" href="https://www.indystar.com/story/money/2015/12/28/10-all-time-greatest-eli-lilly-drugs/76070470/">"10 all-time greatest Eli Lilly drugs"</a>. <i><a href="/wiki/The_Indianapolis_Star" title="The Indianapolis Star">The Indianapolis Star</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Indianapolis+Star&amp;rft.atitle=10+all-time+greatest+Eli+Lilly+drugs&amp;rft.date=2015-12-28&amp;rft.aulast=Swiatek&amp;rft.aufirst=Jeff&amp;rft_id=https%3A%2F%2Fwww.indystar.com%2Fstory%2Fmoney%2F2015%2F12%2F28%2F10-all-time-greatest-eli-lilly-drugs%2F76070470%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://fortune.com/fortune500/eli-lilly">"Fortune 500: Eli Lilly"</a>. <i><a href="/wiki/Fortune_(magazine)" title="Fortune (magazine)">Fortune</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Fortune&amp;rft.atitle=Fortune+500%3A+Eli+Lilly&amp;rft_id=http%3A%2F%2Ffortune.com%2Ffortune500%2Feli-lilly&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.forbes.com/companies/eli-lilly-co/">"Forbes: The World's Biggest Public Companies"</a>. <i><a href="/wiki/Forbes" title="Forbes">Forbes</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Forbes&amp;rft.atitle=Forbes%3A+The+World%27s+Biggest+Public+Companies&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fcompanies%2Feli-lilly-co%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.forbes.com/companies/lilly/">"Forbes: America's Best Employers"</a>. <i><a href="/wiki/Forbes" title="Forbes">Forbes</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Forbes&amp;rft.atitle=Forbes%3A+America%27s+Best+Employers&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fcompanies%2Flilly%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.phrma.org/about/members">"Members"</a>. Pharmaceutical Research and Manufacturers of America<span class="reference-accessdate">. Retrieved <span class="nowrap">14 February</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Members&amp;rft.pub=Pharmaceutical+Research+and+Manufacturers+of+America&amp;rft_id=https%3A%2F%2Fwww.phrma.org%2Fabout%2Fmembers&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20171114145122/http://www.sdggroup.com/en/lilly">"SDG Group Customers: Eli Lilly"</a>. <a href="/wiki/SDG_Group" title="SDG Group">SDG Group</a>. Archived from <a rel="nofollow" class="external text" href="http://www.sdggroup.com/en/lilly">the original</a> on 14 November 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">13 November</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=SDG+Group+Customers%3A+Eli+Lilly&amp;rft_id=http%3A%2F%2Fwww.sdggroup.com%2Fen%2Flilly&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-p58-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-p58_9-0">^</a></b></span> <span class="reference-text"><cite class="citation book">Price, Nelson (1997). <i>Indiana Legends: Famous Hoosiers from Johnny Appleseed to David Letterman</i>. Carmel, Indiana: Guild Press of Indiana. p. 58. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-1-57860-006-9" title="Special:BookSources/978-1-57860-006-9"><bdi>978-1-57860-006-9</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Indiana+Legends%3A+Famous+Hoosiers+from+Johnny+Appleseed+to+David+Letterman&amp;rft.place=Carmel%2C+Indiana&amp;rft.pages=58&amp;rft.pub=Guild+Press+of+Indiana&amp;rft.date=1997&amp;rft.isbn=978-1-57860-006-9&amp;rft.aulast=Price&amp;rft.aufirst=Nelson&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-IHSHBR1-10"><span class="mw-cite-backlink">^ <a href="#cite_ref-IHSHBR1_10-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-IHSHBR1_10-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-IHSHBR1_10-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. Indianapolis: <a href="/wiki/Indiana_Historical_Society" title="Indiana Historical Society">Indiana Historical Society</a>. p. 1. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.place=Indianapolis&amp;rft.pages=1&amp;rft.pub=Indiana+Historical+Society&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-b911-11"><span class="mw-cite-backlink">^ <a href="#cite_ref-b911_11-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-b911_11-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-b911_11-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation book">David J. Bodenhamer and Robert G. Barrows, eds. (1994). <i>The Encyclopedia of Indianapolis</i>. Bloomington and Indianapolis: Indiana University Press. p. 911. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-0-253-31222-8" title="Special:BookSources/978-0-253-31222-8"><bdi>978-0-253-31222-8</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Encyclopedia+of+Indianapolis&amp;rft.place=Bloomington+and+Indianapolis&amp;rft.pages=911&amp;rft.pub=Indiana+University+Press&amp;rft.date=1994&amp;rft.isbn=978-0-253-31222-8&amp;rft.au=David+J.+Bodenhamer+and+Robert+G.+Barrows%2C+eds.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><span class="cs1-maint citation-comment">CS1 maint: extra text: authors list (<a href="/wiki/Category:CS1_maint:_extra_text:_authors_list" title="Category:CS1 maint: extra text: authors list">link</a>)</span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-LillyBio-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-LillyBio_12-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.in.gov/governorhistory/mitchdaniels/files/Press/lillybio.pdf">"Colonel Eli Lilly (1838–1898)"</a> <span class="cs1-format">(PDF)</span>. Lilly Archives. January 2008<span class="reference-accessdate">. Retrieved <span class="nowrap">24 October</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Colonel+Eli+Lilly+%281838%E2%80%931898%29&amp;rft.pub=Lilly+Archives&amp;rft.date=2008-01&amp;rft_id=http%3A%2F%2Fwww.in.gov%2Fgovernorhistory%2Fmitchdaniels%2Ffiles%2FPress%2Flillybio.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-m6-13"><span class="mw-cite-backlink">^ <a href="#cite_ref-m6_13-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-m6_13-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation book">James H. Madison (1989). <a rel="nofollow" class="external text" href="https://archive.org/details/elilillylife188500madi/page/6"><i>Eli Lilly: A Life, 1885–1977</i></a>. Indianapolis: Indiana Historical Society. p. <a rel="nofollow" class="external text" href="https://archive.org/details/elilillylife188500madi/page/6">6</a>. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-0-87195-047-5" title="Special:BookSources/978-0-87195-047-5"><bdi>978-0-87195-047-5</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Eli+Lilly%3A+A+Life%2C+1885%26ndash%3B1977&amp;rft.place=Indianapolis&amp;rft.pages=6&amp;rft.pub=Indiana+Historical+Society&amp;rft.date=1989&amp;rft.isbn=978-0-87195-047-5&amp;rft.au=James+H.+Madison&amp;rft_id=https%3A%2F%2Farchive.org%2Fdetails%2Felilillylife188500madi%2Fpage%2F6&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-b540-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-b540_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-b540_14-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-b540_14-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text">Bodenhamer and Barrows, p. 540.</span>
</li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text">The <a href="/wiki/Indiana_Historical_Society" title="Indiana Historical Society">Indiana Historical Society</a> recreated a replica of the first Lilly laboratory on Pearl Street for its exhibition, "You Are There: <i>Eli Lilly at the Beginning</i>," at the Eugene and Marilyn Glick Indiana History Center in Indianapolis. The temporary exhibition (October 1, 2016, to January 20, 2018) also includes costumed interpreters portraying Colonel Lilly, among others. See <cite class="citation news"><a rel="nofollow" class="external text" href="http://kpcnews.com/features/life/kpcnews/article_1d087ec0-abcb-5641-844d-4ceeaa6b4c5a.html">"The Man Behind State's Most Successful Startup"</a>. <i>Kendallville New Sun</i>. Kendallville, Indiana: KPC News. 9 September 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">21 October</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Kendallville+New+Sun&amp;rft.atitle=The+Man+Behind+State%27s+Most+Successful+Startup&amp;rft.date=2016-09-09&amp;rft_id=http%3A%2F%2Fkpcnews.com%2Ffeatures%2Flife%2Fkpcnews%2Farticle_1d087ec0-abcb-5641-844d-4ceeaa6b4c5a.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"> See also <cite class="citation journal">Tom Alvarez, ed. (Fall 2016). <a rel="nofollow" class="external text" href="https://issuu.com/unitemagazine/docs/indy_fall_2016_web">"Fall Arts Guide"</a>. <i>UNITE Indianapolis</i>. Indianapolis: Joey Amato: 32<span class="reference-accessdate">. Retrieved <span class="nowrap">24 October</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=UNITE+Indianapolis&amp;rft.atitle=Fall+Arts+Guide&amp;rft.ssn=fall&amp;rft.pages=32&amp;rft.date=2016&amp;rft.au=Tom+Alvarez%2C+ed.&amp;rft_id=https%3A%2F%2Fissuu.com%2Funitemagazine%2Fdocs%2Findy_fall_2016_web&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><span class="cs1-maint citation-comment">CS1 maint: extra text: authors list (<a href="/wiki/Category:CS1_maint:_extra_text:_authors_list" title="Category:CS1 maint: extra text: authors list">link</a>)</span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-p59-16"><span class="mw-cite-backlink">^ <a href="#cite_ref-p59_16-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-p59_16-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-p59_16-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text">Price, <i>Indiana Legends</i>, p. 59.</span>
</li>
<li id="cite_note-p57-17"><span class="mw-cite-backlink">^ <a href="#cite_ref-p57_17-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-p57_17-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-p57_17-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text">Price, <i>Indiana Legends</i>, p. 57.</span>
</li>
<li id="cite_note-Kahn23-18"><span class="mw-cite-backlink">^ <a href="#cite_ref-Kahn23_18-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Kahn23_18-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation book">E. J. Kahn (1975). <i>All In A Century: The First 100 Years of Eli Lilly and Company</i>. West Cornwall, CT. p. 23. <a href="/wiki/OCLC" title="OCLC">OCLC</a> <a rel="nofollow" class="external text" href="//www.worldcat.org/oclc/5288809">5288809</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=All+In+A+Century%3A+The+First+100+Years+of+Eli+Lilly+and+Company&amp;rft.place=West+Cornwall%2C+CT&amp;rft.pages=23&amp;rft.date=1975&amp;rft_id=info%3Aoclcnum%2F5288809&amp;rft.au=E.+J.+Kahn&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-IHSHBR14-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-IHSHBR14_19-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. p. 1 and 4. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.pages=1+and+4&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-m27-20"><span class="mw-cite-backlink">^ <a href="#cite_ref-m27_20-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-m27_20-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 27.</span>
</li>
<li id="cite_note-b913-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-b913_21-0">^</a></b></span> <span class="reference-text">Bodenhamer and Barrows, eds., p. 913.</span>
</li>
<li id="cite_note-MadisonM72-22"><span class="mw-cite-backlink">^ <a href="#cite_ref-MadisonM72_22-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MadisonM72_22-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MadisonM72_22-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-MadisonM72_22-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-MadisonM72_22-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">James H. Madison (1989). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20130514134313/http://thebhc.org/publications/BEHprint/v018/p0072-p0078.pdf">"Manufacturing Pharmaceuticals: Eli Lilly and Company, 1876–1948"</a> <span class="cs1-format">(PDF)</span>. <i>Business and Economic History</i>. Business History Conference. <b>18</b>: 72. Archived from <a rel="nofollow" class="external text" href="http://www.thebhc.org/publications/BEHprint/v018/p0072-p0078.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 14 May 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">20 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Business+and+Economic+History&amp;rft.atitle=Manufacturing+Pharmaceuticals%3A+Eli+Lilly+and+Company%2C+1876%E2%80%931948&amp;rft.volume=18&amp;rft.pages=72&amp;rft.date=1989&amp;rft.au=James+H.+Madison&amp;rft_id=http%3A%2F%2Fwww.thebhc.org%2Fpublications%2FBEHprint%2Fv018%2Fp0072-p0078.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-IHSHBR2-23"><span class="mw-cite-backlink">^ <a href="#cite_ref-IHSHBR2_23-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-IHSHBR2_23-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-IHSHBR2_23-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-IHSHBR2_23-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. p. 2. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.pages=2&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><cite class="citation book">Robert M. Taylor Jr.; Errol Wayne Stevens; Mary Ann Ponder; Paul Brockman (1989). <i>Indiana: A New Historical Guide</i>. Indianapolis: Indiana Historical Society. p. 423. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-0-87195-048-2" title="Special:BookSources/978-0-87195-048-2"><bdi>978-0-87195-048-2</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Indiana%3A+A+New+Historical+Guide&amp;rft.place=Indianapolis&amp;rft.pages=423&amp;rft.pub=Indiana+Historical+Society&amp;rft.date=1989&amp;rft.isbn=978-0-87195-048-2&amp;rft.au=Robert+M.+Taylor+Jr.&amp;rft.au=Errol+Wayne+Stevens&amp;rft.au=Mary+Ann+Ponder&amp;rft.au=Paul+Brockman&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-p60-25"><span class="mw-cite-backlink">^ <a href="#cite_ref-p60_25-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-p60_25-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Price, <i>Indiana Legends</i>, p. 60.</span>
</li>
<li id="cite_note-PodczekJones-26"><span class="mw-cite-backlink">^ <a href="#cite_ref-PodczekJones_26-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-PodczekJones_26-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation book">Fridrun Podczeck; Brian E. Jones (2004). <i>Pharmaceutical Capsules</i>. Chicago: Pharmaceutical Press. pp. 12–13. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-0-85369-568-4" title="Special:BookSources/978-0-85369-568-4"><bdi>978-0-85369-568-4</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Pharmaceutical+Capsules&amp;rft.place=Chicago&amp;rft.pages=12-13&amp;rft.pub=Pharmaceutical+Press&amp;rft.date=2004&amp;rft.isbn=978-0-85369-568-4&amp;rft.au=Fridrun+Podczeck&amp;rft.au=Brian+E.+Jones&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-IHSHBR256-27"><span class="mw-cite-backlink">^ <a href="#cite_ref-IHSHBR256_27-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-IHSHBR256_27-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-IHSHBR256_27-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. pp. 2, 5 and 6. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.pages=2%2C+5+and+6&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-IHSHBR3-28"><span class="mw-cite-backlink">^ <a href="#cite_ref-IHSHBR3_28-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-IHSHBR3_28-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-IHSHBR3_28-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-IHSHBR3_28-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-IHSHBR3_28-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-IHSHBR3_28-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. Indiana Historical Society. p. 3. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.pages=3&amp;rft.pub=Indiana+Historical+Society&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-bb912-29"><span class="mw-cite-backlink">^ <a href="#cite_ref-bb912_29-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-bb912_29-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Bodenhamer and Barrows, eds., p. 912.</span>
</li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, pp. 17–18, 21.</span>
</li>
<li id="cite_note-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-31">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, pp. 51, 112–15.</span>
</li>
<li id="cite_note-IHSindustry3-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-IHSindustry3_32-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20130608203946/http://www.indianahistory.org/teachers-students/plan-a-field-trip/The%20Pharmaceutical%20Industry%20in%20Indiana.pdf">"The Pharmaceutical Industry in Indiana"</a> <span class="cs1-format">(PDF)</span>. Indianapolis: Indiana Historical Society. p. 3. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/teachers-students/plan-a-field-trip/The%20Pharmaceutical%20Industry%20in%20Indiana.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 8 June 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">20 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+Pharmaceutical+Industry+in+Indiana&amp;rft.place=Indianapolis&amp;rft.pages=3&amp;rft.pub=Indiana+Historical+Society&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Fteachers-students%2Fplan-a-field-trip%2FThe%2520Pharmaceutical%2520Industry%2520in%2520Indiana.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 30.</span>
</li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><cite class="citation book">Taylor;  et al. <i>Indiana: A New Historical Guide</i>. p. 481.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Indiana%3A+A+New+Historical+Guide&amp;rft.pages=481&amp;rft.au=Taylor&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-SHAARD-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-SHAARD_35-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://secure.in.gov/apps/dnr/shaard/welcome.html">"Indiana State Historic Architectural and Archaeological Research Database (SHAARD)"</a> <span class="cs1-format">(Searchable database)</span>. Department of Natural Resources, Division of Historic Preservation and Archaeology<span class="reference-accessdate">. Retrieved <span class="nowrap">1 April</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Indiana+State+Historic+Architectural+and+Archaeological+Research+Database+%28SHAARD%29&amp;rft.pub=Department+of+Natural+Resources%2C+Division+of+Historic+Preservation+and+Archaeology&amp;rft_id=https%3A%2F%2Fsecure.in.gov%2Fapps%2Fdnr%2Fshaard%2Fwelcome.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"> <i>Note:</i> This includes <cite class="citation web">Eugene F. Rodman (April 1976). <a rel="nofollow" class="external text" href="https://secure.in.gov/apps/dnr/shaard/r/1b3be/N/Lilly_Biological_Labs_Hancock_CO_Nom.pdf">"National Register of Historic Places Inventory Nomination Form: Lilly Biological Laboratories"</a> <span class="cs1-format">(PDF)</span><span class="reference-accessdate">. Retrieved <span class="nowrap">1 April</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=National+Register+of+Historic+Places+Inventory+Nomination+Form%3A+Lilly+Biological+Laboratories&amp;rft.date=1976-04&amp;rft.au=Eugene+F.+Rodman&amp;rft_id=https%3A%2F%2Fsecure.in.gov%2Fapps%2Fdnr%2Fshaard%2Fr%2F1b3be%2FN%2FLilly_Biological_Labs_Hancock_CO_Nom.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"> and Accompanying photographs.</span>
</li>
<li id="cite_note-MadisonM73-36"><span class="mw-cite-backlink">^ <a href="#cite_ref-MadisonM73_36-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MadisonM73_36-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MadisonM73_36-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text">Madison, "Manufacturing Pharmaceuticals," <i>Business and Economic History</i>, p. 73.</span>
</li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 29.</span>
</li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 46.</span>
</li>
<li id="cite_note-MadisonM74-39"><span class="mw-cite-backlink">^ <a href="#cite_ref-MadisonM74_39-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MadisonM74_39-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Madison, "Manufacturing Pharmaceuticals," <i>Business and Economic History</i>, p. 74.</span>
</li>
<li id="cite_note-MadisonM76-40"><span class="mw-cite-backlink">^ <a href="#cite_ref-MadisonM76_40-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MadisonM76_40-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MadisonM76_40-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 76.</span>
</li>
<li id="cite_note-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-41">^</a></b></span> <span class="reference-text"><cite class="citation book">Bliss, Michael (1984). <a rel="nofollow" class="external text" href="https://books.google.com/?id=7uhtHQAACAAJ"><i>The Discovery of Insulin</i></a>. University of Chicago Press. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/9780226058986" title="Special:BookSources/9780226058986"><bdi>9780226058986</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Discovery+of+Insulin&amp;rft.pub=University+of+Chicago+Press&amp;rft.date=1984&amp;rft.isbn=9780226058986&amp;rft.aulast=Bliss&amp;rft.aufirst=Michael&amp;rft_id=https%3A%2F%2Fbooks.google.com%2F%3Fid%3D7uhtHQAACAAJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><cite class="citation web">Rutty, Christopher J. <a rel="nofollow" class="external text" href="http://connaught.research.utoronto.ca/history/article3/">"Connaught Laboratories &amp; The Making of Insulin"</a>. <i>Connaught Fund</i><span class="reference-accessdate">. Retrieved <span class="nowrap">20 June</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Connaught+Fund&amp;rft.atitle=Connaught+Laboratories+%26+The+Making+of+Insulin&amp;rft.aulast=Rutty&amp;rft.aufirst=Christopher+J.&amp;rft_id=http%3A%2F%2Fconnaught.research.utoronto.ca%2Fhistory%2Farticle3%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-43">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 55–57.</span>
</li>
<li id="cite_note-Roberts-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-Roberts_44-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Roberts, Jacob (2015). <a rel="nofollow" class="external text" href="https://www.sciencehistory.org/distillations/magazine/sickening-sweet">"Sickening sweet"</a>. <i>Distillations</i>. <b>1</b> (4): 12–15<span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Distillations&amp;rft.atitle=Sickening+sweet&amp;rft.volume=1&amp;rft.issue=4&amp;rft.pages=12-15&amp;rft.date=2015&amp;rft.aulast=Roberts&amp;rft.aufirst=Jacob&amp;rft_id=https%3A%2F%2Fwww.sciencehistory.org%2Fdistillations%2Fmagazine%2Fsickening-sweet&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-MLilly61-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-MLilly61_45-0">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 61.</span>
</li>
<li id="cite_note-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-46">^</a></b></span> <span class="reference-text"><cite class="citation book">Bliss, Michael (1984). <a rel="nofollow" class="external text" href="https://books.google.com/?id=7uhtHQAACAAJ"><i>The Discovery of Insulin</i></a>. University of Chicago Press. pp. 174–175. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/9780226058986" title="Special:BookSources/9780226058986"><bdi>9780226058986</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Discovery+of+Insulin&amp;rft.pages=174-175&amp;rft.pub=University+of+Chicago+Press&amp;rft.date=1984&amp;rft.isbn=9780226058986&amp;rft.aulast=Bliss&amp;rft.aufirst=Michael&amp;rft_id=https%3A%2F%2Fbooks.google.com%2F%3Fid%3D7uhtHQAACAAJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-47">^</a></b></span> <span class="reference-text"><cite class="citation web">Hutchison, F. Lorne (18 October 1924). <a rel="nofollow" class="external text" href="https://insulin.library.utoronto.ca/islandora/object/insulin%3AW10044">"Notes on the history of the Insulin Committee's objection to Lilly's use of the term Iletin"</a>. <i>University of Toronto Libraries</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=University+of+Toronto+Libraries&amp;rft.atitle=Notes+on+the+history+of+the+Insulin+Committee%27s+objection+to+Lilly%27s+use+of+the+term+Iletin&amp;rft.date=1924-10-18&amp;rft.aulast=Hutchison&amp;rft.aufirst=F.+Lorne&amp;rft_id=https%3A%2F%2Finsulin.library.utoronto.ca%2Fislandora%2Fobject%2Finsulin%253AW10044&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://insulin.library.utoronto.ca/islandora/object/insulin%3AT10091">"Insulin wins a great prize"</a>. <i>University of Toronto Libraries</i>. New York, NY: Literary Digest. 8 December 1923.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=University+of+Toronto+Libraries&amp;rft.atitle=Insulin+wins+a+great+prize&amp;rft.date=1923-12-08&amp;rft_id=https%3A%2F%2Finsulin.library.utoronto.ca%2Fislandora%2Fobject%2Finsulin%253AT10091&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://insulin.library.utoronto.ca/islandora/object/insulin%3AA10013">"Citation to F. G. Banting and J. J. R. Macleod accompanying the Nobel Prize"</a>. <i>University of Toronto Libraries</i>. Stockholm, Sweden: Royal Karolinska Institute. 1923.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=University+of+Toronto+Libraries&amp;rft.atitle=Citation+to+F.+G.+Banting+and+J.+J.+R.+Macleod+accompanying+the+Nobel+Prize&amp;rft.date=1923&amp;rft_id=https%3A%2F%2Finsulin.library.utoronto.ca%2Fislandora%2Fobject%2Finsulin%253AA10013&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-50">^</a></b></span> <span class="reference-text"><cite class="citation book">Bliss, Michael (1984). <a rel="nofollow" class="external text" href="https://books.google.com/?id=7uhtHQAACAAJ"><i>The Discovery of Insulin</i></a>. University of Chicago Press. p. 181. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/9780226058986" title="Special:BookSources/9780226058986"><bdi>9780226058986</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Discovery+of+Insulin&amp;rft.pages=181&amp;rft.pub=University+of+Chicago+Press&amp;rft.date=1984&amp;rft.isbn=9780226058986&amp;rft.aulast=Bliss&amp;rft.aufirst=Michael&amp;rft_id=https%3A%2F%2Fbooks.google.com%2F%3Fid%3D7uhtHQAACAAJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-51">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 66–67.</span>
</li>
<li id="cite_note-MLilly67-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-MLilly67_52-0">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 67.</span>
</li>
<li id="cite_note-IHSHBR5-53"><span class="mw-cite-backlink">^ <a href="#cite_ref-IHSHBR5_53-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-IHSHBR5_53-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-IHSHBR5_53-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. Indianapolis: Indiana Historical Society. p. 5. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.place=Indianapolis&amp;rft.pages=5&amp;rft.pub=Indiana+Historical+Society&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-54">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 28–34.</span>
</li>
<li id="cite_note-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-55">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 62–65.</span>
</li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 91.</span>
</li>
<li id="cite_note-MLilly111-57"><span class="mw-cite-backlink">^ <a href="#cite_ref-MLilly111_57-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MLilly111_57-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MLilly111_57-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-MLilly111_57-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 111.</span>
</li>
<li id="cite_note-Madison,_Eli_Lilly,_p._105-58"><span class="mw-cite-backlink">^ <a href="#cite_ref-Madison,_Eli_Lilly,_p._105_58-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Madison,_Eli_Lilly,_p._105_58-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 105.</span>
</li>
<li id="cite_note-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-59">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 65 and 106.</span>
</li>
<li id="cite_note-MLilly65-60"><span class="mw-cite-backlink">^ <a href="#cite_ref-MLilly65_60-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MLilly65_60-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MLilly65_60-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation book">Madison, James H. (1989). <a rel="nofollow" class="external text" href="https://archive.org/details/elilillylife188500madi/page/65"><i>Eli Lilly: A Life, 1885–1977</i></a>. Indianapolis: Indiana Historical Society. p. <a rel="nofollow" class="external text" href="https://archive.org/details/elilillylife188500madi/page/65">65</a>. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-0-87195-047-5" title="Special:BookSources/978-0-87195-047-5"><bdi>978-0-87195-047-5</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Eli+Lilly%3A+A+Life%2C+1885%26ndash%3B1977&amp;rft.place=Indianapolis&amp;rft.pages=65&amp;rft.pub=Indiana+Historical+Society&amp;rft.date=1989&amp;rft.isbn=978-0-87195-047-5&amp;rft.aulast=Madison&amp;rft.aufirst=James+H.&amp;rft_id=https%3A%2F%2Farchive.org%2Fdetails%2Felilillylife188500madi%2Fpage%2F65&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-61">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 107–8.</span>
</li>
<li id="cite_note-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-62">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 110.</span>
</li>
<li id="cite_note-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-63">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 91, 119–20.</span>
</li>
<li id="cite_note-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-64">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 120 and 249.</span>
</li>
<li id="cite_note-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-65">^</a></b></span> <span class="reference-text">Price, <i>Indiana Legends</i>, p. 61.</span>
</li>
<li id="cite_note-IHSpolio5-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-IHSpolio5_66-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20130608203902/http://www.indianahistory.org/teachers-students/plan-a-field-trip/Polio%20and%20Lilly%20background%20essay.pdf">"Polio and Eli Lilly and Company"</a> <span class="cs1-format">(PDF)</span>. Indianapolis: Indiana Historical Society. p. 5. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/teachers-students/plan-a-field-trip/Polio%20and%20Lilly%20background%20essay.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 8 June 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">20 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Polio+and+Eli+Lilly+and+Company&amp;rft.place=Indianapolis&amp;rft.pages=5&amp;rft.pub=Indiana+Historical+Society&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Fteachers-students%2Fplan-a-field-trip%2FPolio%2520and%2520Lilly%2520background%2520essay.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-IHSpolio6-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-IHSpolio6_67-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20130608203902/http://www.indianahistory.org/teachers-students/plan-a-field-trip/Polio%20and%20Lilly%20background%20essay.pdf">"Polio and Eli Lilly and Company"</a> <span class="cs1-format">(PDF)</span>. Indianapolis: Indiana Historical Society. p. 6. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/teachers-students/plan-a-field-trip/Polio%20and%20Lilly%20background%20essay.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 8 June 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">20 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Polio+and+Eli+Lilly+and+Company&amp;rft.place=Indianapolis&amp;rft.pages=6&amp;rft.pub=Indiana+Historical+Society&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Fteachers-students%2Fplan-a-field-trip%2FPolio%2520and%2520Lilly%2520background%2520essay.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-b541-68"><span class="mw-cite-backlink">^ <a href="#cite_ref-b541_68-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-b541_68-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Bodenhamer and Barrows, p. 541.</span>
</li>
<li id="cite_note-IHSHBR6-69"><span class="mw-cite-backlink">^ <a href="#cite_ref-IHSHBR6_69-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-IHSHBR6_69-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-IHSHBR6_69-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. Indianapolis: Indiana Historical Society. p. 6. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.place=Indianapolis&amp;rft.pages=6&amp;rft.pub=Indiana+Historical+Society&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-IHSHBR7-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-IHSHBR7_70-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. p. 7. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.pages=7&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-71">^</a></b></span> <span class="reference-text"><cite class="citation news">Times, Special to the New York (14 October 1977). <a rel="nofollow" class="external text" href="https://www.nytimes.com/1977/10/14/archives/eli-lilly-signs-agreement-to-acquire-ivac-corp.html?nytmobile=0">"Eli Lilly Signs Agreement To Acquire Ivac Corp"</a>. <i>The New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">17 August</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Eli+Lilly+Signs+Agreement+To+Acquire+Ivac+Corp.&amp;rft.date=1977-10-14&amp;rft.aulast=Times&amp;rft.aufirst=Special+to+the+New+York&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F1977%2F10%2F14%2Farchives%2Feli-lilly-signs-agreement-to-acquire-ivac-corp.html%3Fnytmobile%3D0&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-72">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="http://articles.latimes.com/1997-05-16/business/fi-59266_1_dow-elanco">"Dow to Buy Lilly's 40% Stake in Dow Elanco"</a>. <i><a href="/wiki/Los_Angeles_Times" title="Los Angeles Times">Los Angeles Times</a></i>. <a href="/wiki/Reuters" title="Reuters">Reuters</a>. 16 May 1997.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Los+Angeles+Times&amp;rft.atitle=Dow+to+Buy+Lilly%27s+40%25+Stake+in+Dow+Elanco&amp;rft.date=1997-05-16&amp;rft_id=http%3A%2F%2Farticles.latimes.com%2F1997-05-16%2Fbusiness%2Ffi-59266_1_dow-elanco&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-IHSHBR8-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-IHSHBR8_73-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. p. 8. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.pages=8&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Kokomo73194-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-Kokomo73194_74-0">^</a></b></span> <span class="reference-text"><cite class="citation news">Armor, Nancy (31 July 1994). "New Lilly Chief Nurtures Change". <i>Kokomo Tribune</i>. Kokomo, IN.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Kokomo+Tribune&amp;rft.atitle=New+Lilly+Chief+Nurtures+Change&amp;rft.date=1994-07-31&amp;rft.aulast=Armor&amp;rft.aufirst=Nancy&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-KokomoTrib62893-75"><span class="mw-cite-backlink">^ <a href="#cite_ref-KokomoTrib62893_75-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-KokomoTrib62893_75-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-KokomoTrib62893_75-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">Associated Press (26 June 1993). <span class="cs1-lock-subscription" title="Paid subscription required"><a rel="nofollow" class="external text" href="https://www.newspapers.com/newspage/2578015/">"New Lilly Chief Doesn't Have Own 'Agenda<span class="cs1-kern-right">'</span>"</a></span>. <i><a href="/wiki/Kokomo_Tribune" title="Kokomo Tribune">Kokomo Tribune</a></i>. Kokomi, IN<span class="reference-accessdate">. Retrieved <span class="nowrap">27 October</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Kokomo+Tribune&amp;rft.atitle=New+Lilly+Chief+Doesn%27t+Have+Own+%27Agenda%27&amp;rft.date=1993-06-26&amp;rft.au=Associated+Press&amp;rft_id=https%3A%2F%2Fwww.newspapers.com%2Fnewspage%2F2578015%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-KokomoTrib62693-76"><span class="mw-cite-backlink"><b><a href="#cite_ref-KokomoTrib62693_76-0">^</a></b></span> <span class="reference-text"><cite class="citation news">Associated Press (26 June 1993). "Eli Lilly CEO Resigns in Dispute". <i>Kokomo Tribune</i>. Kokomi, IN.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Kokomo+Tribune&amp;rft.atitle=Eli+Lilly+CEO+Resigns+in+Dispute&amp;rft.date=1993-06-26&amp;rft.au=Associated+Press&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-IHSHBR89-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-IHSHBR89_77-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. p. 8 and 9. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.pages=8+and+9&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-78">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.nytimes.com/2006/12/19/business/19drug.html">"Lilly Increases Offer for Icos; Shareholders' Vote Is Put Off"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>. Associated Press. 19 December 2006<span class="reference-accessdate">. Retrieved <span class="nowrap">27 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Lilly+Increases+Offer+for+Icos%3B+Shareholders%27+Vote+Is+Put+Off&amp;rft.date=2006-12-19&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2006%2F12%2F19%2Fbusiness%2F19drug.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-79">^</a></b></span> <span class="reference-text"><cite class="citation news">Timmerman, Luke (13 January 2007). <a rel="nofollow" class="external text" href="http://seattletimes.nwsource.com/html/businesstechnology/2003523029_icos13.html">"Reject Icos Offer, Holders of Shares Advised"</a>. <i><a href="/wiki/The_Seattle_Times" title="The Seattle Times">The Seattle Times</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">16 January</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Seattle+Times&amp;rft.atitle=Reject+Icos+Offer%2C+Holders+of+Shares+Advised&amp;rft.date=2007-01-13&amp;rft.aulast=Timmerman&amp;rft.aufirst=Luke&amp;rft_id=http%3A%2F%2Fseattletimes.nwsource.com%2Fhtml%2Fbusinesstechnology%2F2003523029_icos13.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-TimmermanProposed-80"><span class="mw-cite-backlink">^ <a href="#cite_ref-TimmermanProposed_80-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-TimmermanProposed_80-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">Timmerman, Luke (7 November 2006). <a rel="nofollow" class="external text" href="http://community.seattletimes.nwsource.com/archive/?date=20061107&amp;slug=icos07">"Proposed Icos Sale Gets More Criticism: Payouts for Execs Called 'Overkill<span class="cs1-kern-right">'</span>"</a>. <i><a href="/wiki/The_Seattle_Times" title="The Seattle Times">The Seattle Times</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">16 January</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Seattle+Times&amp;rft.atitle=Proposed+Icos+Sale+Gets+More+Criticism%3A+Payouts+for+Execs+Called+%27Overkill%27&amp;rft.date=2006-11-07&amp;rft.aulast=Timmerman&amp;rft.aufirst=Luke&amp;rft_id=http%3A%2F%2Fcommunity.seattletimes.nwsource.com%2Farchive%2F%3Fdate%3D20061107%26slug%3Dicos07&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-81">^</a></b></span> <span class="reference-text"><cite class="citation news">James, Andrea (26 January 2007). <a rel="nofollow" class="external text" href="http://www.seattlepi.com/business/301248_icos26.html">"Icos Voters Approve Buyout by Eli Lilly"</a>. <i><a href="/wiki/Seattle_Post-Intelligencer" title="Seattle Post-Intelligencer">Seattle Post-Intelligencer</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">16 January</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Seattle+Post-Intelligencer&amp;rft.atitle=Icos+Voters+Approve+Buyout+by+Eli+Lilly&amp;rft.date=2007-01-26&amp;rft.aulast=James&amp;rft.aufirst=Andrea&amp;rft_id=http%3A%2F%2Fwww.seattlepi.com%2Fbusiness%2F301248_icos26.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-82"><span class="mw-cite-backlink"><b><a href="#cite_ref-82">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="http://seattletimes.nwsource.com/html/businesstechnology/2003547114_bizbriefs30.html">"Eli Lilly Completes Icos Takeover"</a>. <i><a href="/wiki/The_Seattle_Times" title="The Seattle Times">The Seattle Times</a></i>. 30 January 2007<span class="reference-accessdate">. Retrieved <span class="nowrap">16 January</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Seattle+Times&amp;rft.atitle=Eli+Lilly+Completes+Icos+Takeover&amp;rft.date=2007-01-30&amp;rft_id=http%3A%2F%2Fseattletimes.nwsource.com%2Fhtml%2Fbusinesstechnology%2F2003547114_bizbriefs30.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Tartakoff-83"><span class="mw-cite-backlink">^ <a href="#cite_ref-Tartakoff_83-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Tartakoff_83-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">Tartakoff, Joseph (5 December 2007). <a rel="nofollow" class="external text" href="http://www.seattlepi.com/business/342288_icos05.html">"New Owner Will Invest $50 Million in Icos Facility"</a>. <i><a href="/wiki/Seattle_Post-Intelligencer" title="Seattle Post-Intelligencer">Seattle Post-Intelligencer</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">27 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Seattle+Post-Intelligencer&amp;rft.atitle=New+Owner+Will+Invest+%2450+Million+in+Icos+Facility&amp;rft.date=2007-12-05&amp;rft.aulast=Tartakoff&amp;rft.aufirst=Joseph&amp;rft_id=http%3A%2F%2Fwww.seattlepi.com%2Fbusiness%2F342288_icos05.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-84">^</a></b></span> <span class="reference-text"><cite class="citation news">Timmerman, Luke (12 December 2006). <a rel="nofollow" class="external text" href="http://seattletimes.nwsource.com/html/businesstechnology/2003473217_icos12.html">"All Icos Workers Losing Their Jobs"</a>. <i><a href="/wiki/The_Seattle_Times" title="The Seattle Times">The Seattle Times</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">16 January</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Seattle+Times&amp;rft.atitle=All+Icos+Workers+Losing+Their+Jobs&amp;rft.date=2006-12-12&amp;rft.aulast=Timmerman&amp;rft.aufirst=Luke&amp;rft_id=http%3A%2F%2Fseattletimes.nwsource.com%2Fhtml%2Fbusinesstechnology%2F2003473217_icos12.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-85">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20110828050559/http://medheadlines.com/2009/02/eli-lilly-gets-14b-fine-for-zyprexa-off-label-marketing/">"Eli Lilly Gets $1.4B Fine for Zyprexa Off-Label Marketing"</a>. <i>medheadlines.com</i>. Archived from <a rel="nofollow" class="external text" href="http://medheadlines.com/2009/02/eli-lilly-gets-14b-fine-for-zyprexa-off-label-marketing/">the original</a> on 28 August 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">30 August</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=medheadlines.com&amp;rft.atitle=Eli+Lilly+Gets+%241.4B+Fine+for+Zyprexa+Off-Label+Marketing&amp;rft_id=http%3A%2F%2Fmedheadlines.com%2F2009%2F02%2Feli-lilly-gets-14b-fine-for-zyprexa-off-label-marketing%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-86"><span class="mw-cite-backlink"><b><a href="#cite_ref-86">^</a></b></span> <span class="reference-text"><cite class="citation news">Murphy, Tom (12 January 2011). "Lilly, Boehringer Collaborate on Diabetes Drugs". <i>Anderson Herald Bulletin</i>. Anderson, IN. p. A7.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Anderson+Herald+Bulletin&amp;rft.atitle=Lilly%2C+Boehringer+Collaborate+on+Diabetes+Drugs&amp;rft.pages=A7&amp;rft.date=2011-01-12&amp;rft.aulast=Murphy&amp;rft.aufirst=Tom&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-87">^</a></b></span> <span class="reference-text"><cite class="citation pressrelease"><a rel="nofollow" class="external text" href="https://www.prnewswire.com/news-releases/lilly-and-boehringer-ingelheim-announce-strategic-alliance-to-bring-new-diabetes-treatments-to-patients-worldwide-113263519.html">"Lilly and Boehringer Ingelheim Announce Strategic Alliance to Bring New Diabetes Treatments to Patients Worldwide"</a> (Press release). <a href="/wiki/PRNewswire" class="mw-redirect" title="PRNewswire">PRNewswire</a>. 11 January 2011.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lilly+and+Boehringer+Ingelheim+Announce+Strategic+Alliance+to+Bring+New+Diabetes+Treatments+to+Patients+Worldwide&amp;rft.pub=PRNewswire&amp;rft.date=2011-01-11&amp;rft_id=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Flilly-and-boehringer-ingelheim-announce-strategic-alliance-to-bring-new-diabetes-treatments-to-patients-worldwide-113263519.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-88"><span class="mw-cite-backlink"><b><a href="#cite_ref-88">^</a></b></span> <span class="reference-text"><cite class="citation news">Sen, Arnab (22 April 2014).  Warrier, Gopakumar (ed.). <a rel="nofollow" class="external text" href="https://www.reuters.com/article/2014/04/22/us-novartis-divestiture-eli-lilly-idUSBREA3L08020140422">"Eli Lilly to buy Novartis' animal health unit for $5.4 billion"</a>. Reuters<span class="reference-accessdate">. Retrieved <span class="nowrap">21 April</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Eli+Lilly+to+buy+Novartis%27+animal+health+unit+for+%245.4+billion&amp;rft.date=2014-04-22&amp;rft.au=Sen%2C+Arnab&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2F2014%2F04%2F22%2Fus-novartis-divestiture-eli-lilly-idUSBREA3L08020140422&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-89"><span class="mw-cite-backlink"><b><a href="#cite_ref-89">^</a></b></span> <span class="reference-text"><cite class="citation news">Bartz, Diane (22 December 2014).  Benkoe, Jeffrey; Baum, Bernadette (eds.). <a rel="nofollow" class="external text" href="https://www.reuters.com/article/2014/12/22/us-lilly-novartis-deal-idUSKBN0K01HX20141222">"Lilly must divest Sentinel products after FTC nod on Novartis deal"</a>. <a href="/wiki/Reuters" title="Reuters">Reuters</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Lilly+must+divest+Sentinel+products+after+FTC+nod+on+Novartis+deal&amp;rft.date=2014-12-22&amp;rft.aulast=Bartz&amp;rft.aufirst=Diane&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2F2014%2F12%2F22%2Fus-lilly-novartis-deal-idUSKBN0K01HX20141222&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-90">^</a></b></span> <span class="reference-text"><cite class="citation news">Staff (19 March 2015). <a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/eli-lilly-to-co-develop-hanmi-btk-inhibitor-for-up-to-690m/81251050/">"Eli Lilly to Co-Develop Hanmi BTK Inhibitor for Up-to-$690M"</a>. GEN News Highlights. <i><a href="/wiki/Mary_Ann_Liebert,_Inc." class="mw-redirect" title="Mary Ann Liebert, Inc.">Mary Ann Liebert, Inc.</a></i><span class="reference-accessdate"> Retrieved <span class="nowrap">21 April</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mary+Ann+Liebert%2C+Inc.&amp;rft.atitle=Eli+Lilly+to+Co-Develop+Hanmi+BTK+Inhibitor+for+Up-to-%24690M&amp;rft.date=2015-03-19&amp;rft.au=Staff&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Feli-lilly-to-co-develop-hanmi-btk-inhibitor-for-up-to-690m%2F81251050%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-91"><span class="mw-cite-backlink"><b><a href="#cite_ref-91">^</a></b></span> <span class="reference-text"><cite class="citation news">Staff (20 March 2015). <a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/lilly-joins-innovent-in-up-to-456m-cancer-collaboration/81251053/">"Lilly Joins Innovent in Up-to-$456M+ Cancer Collaboration"</a>. GEN News Highlights. <i><a href="/wiki/Gen._Eng._Biotechnol._News" class="mw-redirect" title="Gen. Eng. Biotechnol. News">Genetic Engineering &amp; Biotechnology News</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">21 April</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Genetic+Engineering+%26+Biotechnology+News&amp;rft.atitle=Lilly+Joins+Innovent+in+Up-to-%24456M%2B+Cancer+Collaboration&amp;rft.date=2015-03-20&amp;rft.au=Staff&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Flilly-joins-innovent-in-up-to-456m-cancer-collaboration%2F81251053%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-92"><span class="mw-cite-backlink"><b><a href="#cite_ref-92">^</a></b></span> <span class="reference-text"><cite class="citation news">Philippidis, Alex (23 March 2015). <a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/pfizer-lilly-to-resume-phase-iii-tanezumab-clinical-program/81251059/">"Pfizer, Lilly to Resume Phase III Tanezumab Clinical Program"</a>. GEN News Highlights. <i><a href="/wiki/Mary_Ann_Liebert,_Inc." class="mw-redirect" title="Mary Ann Liebert, Inc.">Mary Ann Liebert, Inc.</a></i><span class="reference-accessdate"> Retrieved <span class="nowrap">21 April</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mary+Ann+Liebert%2C+Inc.&amp;rft.atitle=Pfizer%2C+Lilly+to+Resume+Phase+III+Tanezumab+Clinical+Program&amp;rft.date=2015-03-23&amp;rft.aulast=Philippidis&amp;rft.aufirst=Alex&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fpfizer-lilly-to-resume-phase-iii-tanezumab-clinical-program%2F81251059%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-plantsale2015-93"><span class="mw-cite-backlink">^ <a href="#cite_ref-plantsale2015_93-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-plantsale2015_93-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="http://www.pharmpro.com/news/2015/04/eli-lilly-biomanufacturing-plant-sale">"Eli Lilly Biomanufacturing Plant For Sale"</a>. <i><a href="/wiki/Advantage_Business_Media" title="Advantage Business Media">Advantage Business Media</a></i>. 21 April 2015.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Advantage+Business+Media&amp;rft.atitle=Eli+Lilly+Biomanufacturing+Plant+For+Sale&amp;rft.date=2015-04-21&amp;rft_id=http%3A%2F%2Fwww.pharmpro.com%2Fnews%2F2015%2F04%2Feli-lilly-biomanufacturing-plant-sale&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-94"><span class="mw-cite-backlink"><b><a href="#cite_ref-94">^</a></b></span> <span class="reference-text"><cite class="citation pressrelease"><a rel="nofollow" class="external text" href="https://www.prnewswire.com/news-releases/elanco-animal-health-completes-acquisition-of-boehringer-ingelheim-vetmedicas-us-feline-canine-and-rabies-vaccines-portfolio-300384820.html">"Elanco Animal Health Completes Acquisition of Boehringer Ingelheim Vetmedica's U.S. Feline, Canine and Rabies Vaccines Portfolio"</a> (Press release). <a href="/wiki/PRNewswire" class="mw-redirect" title="PRNewswire">PRNewswire</a>. 3 January 2017.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Elanco+Animal+Health+Completes+Acquisition+of+Boehringer+Ingelheim+Vetmedica%27s+U.S.+Feline%2C+Canine+and+Rabies+Vaccines+Portfolio&amp;rft.pub=PRNewswire&amp;rft.date=2017-01-03&amp;rft_id=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Felanco-animal-health-completes-acquisition-of-boehringer-ingelheim-vetmedicas-us-feline-canine-and-rabies-vaccines-portfolio-300384820.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-95"><span class="mw-cite-backlink"><b><a href="#cite_ref-95">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/lilly-to-buy-colucid-for-960m-to-acquire-late-stage-migraine-drug/81253729">"Lilly to Buy CoLucid for $960M to Acquire Late-Stage Migraine Drug - GEN Genetic Engineering &amp; Biotechnology News - Biotech from Bench to Business - GEN"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lilly+to+Buy+CoLucid+for+%24960M+to+Acquire+Late-Stage+Migraine+Drug+-+GEN+Genetic+Engineering+%26+Biotechnology+News+-+Biotech+from+Bench+to+Business+-+GEN&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Flilly-to-buy-colucid-for-960m-to-acquire-late-stage-migraine-drug%2F81253729&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-96"><span class="mw-cite-backlink"><b><a href="#cite_ref-96">^</a></b></span> <span class="reference-text"><cite class="citation pressrelease"><a rel="nofollow" class="external text" href="https://www.prnewswire.com/news-releases/lilly-completes-acquisition-of-colucid-pharmaceuticals-300415941.html">"Lilly Completes Acquisition of CoLucid Pharmaceuticals"</a> (Press release). <a href="/wiki/PRNewswire" class="mw-redirect" title="PRNewswire">PRNewswire</a>. 1 March 2017.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lilly+Completes+Acquisition+of+CoLucid+Pharmaceuticals&amp;rft.pub=PRNewswire&amp;rft.date=2017-03-01&amp;rft_id=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Flilly-completes-acquisition-of-colucid-pharmaceuticals-300415941.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-97"><span class="mw-cite-backlink"><b><a href="#cite_ref-97">^</a></b></span> <span class="reference-text"><cite class="citation news">Mishra, Manas (10 May 2018). <a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-armo-biosciences-m-a/lilly-to-buy-armo-biosciences-for-16-billion-to-bolster-cancer-pipeline-idUSKBN1IB1KV">"Lilly to buy Armo Biosciences for $1.6 billion to bolster cancer..."</a> <i>Reuters</i><span class="reference-accessdate">. Retrieved <span class="nowrap">8 June</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Lilly+to+buy+Armo+Biosciences+for+%241.6+billion+to+bolster+cancer...&amp;rft.date=2018-05-10&amp;rft.aulast=Mishra&amp;rft.aufirst=Manas&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-armo-biosciences-m-a%2Flilly-to-buy-armo-biosciences-for-16-billion-to-bolster-cancer-pipeline-idUSKBN1IB1KV&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-98"><span class="mw-cite-backlink"><b><a href="#cite_ref-98">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.genengnews.com/gen-news-highlights/lilly-continues-oncology-expansion-with-plans-to-buy-aurka-pharma-for-up-to-575m/81255814">"Lilly Continues Oncology Expansion with Plans to Buy AurKa Pharma for Up to $575M - GEN"</a>. <i>GEN</i><span class="reference-accessdate">. Retrieved <span class="nowrap">8 June</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GEN&amp;rft.atitle=Lilly+Continues+Oncology+Expansion+with+Plans+to+Buy+AurKa+Pharma+for+Up+to+%24575M+-+GEN&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Flilly-continues-oncology-expansion-with-plans-to-buy-aurka-pharma-for-up-to-575m%2F81255814&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-99"><span class="mw-cite-backlink"><b><a href="#cite_ref-99">^</a></b></span> <span class="reference-text"><cite class="citation news">Editorial, Reuters (14 May 2018). <a rel="nofollow" class="external text" href="https://uk.reuters.com/article/us-aurka-pharma-m-a-lilly/lilly-to-buy-cancer-drug-developer-aurka-pharma-idUKKCN1IF1IE">"Lilly to buy cancer drug developer AurKa Pharma"</a>. <i>Reuters</i><span class="reference-accessdate">. Retrieved <span class="nowrap">8 June</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Lilly+to+buy+cancer+drug+developer+AurKa+Pharma&amp;rft.date=2018-05-14&amp;rft.aulast=Editorial&amp;rft.aufirst=Reuters&amp;rft_id=https%3A%2F%2Fuk.reuters.com%2Farticle%2Fus-aurka-pharma-m-a-lilly%2Flilly-to-buy-cancer-drug-developer-aurka-pharma-idUKKCN1IF1IE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-100"><span class="mw-cite-backlink"><b><a href="#cite_ref-100">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/-eli-lilly-buys-loxo-oncology-for-8-billion/?s=79">"Eli Lilly Deepens its Oncology Offerings with an $8 Billion Acquisition of Loxo Oncology"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+Deepens+its+Oncology+Offerings+with+an+%248+Billion+Acquisition+of+Loxo+Oncology&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2F-eli-lilly-buys-loxo-oncology-for-8-billion%2F%3Fs%3D79&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-101"><span class="mw-cite-backlink"><b><a href="#cite_ref-101">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/releases/lilly-announces-agreement-to-acquire-loxo-oncology/?s=79">"Lilly Announces Agreement to Acquire Loxo Oncology"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lilly+Announces+Agreement+to+Acquire+Loxo+Oncology&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Freleases%2Flilly-announces-agreement-to-acquire-loxo-oncology%2F%3Fs%3D79&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-102"><span class="mw-cite-backlink"><b><a href="#cite_ref-102">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-bayer-divestiture-elanco-animal/elanco-to-buy-bayers-animal-health-unit-for-7-6-billion-idUSKCN1VA0UI">"Elanco to buy Bayer's animal health unit for $7.6 billion"</a>. Reuters.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Elanco+to+buy+Bayer%27s+animal+health+unit+for+%247.6+billion&amp;rft.pub=Reuters&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-bayer-divestiture-elanco-animal%2Felanco-to-buy-bayers-animal-health-unit-for-7-6-billion-idUSKCN1VA0UI&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-103"><span class="mw-cite-backlink"><b><a href="#cite_ref-103">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="https://uk.reuters.com/article/uk-bayer-divestiture-elanco-animal/elanco-to-become-no-2-in-animal-health-with-7-6-billion-bayer-deal-idUKKCN1VA0UE">https://uk.reuters.com/article/uk-bayer-divestiture-elanco-animal/elanco-to-become-no-2-in-animal-health-with-7-6-billion-bayer-deal-idUKKCN1VA0UE</a></span>
</li>
<li id="cite_note-104"><span class="mw-cite-backlink"><b><a href="#cite_ref-104">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="https://www.biospace.com/article/eli-lilly-bags-dermatology-company-dermira-for-1-1-billion/?s=79">https://www.biospace.com/article/eli-lilly-bags-dermatology-company-dermira-for-1-1-billion/?s=79</a></span>
</li>
<li id="cite_note-105"><span class="mw-cite-backlink"><b><a href="#cite_ref-105">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="https://www.biospace.com/article/releases/lilly-announces-agreement-to-acquire-dermira/?s=79">https://www.biospace.com/article/releases/lilly-announces-agreement-to-acquire-dermira/?s=79</a></span>
</li>
<li id="cite_note-106"><span class="mw-cite-backlink"><b><a href="#cite_ref-106">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/lilly-completes-acquisition-of-dermira/">"Lilly Completes Acquisition of Dermira"</a>. <i>BioSpace</i><span class="reference-accessdate">. Retrieved <span class="nowrap">3 March</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Lilly+Completes+Acquisition+of+Dermira&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Flilly-completes-acquisition-of-dermira%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-107"><span class="mw-cite-backlink"><b><a href="#cite_ref-107">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://lilly.mediaroom.com/index.php?s=9042&amp;item=11942">"Lilly Announces Completion of Hypnion Acquisition"</a>. <a href="/wiki/PRNewswire" class="mw-redirect" title="PRNewswire">PRNewswire</a>. 3 April 2007.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lilly+Announces+Completion+of+Hypnion+Acquisition&amp;rft.pub=PRNewswire&amp;rft.date=2007-04-03&amp;rft_id=http%3A%2F%2Flilly.mediaroom.com%2Findex.php%3Fs%3D9042%26item%3D11942&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-108"><span class="mw-cite-backlink"><b><a href="#cite_ref-108">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://lilly.mediaroom.com/index.php?s=9042&amp;item=11805">"Lilly to Acquire ImClone Systems in $6.5 Billion Transaction"</a>. <a href="/wiki/PRNewswire" class="mw-redirect" title="PRNewswire">PRNewswire</a>. 6 October 2008.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lilly+to+Acquire+ImClone+Systems+in+%246.5+Billion+Transaction&amp;rft.pub=PRNewswire&amp;rft.date=2008-10-06&amp;rft_id=http%3A%2F%2Flilly.mediaroom.com%2Findex.php%3Fs%3D9042%26item%3D11805&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-109"><span class="mw-cite-backlink"><b><a href="#cite_ref-109">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://lilly.mediaroom.com/index.php?s=9042&amp;item=118134">"Lilly to Acquire SGX Pharmaceuticals"</a>. <a href="/wiki/PRNewswire" class="mw-redirect" title="PRNewswire">PRNewswire</a>. 8 July 2008.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lilly+to+Acquire+SGX+Pharmaceuticals&amp;rft.pub=PRNewswire&amp;rft.date=2008-07-08&amp;rft_id=http%3A%2F%2Flilly.mediaroom.com%2Findex.php%3Fs%3D9042%26item%3D118134&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-110"><span class="mw-cite-backlink"><b><a href="#cite_ref-110">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://lilly.mediaroom.com/index.php?s=9042&amp;item=17977">"Lilly to Acquire Avid Radiopharmaceuticals"</a>. <a href="/wiki/PRNewswire" class="mw-redirect" title="PRNewswire">PRNewswire</a>. 8 November 2010.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lilly+to+Acquire+Avid+Radiopharmaceuticals&amp;rft.pub=PRNewswire&amp;rft.date=2010-11-08&amp;rft_id=http%3A%2F%2Flilly.mediaroom.com%2Findex.php%3Fs%3D9042%26item%3D17977&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-111"><span class="mw-cite-backlink"><b><a href="#cite_ref-111">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://lilly.mediaroom.com/index.php?s=9042&amp;item=6056">"Lilly to Acquire Alnara Pharmaceuticals"</a>. <a href="/wiki/PRNewswire" class="mw-redirect" title="PRNewswire">PRNewswire</a>. 2 July 2010.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lilly+to+Acquire+Alnara+Pharmaceuticals&amp;rft.pub=PRNewswire&amp;rft.date=2010-07-02&amp;rft_id=http%3A%2F%2Flilly.mediaroom.com%2Findex.php%3Fs%3D9042%26item%3D6056&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-112"><span class="mw-cite-backlink"><b><a href="#cite_ref-112">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://lilly.mediaroom.com/index.php?s=9042&amp;item=12328">"Eli Lilly and Company Announces Acquisition of Ivy Animal Health"</a>. <a href="/wiki/PRNewswire" class="mw-redirect" title="PRNewswire">PRNewswire</a>. 25 May 2007.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+and+Company+Announces+Acquisition+of+Ivy+Animal+Health&amp;rft.pub=PRNewswire&amp;rft.date=2007-05-25&amp;rft_id=http%3A%2F%2Flilly.mediaroom.com%2Findex.php%3Fs%3D9042%26item%3D12328&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-113"><span class="mw-cite-backlink"><b><a href="#cite_ref-113">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://lilly.mediaroom.com/index.php?s=9042&amp;item=6125">"Lilly to Acquire European Rights to Pfizer Animal Health Assets"</a>. <a href="/wiki/PRNewswire" class="mw-redirect" title="PRNewswire">PRNewswire</a>. 8 March 2010.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lilly+to+Acquire+European+Rights+to+Pfizer+Animal+Health+Assets&amp;rft.pub=PRNewswire&amp;rft.date=2010-03-08&amp;rft_id=http%3A%2F%2Flilly.mediaroom.com%2Findex.php%3Fs%3D9042%26item%3D6125&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-114"><span class="mw-cite-backlink"><b><a href="#cite_ref-114">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://lilly.mediaroom.com/index.php?s=9042&amp;item=30256">"Lilly Makes an Irrevocable Offer to Acquire Janssen Animal Health"</a>. <a href="/wiki/PRNewswire" class="mw-redirect" title="PRNewswire">PRNewswire</a>. 14 March 2011.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lilly+Makes+an+Irrevocable+Offer+to+Acquire+Janssen+Animal+Health&amp;rft.pub=PRNewswire&amp;rft.date=2011-03-14&amp;rft_id=http%3A%2F%2Flilly.mediaroom.com%2Findex.php%3Fs%3D9042%26item%3D30256&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-115"><span class="mw-cite-backlink"><b><a href="#cite_ref-115">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://lilly.mediaroom.com/index.php?s=9042&amp;item=111145">"Elanco Animal Health Announces Lilly's Agreement to Acquire ChemGen Corp"</a>. <a href="/wiki/PRNewswire" class="mw-redirect" title="PRNewswire">PRNewswire</a>. 24 January 2012.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Elanco+Animal+Health+Announces+Lilly%27s+Agreement+to+Acquire+ChemGen+Corp.&amp;rft.pub=PRNewswire&amp;rft.date=2012-01-24&amp;rft_id=http%3A%2F%2Flilly.mediaroom.com%2Findex.php%3Fs%3D9042%26item%3D111145&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-116"><span class="mw-cite-backlink"><b><a href="#cite_ref-116">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://lilly.mediaroom.com/index.php?s=9042&amp;item=137283">"Elanco Announces Agreement to Acquire Lohmann Animal Health"</a>. <a href="/wiki/PRNewswire" class="mw-redirect" title="PRNewswire">PRNewswire</a>. 24 February 2014.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Elanco+Announces+Agreement+to+Acquire+Lohmann+Animal+Health&amp;rft.pub=PRNewswire&amp;rft.date=2014-02-24&amp;rft_id=http%3A%2F%2Flilly.mediaroom.com%2Findex.php%3Fs%3D9042%26item%3D137283&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-IHSHBR12-117"><span class="mw-cite-backlink"><b><a href="#cite_ref-IHSHBR12_117-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. p. 1 and 2. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.pages=1+and+2&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-118"><span class="mw-cite-backlink"><b><a href="#cite_ref-118">^</a></b></span> <span class="reference-text">Eberhardt and Evans were <a href="/wiki/Purdue_University" title="Purdue University">Purdue University</a> graduates. See <cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. p. 2. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.pages=2&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-119"><span class="mw-cite-backlink"><b><a href="#cite_ref-119">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 53.</span>
</li>
<li id="cite_note-MLilly55-120"><span class="mw-cite-backlink">^ <a href="#cite_ref-MLilly55_120-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MLilly55_120-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 55.</span>
</li>
<li id="cite_note-121"><span class="mw-cite-backlink"><b><a href="#cite_ref-121">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 63.</span>
</li>
<li id="cite_note-IHSHBR4-122"><span class="mw-cite-backlink"><b><a href="#cite_ref-IHSHBR4_122-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. p. 4. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.pages=4&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608">.</span>
</li>
<li id="cite_note-123"><span class="mw-cite-backlink"><b><a href="#cite_ref-123">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genedata.com/alliances.html">"Alliances"</a>. Basel, Switzerland: Genedata<span class="reference-accessdate">. Retrieved <span class="nowrap">27 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Alliances&amp;rft.place=Basel%2C+Switzerland&amp;rft.pub=Genedata&amp;rft_id=http%3A%2F%2Fwww.genedata.com%2Falliances.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"><sup class="noprint Inline-Template"><span style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Link_rot" title="Wikipedia:Link rot"><span title=" Dead link since September 2017">permanent dead link</span></a></i>]</span></sup></span>
</li>
<li id="cite_note-Consortium-124"><span class="mw-cite-backlink">^ <a href="#cite_ref-Consortium_124-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Consortium_124-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://archive.today/20130411003210/http://www.genedata.com/index.php?id=211&amp;L=0&amp;tx_ttnews%5BpS%5D=1259741735&amp;tx_ttnews%5Btt_news%5D=22&amp;cHash=139a0c79812ccfccf9dbf2a79a1001ab">"InnoMed PredTox Consortium Members Present Preliminary Study Results"</a>. Basel, Switzerland: Genedata. 15 May 2008. Archived from <a rel="nofollow" class="external text" href="http://www.genedata.com/index.php?id=211&amp;L=0&amp;tx_ttnews%5bpS%5d=1259741735&amp;tx_ttnews%5btt_news%5d=22&amp;cHash=139a0c79812ccfccf9dbf2a79a1001ab">the original</a> on 11 April 2013.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=InnoMed+PredTox+Consortium+Members+Present+Preliminary+Study+Results&amp;rft.place=Basel%2C+Switzerland&amp;rft.pub=Genedata&amp;rft.date=2008-05-15&amp;rft_id=http%3A%2F%2Fwww.genedata.com%2Findex.php%3Fid%3D211%26L%3D0%26tx_ttnews%255bpS%255d%3D1259741735%26tx_ttnews%255btt_news%255d%3D22%26cHash%3D139a0c79812ccfccf9dbf2a79a1001ab&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-125"><span class="mw-cite-backlink"><b><a href="#cite_ref-125">^</a></b></span> <span class="reference-text"><cite class="citation book">Mattes, William B. (2008). "Public Consortium Efforts in Toxicogenomics".  In Mendrick, Donna L.; Mattes, William B. (eds.). <i>Essential Concepts in Toxicogenomics</i>. <a href="/wiki/Methods_in_Molecular_Biology" title="Methods in Molecular Biology">Methods in Molecular Biology</a>. <b>460</b>. pp. 221–238. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2F978-1-60327-048-9_11">10.1007/978-1-60327-048-9_11</a>. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-1-58829-638-2" title="Special:BookSources/978-1-58829-638-2"><bdi>978-1-58829-638-2</bdi></a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18449490">18449490</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Public+Consortium+Efforts+in+Toxicogenomics&amp;rft.btitle=Essential+Concepts+in+Toxicogenomics&amp;rft.series=Methods+in+Molecular+Biology&amp;rft.pages=221-238&amp;rft.date=2008&amp;rft_id=info%3Apmid%2F18449490&amp;rft_id=info%3Adoi%2F10.1007%2F978-1-60327-048-9_11&amp;rft.isbn=978-1-58829-638-2&amp;rft.aulast=Mattes&amp;rft.aufirst=William+B.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-InnoMed_PredTox_official_project_website-126"><span class="mw-cite-backlink"><b><a href="#cite_ref-InnoMed_PredTox_official_project_website_126-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20080926214522/http://www.innomed-predtox.com/consortium/members/">"InnoMed PredTox Member Organizations"</a>. Archived from <a rel="nofollow" class="external text" href="http://www.innomed-predtox.com/consortium/members/">the original</a> on 26 September 2008<span class="reference-accessdate">. Retrieved <span class="nowrap">2008-08-25</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=InnoMed+PredTox+Member+Organizations&amp;rft_id=http%3A%2F%2Fwww.innomed-predtox.com%2Fconsortium%2Fmembers%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-127"><span class="mw-cite-backlink"><b><a href="#cite_ref-127">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.imi.europa.eu/content/home#&amp;panel1-1">"The Innovative Medicines Initiative"</a>. Innovative Medicines Initiative<span class="reference-accessdate">. Retrieved <span class="nowrap">27 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+Innovative+Medicines+Initiative&amp;rft.pub=Innovative+Medicines+Initiative&amp;rft_id=http%3A%2F%2Fwww.imi.europa.eu%2Fcontent%2Fhome%23%26panel1-1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-128"><span class="mw-cite-backlink"><b><a href="#cite_ref-128">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20130121005243/http://www.imi.europa.eu/content/1st-call-2008">"IMI 1st Call 2008"</a>. Innovative Medicines Initiative. Archived from <a rel="nofollow" class="external text" href="http://www.imi.europa.eu/content/1st-call-2008">the original</a> on 21 January 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">27 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=IMI+1st+Call+2008&amp;rft.pub=Innovative+Medicines+Initiative&amp;rft_id=http%3A%2F%2Fwww.imi.europa.eu%2Fcontent%2F1st-call-2008&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-IMI_Call_Topics_2008-129"><span class="mw-cite-backlink"><b><a href="#cite_ref-IMI_Call_Topics_2008_129-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Innovative Medicines Initiative. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20091015122459/http://imi.europa.eu/docs/calls01_en.zip">"IMI Call Topics 2008"</a>. <i>IMI-GB-018v2-24042008-CallTopics.pdf</i>. European Commission. Archived from <a rel="nofollow" class="external text" href="http://imi.europa.eu/docs/calls01_en.zip">the original</a> on 15 October 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">25 August</span> 2008</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=IMI-GB-018v2-24042008-CallTopics.pdf&amp;rft.atitle=IMI+Call+Topics+2008&amp;rft.au=Innovative+Medicines+Initiative&amp;rft_id=http%3A%2F%2Fimi.europa.eu%2Fdocs%2Fcalls01_en.zip&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-130"><span class="mw-cite-backlink"><b><a href="#cite_ref-130">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 105–6.</span>
</li>
<li id="cite_note-131"><span class="mw-cite-backlink"><b><a href="#cite_ref-131">^</a></b></span> <span class="reference-text">With its television advertisement for Cialis during the <a href="/wiki/Super_Bowl_XXXVIII" title="Super Bowl XXXVIII">2004 Super Bowl Halftime Show</a>, Eli Lilly was one of several companies whose costly 2004 <a href="/wiki/Super_Bowl" title="Super Bowl">Super Bowl</a> Halftime advertisements were largely overshadowed by the <a href="/wiki/Janet_Jackson" title="Janet Jackson">Janet Jackson</a> and <a href="/wiki/Justin_Timberlake" title="Justin Timberlake">Justin Timberlake</a> <a href="/wiki/Super_Bowl_XXXVIII_halftime_show_controversy" title="Super Bowl XXXVIII halftime show controversy">Super Bowl XXXVIII halftime show controversy</a>.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (July 2018)">citation needed</span></a></i>]</sup></span>
</li>
<li id="cite_note-132"><span class="mw-cite-backlink"><b><a href="#cite_ref-132">^</a></b></span> <span class="reference-text"><cite class="citation book">Current, John D. <a rel="nofollow" class="external text" href="https://books.google.com/books?id=_Du2bfrO9FwC&amp;pg=PA386"><i>Pharmacology for Anesthetists:Anesthetics and Adjuvants</i></a><span class="reference-accessdate">. Retrieved <span class="nowrap">19 July</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Pharmacology+for+Anesthetists%3AAnesthetics+and+Adjuvants&amp;rft.aulast=Current&amp;rft.aufirst=John+D.&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D_Du2bfrO9FwC%26pg%3DPA386&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-133"><span class="mw-cite-backlink"><b><a href="#cite_ref-133">^</a></b></span> <span class="reference-text"><cite class="citation news">Wilson, Duff (2 October 2010). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2010/10/03/business/03psych.html?pagewanted=all">"Side Effects May Include Lawsuits"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Side+Effects+May+Include+Lawsuits&amp;rft.date=2010-10-02&amp;rft.aulast=Wilson&amp;rft.aufirst=Duff&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2010%2F10%2F03%2Fbusiness%2F03psych.html%3Fpagewanted%3Dall&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-MLilly112-134"><span class="mw-cite-backlink"><b><a href="#cite_ref-MLilly112_134-0">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 112.</span>
</li>
<li id="cite_note-135"><span class="mw-cite-backlink"><b><a href="#cite_ref-135">^</a></b></span> <span class="reference-text"><cite class="citation news">Associated Press (29 March 1977). "Lilly Director Dies in Hawaii". <i>Anderson Herald</i>. Anderson, IN.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Anderson+Herald&amp;rft.atitle=Lilly+Director+Dies+in+Hawaii&amp;rft.date=1977-03-29&amp;rft.au=Associated+Press&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-136"><span class="mw-cite-backlink"><b><a href="#cite_ref-136">^</a></b></span> <span class="reference-text"><cite class="citation news">Associated Press (18 September 1991). "Lilly Move No Big Surprise". <i>Kokomo Tribune</i>. Kokomi, IN.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Kokomo+Tribune&amp;rft.atitle=Lilly+Move+No+Big+Surprise&amp;rft.date=1991-09-18&amp;rft.au=Associated+Press&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-137"><span class="mw-cite-backlink"><b><a href="#cite_ref-137">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.gpo.gov/fdsys/pkg/CREC-2006-03-29/pdf/CREC-2006-03-29-pt1-PgS2546-3.pdf">"Congressional Record, March 29, 2006, S2546"</a> <span class="cs1-format">(PDF)</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Congressional+Record%2C+March+29%2C+2006%2C+S2546&amp;rft_id=http%3A%2F%2Fwww.gpo.gov%2Ffdsys%2Fpkg%2FCREC-2006-03-29%2Fpdf%2FCREC-2006-03-29-pt1-PgS2546-3.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-IHSHBR9-138"><span class="mw-cite-backlink"><b><a href="#cite_ref-IHSHBR9_138-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. p. 9. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.pages=9&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-TaurelRetires-139"><span class="mw-cite-backlink"><b><a href="#cite_ref-TaurelRetires_139-0">^</a></b></span> <span class="reference-text"><cite class="citation news">Associated Press (19 December 2007). "Lechleiter Named Lilly CEO". <i>Kokomo Tribune</i>. Kokomo, IN. p. A7.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Kokomo+Tribune&amp;rft.atitle=Lechleiter+Named+Lilly+CEO&amp;rft.pages=A7&amp;rft.date=2007-12-19&amp;rft.au=Associated+Press&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-140"><span class="mw-cite-backlink"><b><a href="#cite_ref-140">^</a></b></span> <span class="reference-text"><cite class="citation news">Armstrong, Drew; Koons, Cynthia (27 July 2016). <a rel="nofollow" class="external text" href="https://www.bloomberg.com/news/articles/2016-07-27/lilly-ceo-lechleiter-to-retire-will-be-replaced-by-david-ricks">"Lilly Turns From One Company Veteran to Another for New CEO"</a>. <i>Bloomberg</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg&amp;rft.atitle=Lilly+Turns+From+One+Company+Veteran+to+Another+for+New+CEO&amp;rft.date=2016-07-27&amp;rft.aulast=Armstrong&amp;rft.aufirst=Drew&amp;rft.au=Koons%2C+Cynthia&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2016-07-27%2Flilly-ceo-lechleiter-to-retire-will-be-replaced-by-david-ricks&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-WorkingMother-141"><span class="mw-cite-backlink"><b><a href="#cite_ref-WorkingMother_141-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">"Working Mother Report: Meet the 2012 100 Best Companies". <i>Working Mother</i>. New York: Bonnier Working Mother Media Inc. <b>35</b> (6): 46. October–November 2012.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Working+Mother&amp;rft.atitle=Working+Mother+Report%3A+Meet+the+2012+100+Best+Companies&amp;rft.volume=35&amp;rft.issue=6&amp;rft.pages=46&amp;rft.date=2012-10%2F2012-11&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-142"><span class="mw-cite-backlink"><b><a href="#cite_ref-142">^</a></b></span> <span class="reference-text">The company was named one of the top 10 best companies for working mothers in 2004 by <i>Working Mothers</i> magazine.</span>
</li>
<li id="cite_note-143"><span class="mw-cite-backlink"><b><a href="#cite_ref-143">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.lilly.com/lilly-among-the-2018-worlds-most-ethical-companies">"Lilly Among the 2018 World's Most Ethical Companies"</a>. <i>Lilly.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">8 June</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Lilly.com&amp;rft.atitle=Lilly+Among+the+2018+World%27s+Most+Ethical+Companies&amp;rft_id=https%3A%2F%2Fwww.lilly.com%2Flilly-among-the-2018-worlds-most-ethical-companies&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-b399-144"><span class="mw-cite-backlink"><b><a href="#cite_ref-b399_144-0">^</a></b></span> <span class="reference-text">Bodenhamer and Barrows, eds., p. 399.</span>
</li>
<li id="cite_note-145"><span class="mw-cite-backlink"><b><a href="#cite_ref-145">^</a></b></span> <span class="reference-text">Bodenhamer and Barrows, eds., pp. 402–03, 911–12, and 560–61.</span>
</li>
<li id="cite_note-b91012-146"><span class="mw-cite-backlink"><b><a href="#cite_ref-b91012_146-0">^</a></b></span> <span class="reference-text">Bodenhamer and Barrows, eds., pp. 910–12.</span>
</li>
<li id="cite_note-MLilly20506-147"><span class="mw-cite-backlink"><b><a href="#cite_ref-MLilly20506_147-0">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 205–6.</span>
</li>
<li id="cite_note-148"><span class="mw-cite-backlink"><b><a href="#cite_ref-148">^</a></b></span> <span class="reference-text"><cite class="citation web">Meek, Heather. <a rel="nofollow" class="external text" href="http://learningtogive.org/papers/paper108.html">"Lilly, Eli"</a>. LearningToGive.org and the Center on Philanthropy at Indiana University<span class="reference-accessdate">. Retrieved <span class="nowrap">20 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lilly%2C+Eli&amp;rft.pub=LearningToGive.org+and+the+Center+on+Philanthropy+at+Indiana+University&amp;rft.aulast=Meek&amp;rft.aufirst=Heather&amp;rft_id=http%3A%2F%2Flearningtogive.org%2Fpapers%2Fpaper108.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-149"><span class="mw-cite-backlink"><b><a href="#cite_ref-149">^</a></b></span> <span class="reference-text"><cite class="citation journal">Vitiello, B; Silva, SG; Rohde, P; Kratochvil, CJ; Kennard, BD; Reinecke, MA; Mayes, TL; Posner, K; May, DE; March, JS (2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2702701">"Suicidal events in the Treatment for Adolescents With Depression Study (TADS)"</a>. <i>J Clin Psychiatry</i>. <b>70</b> (5): 741–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.4088%2FJCP.08m04607">10.4088/JCP.08m04607</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2702701">2702701</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19552869">19552869</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.atitle=Suicidal+events+in+the+Treatment+for+Adolescents+With+Depression+Study+%28TADS%29&amp;rft.volume=70&amp;rft.issue=5&amp;rft.pages=741-7&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2702701&amp;rft_id=info%3Apmid%2F19552869&amp;rft_id=info%3Adoi%2F10.4088%2FJCP.08m04607&amp;rft.aulast=Vitiello&amp;rft.aufirst=B&amp;rft.au=Silva%2C+SG&amp;rft.au=Rohde%2C+P&amp;rft.au=Kratochvil%2C+CJ&amp;rft.au=Kennard%2C+BD&amp;rft.au=Reinecke%2C+MA&amp;rft.au=Mayes%2C+TL&amp;rft.au=Posner%2C+K&amp;rft.au=May%2C+DE&amp;rft.au=March%2C+JS&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2702701&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-150"><span class="mw-cite-backlink"><b><a href="#cite_ref-150">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://undark.org/article/wilo-lenzer-danger-within-us/">"When the Cure Is the Cause: The Case of the Green Hairy Tongue"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">8 June</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=When+the+Cure+Is+the+Cause%3A+The+Case+of+the+Green+Hairy+Tongue&amp;rft_id=https%3A%2F%2Fundark.org%2Farticle%2Fwilo-lenzer-danger-within-us%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-151"><span class="mw-cite-backlink"><b><a href="#cite_ref-151">^</a></b></span> <span class="reference-text"><cite class="citation web">MarketWatch, CBS. <a rel="nofollow" class="external text" href="https://www.marketwatch.com/story/fda-reportedly-reviewing-eli-lilly-prozac-papers">"Eli Lilly in Prozac controversy"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">8 June</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+in+Prozac+controversy&amp;rft.aulast=MarketWatch&amp;rft.aufirst=CBS&amp;rft_id=https%3A%2F%2Fwww.marketwatch.com%2Fstory%2Ffda-reportedly-reviewing-eli-lilly-prozac-papers&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-152"><span class="mw-cite-backlink"><b><a href="#cite_ref-152">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://ahrp.org/eli-lilly-prozac-documents-what-do-they-reveal/">"Eli Lilly Prozac Documents: What do They Reveal? - AHRP"</a>. 26 October 2006<span class="reference-accessdate">. Retrieved <span class="nowrap">8 June</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+Prozac+Documents%3A+What+do+They+Reveal%3F+-+AHRP&amp;rft.date=2006-10-26&amp;rft_id=http%3A%2F%2Fahrp.org%2Feli-lilly-prozac-documents-what-do-they-reveal%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-153"><span class="mw-cite-backlink"><b><a href="#cite_ref-153">^</a></b></span> <span class="reference-text"><cite class="citation web">Stastna, Kazi (13 September 2013). <a rel="nofollow" class="external text" href="http://www.cbc.ca/news/business/eli-lilly-files-500m-nafta-suit-against-canada-over-drug-patents-1.1829854">"Eli Lilly files $500M NAFTA suit against Canada over drug patents"</a>. CBC<span class="reference-accessdate">. Retrieved <span class="nowrap">1 April</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+files+%24500M+NAFTA+suit+against+Canada+over+drug+patents&amp;rft.pub=CBC&amp;rft.date=2013-09-13&amp;rft.au=Stastna%2C+Kazi&amp;rft_id=http%3A%2F%2Fwww.cbc.ca%2Fnews%2Fbusiness%2Feli-lilly-files-500m-nafta-suit-against-canada-over-drug-patents-1.1829854&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-usdoj-2009-154"><span class="mw-cite-backlink"><b><a href="#cite_ref-usdoj-2009_154-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.justice.gov/opa/pr/2009/January/09-civ-038.html">"Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-label Promotion of Zyprexa"</a>. <i>09-civ-038</i>. United States Department of Justice. 15 January 2009.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=09-civ-038&amp;rft.atitle=Eli+Lilly+and+Company+Agrees+to+Pay+%241.415+Billion+to+Resolve+Allegations+of+Off-label+Promotion+of+Zyprexa&amp;rft.date=2009-01-15&amp;rft_id=http%3A%2F%2Fwww.justice.gov%2Fopa%2Fpr%2F2009%2FJanuary%2F09-civ-038.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-155"><span class="mw-cite-backlink"><b><a href="#cite_ref-155">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20121017203119/http://www.justice.gov/usao/pae/News/Pr/2009/jan/lillyrelease.pdf">"Pharmaceutical Company Eli Lilly to Pay Record $1.415 Billion for Off-Label Drug Marketing"</a> <span class="cs1-format">(PDF)</span>. <i>United States Attorney, Eastern District of Pennsylvania</i>. United States Department of Justice. 15 January 2009. Archived from <a rel="nofollow" class="external text" href="https://www.justice.gov/usao/pae/News/Pr/2009/jan/lillyrelease.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 17 October 2012.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=United+States+Attorney%2C+Eastern+District+of+Pennsylvania&amp;rft.atitle=Pharmaceutical+Company+Eli+Lilly+to+Pay+Record+%241.415+Billion+for+Off-Label+Drug+Marketing&amp;rft.date=2009-01-15&amp;rft_id=http%3A%2F%2Fwww.justice.gov%2Fusao%2Fpae%2FNews%2FPr%2F2009%2Fjan%2Flillyrelease.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-156"><span class="mw-cite-backlink"><b><a href="#cite_ref-156">^</a></b></span> <span class="reference-text"><cite class="citation news">Wilson, Duff (2 October 2010). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2010/10/03/business/03psych.html">"Side Effects May Include Lawsuits"</a>. <i>The New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">23 September</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Side+Effects+May+Include+Lawsuits&amp;rft.date=2010-10-02&amp;rft.au=Wilson%2C+Duff&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2010%2F10%2F03%2Fbusiness%2F03psych.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Berenson-157"><span class="mw-cite-backlink"><b><a href="#cite_ref-Berenson_157-0">^</a></b></span> <span class="reference-text"><cite class="citation news">Berenson, Alex (15 March 2008). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2008/03/15/business/15drug.html?ref=johnclechleiter&amp;_r=0">"Eli Lilly E-Mail Discussed Unapproved Use of Drug"</a>. <i>The New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">24 August</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Eli+Lilly+E-Mail+Discussed+Unapproved+Use+of+Drug&amp;rft.date=2008-03-15&amp;rft.aulast=Berenson&amp;rft.aufirst=Alex&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2008%2F03%2F15%2Fbusiness%2F15drug.html%3Fref%3Djohnclechleiter%26_r%3D0&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-158"><span class="mw-cite-backlink"><b><a href="#cite_ref-158">^</a></b></span> <span class="reference-text"><cite class="citation news">Abutaleb, Yasmeen (30 January 2019). <a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-usa-healthcare-insulin/u-s-lawmakers-request-info-from-insulin-makers-on-rising-prices-idUSKCN1PO2LQ">"U.S. lawmakers request info from insulin makers on rising prices"</a>. Reuters<span class="reference-accessdate">. Retrieved <span class="nowrap">1 February</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=U.S.+lawmakers+request+info+from+insulin+makers+on+rising+prices&amp;rft.date=2019-01-30&amp;rft.au=Abutaleb%2C+Yasmeen&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-usa-healthcare-insulin%2Fu-s-lawmakers-request-info-from-insulin-makers-on-rising-prices-idUSKCN1PO2LQ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
</ol></div>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(9)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Bibliography">Bibliography</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=33" title="Edit section: Bibliography" data-section="33" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-9 collapsible-block" id="mf-section-9">
<ul><li><cite class="citation book">Bodenhamer, David J., and Robert G. Barrows, eds. (1994). <i>The Encyclopedia of Indianapolis</i>. Bloomington and Indianapolis: Indiana University Press. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-0-253-31222-8" title="Special:BookSources/978-0-253-31222-8"><bdi>978-0-253-31222-8</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Encyclopedia+of+Indianapolis&amp;rft.place=Bloomington+and+Indianapolis&amp;rft.pub=Indiana+University+Press&amp;rft.date=1994&amp;rft.isbn=978-0-253-31222-8&amp;rft.au=Bodenhamer%2C+David+J.%2C+and+Robert+G.+Barrows%2C+eds.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (<a href="/wiki/Category:CS1_maint:_multiple_names:_authors_list" title="Category:CS1 maint: multiple names: authors list">link</a>) CS1 maint: extra text: authors list (<a href="/wiki/Category:CS1_maint:_extra_text:_authors_list" title="Category:CS1 maint: extra text: authors list">link</a>)</span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></li>
<li><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. Indiana Historical Society. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">24 October</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.pub=Indiana+Historical+Society&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></li>
<li><cite class="citation book">Kahn, E. J. (1975). <i>All In A Century: The First 100 Years of Eli Lilly and Company</i>. West Cornwall, CT. <a href="/wiki/OCLC" title="OCLC">OCLC</a> <a rel="nofollow" class="external text" href="//www.worldcat.org/oclc/5288809">5288809</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=All+In+A+Century%3A+The+First+100+Years+of+Eli+Lilly+and+Company&amp;rft.place=West+Cornwall%2C+CT&amp;rft.date=1975&amp;rft_id=info%3Aoclcnum%2F5288809&amp;rft.au=Kahn%2C+E.+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></li>
<li><cite class="citation book">Madison, James H. (1989). <a rel="nofollow" class="external text" href="https://archive.org/details/elilillylife188500madi"><i>Eli Lilly: A Life, 1885–1977</i></a>. Indianapolis: Indiana Historical Society. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-0-87195-047-5" title="Special:BookSources/978-0-87195-047-5"><bdi>978-0-87195-047-5</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Eli+Lilly%3A+A+Life%2C+1885%26ndash%3B1977&amp;rft.place=Indianapolis&amp;rft.pub=Indiana+Historical+Society&amp;rft.date=1989&amp;rft.isbn=978-0-87195-047-5&amp;rft.aulast=Madison&amp;rft.aufirst=James+H.&amp;rft_id=https%3A%2F%2Farchive.org%2Fdetails%2Felilillylife188500madi&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></li>
<li><cite class="citation journal">Madison, James H. (1989). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20130514134313/http://thebhc.org/publications/BEHprint/v018/p0072-p0078.pdf">"Manufacturing Pharmaceuticals: Eli Lilly and Company, 1876–1948"</a> <span class="cs1-format">(PDF)</span>. <i>Business and Economic History</i>. Business History Conference. <b>18</b>: 72. Archived from <a rel="nofollow" class="external text" href="http://www.thebhc.org/publications/BEHprint/v018/p0072-p0078.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 14 May 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">20 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Business+and+Economic+History&amp;rft.atitle=Manufacturing+Pharmaceuticals%3A+Eli+Lilly+and+Company%2C+1876%E2%80%931948&amp;rft.volume=18&amp;rft.pages=72&amp;rft.date=1989&amp;rft.aulast=Madison&amp;rft.aufirst=James+H.&amp;rft_id=http%3A%2F%2Fwww.thebhc.org%2Fpublications%2FBEHprint%2Fv018%2Fp0072-p0078.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></li>
<li><cite class="citation book">Podczeck, Fridrun; Brian E. Jones (2004). <i>Pharmaceutical Capsules</i>. Chicago: Pharmaceutical Press. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-0-85369-568-4" title="Special:BookSources/978-0-85369-568-4"><bdi>978-0-85369-568-4</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Pharmaceutical+Capsules&amp;rft.place=Chicago&amp;rft.pub=Pharmaceutical+Press&amp;rft.date=2004&amp;rft.isbn=978-0-85369-568-4&amp;rft.au=Podczeck%2C+Fridrun&amp;rft.au=Brian+E.+Jones&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></li>
<li><cite class="citation book">Price, Nelson (1997). <i>Indiana Legends: Famous Hoosiers From Johnny Appleseed to David Letterman</i>. Indianapolis: Guild Press of Indiana. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-1-57860-006-9" title="Special:BookSources/978-1-57860-006-9"><bdi>978-1-57860-006-9</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Indiana+Legends%3A+Famous+Hoosiers+From+Johnny+Appleseed+to+David+Letterman&amp;rft.place=Indianapolis&amp;rft.pub=Guild+Press+of+Indiana&amp;rft.date=1997&amp;rft.isbn=978-1-57860-006-9&amp;rft.au=Price%2C+Nelson&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></li>
<li><cite class="citation book">Taylor Jr., Robert M.; Errol Wayne Stevens; Mary Ann Ponder; Paul Brockman (1989). <i>Indiana: A New Historical Guide</i>. Indianapolis: Indiana Historical Society. p. 481. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-0-87195-048-2" title="Special:BookSources/978-0-87195-048-2"><bdi>978-0-87195-048-2</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Indiana%3A+A+New+Historical+Guide&amp;rft.place=Indianapolis&amp;rft.pages=481&amp;rft.pub=Indiana+Historical+Society&amp;rft.date=1989&amp;rft.isbn=978-0-87195-048-2&amp;rft.au=Taylor+Jr.%2C+Robert+M.&amp;rft.au=Errol+Wayne+Stevens&amp;rft.au=Mary+Ann+Ponder&amp;rft.au=Paul+Brockman&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></li>
<li><cite class="citation book">Tobias, Randall; Tobias, Todd (2003). <a rel="nofollow" class="external text" href="https://archive.org/details/putmooseontablel0000tobi"><i>Put the Moose on the Table: Lessons in Leadership from a CEO's Journey through Business and Life</i></a>. Indiana University Press. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-0-253-11011-4" title="Special:BookSources/978-0-253-11011-4"><bdi>978-0-253-11011-4</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Put+the+Moose+on+the+Table%3A+Lessons+in+Leadership+from+a+CEO%27s+Journey+through+Business+and+Life&amp;rft.pub=Indiana+University+Press&amp;rft.date=2003&amp;rft.isbn=978-0-253-11011-4&amp;rft.aulast=Tobias&amp;rft.aufirst=Randall&amp;rft.au=Tobias%2C+Todd&amp;rft_id=https%3A%2F%2Farchive.org%2Fdetails%2Fputmooseontablel0000tobi&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></li>
<li><cite class="citation journal">Weintraut, Linda; Jane R. Nolan. "The Secret Life of Building 314". <i>Traces of Indiana and Midwestern History</i>. Indianapolis: Indiana Historical Society. <b>8</b> (3): 16–27.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Traces+of+Indiana+and+Midwestern+History&amp;rft.atitle=The+Secret+Life+of+Building+314&amp;rft.volume=8&amp;rft.issue=3&amp;rft.pages=16-27&amp;rft.au=Weintraut%2C+Linda&amp;rft.au=Jane+R.+Nolan&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></li></ul></section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(10)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=34" title="Edit section: External links" data-section="34" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-10 collapsible-block" id="mf-section-10">
<table role="presentation" class="mbox-small plainlinks sistersitebox" style="background-color:#f9f9f9;border:1px solid #aaa;color:#000"><tbody><tr>
<td class="mbox-text plainlist">Wikimedia Commons has media related to <i><b><a href="https://commons.wikimedia.org/wiki/Category:Eli_Lilly_and_Company" class="extiw" title="commons:Category:Eli Lilly and Company"><span style="">Eli Lilly and Company</span></a></b></i>.</td></tr></tbody></table><ul><li><a rel="nofollow" class="external text" href="http://www.lilly.com/">Eli Lilly and Company official website</a></li>
<li>Business data for Eli Lilly and Company: <div class="hlist hlist-separated inline"><ul><li><a rel="nofollow" class="external text" href="https://www.google.com/finance?q=LLY">Google Finance</a></li><li><a rel="nofollow" class="external text" href="https://finance.yahoo.com/q?s=LLY">Yahoo! Finance</a></li><li><a rel="nofollow" class="external text" href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=LLY">SEC filings</a></li></ul></div></li></ul>







</section></div><noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1&amp;mobile=1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Eli_Lilly_and_Company&amp;oldid=949908777">https://en.wikipedia.org/w/index.php?title=Eli_Lilly_and_Company&amp;oldid=949908777</a>"</div>
</div>
			<div class="post-content" id="page-secondary-actions">
			
			</div>
		</main>
		<footer class="minerva-footer">
		<div class="last-modified-bar">
	<div class="post-content last-modified-bar__content">
		<span class="last-modified-bar__icon mw-ui-icon mw-ui-icon-mw-ui-icon-small mw-ui-icon-wikimedia-history-base20 "></span>
		<a class="last-modified-bar__text" href="/wiki/Special:History/Eli_Lilly_and_Company"
				data-user-name="Cleovulcan"
				data-user-gender="unknown"
				data-timestamp="1586410764">
				<span>Last edited on 9 April 2020, at 05:39</span>
		</a>
		<span class="mw-ui-icon mw-ui-icon-small mw-ui-icon-mf-expand-gray mf-mw-ui-icon-rotate-anti-clockwise indicator"></span>
	</div>
</div>

		<div class="post-content footer-content">
			<div id='mw-data-after-content'>
	<div class="read-more-container"></div>
</div>

			<h2><img src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" width="116" height="18" alt="Wikipedia"/></h2>
			<div class="license">Content is available under <a class="external" rel="nofollow" href="https://creativecommons.org/licenses/by-sa/3.0/">CC BY-SA 3.0</a> unless otherwise noted.</div>
			<ul class="footer-places hlist hlist-separated">
				<li id="footer-places-terms-use"><a href="//m.wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a></li><li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Privacy_policy" class="extiw" title="wmf:Privacy policy">Privacy</a></li><li id="footer-places-desktop-toggle"><a id="mw-mf-display-toggle" href="//en.wikipedia.org/w/index.php?title=Eli_Lilly_and_Company&amp;mobileaction=toggle_view_desktop">Desktop</a></li>
			</ul>
		</div>
		</footer>
	</div>
</div>
<div class="mw-notification-area" data-mw="interface"></div>
<!-- v:8.3.0 -->

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"1.540","walltime":"1.862","ppvisitednodes":{"value":10503,"limit":1000000},"postexpandincludesize":{"value":281108,"limit":2097152},"templateargumentsize":{"value":10883,"limit":2097152},"expansiondepth":{"value":19,"limit":40},"expensivefunctioncount":{"value":17,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":403953,"limit":5000000},"entityaccesscount":{"value":4,"limit":400},"timingprofile":["100.00% 1596.983      1 -total"," 42.92%  685.442      1 Template:Reflist"," 18.31%  292.338     63 Template:Cite_web"," 15.12%  241.467      1 Template:Infobox_company"," 14.15%  226.034      1 Template:Infobox","  8.35%  133.422     20 Template:Cite_book","  8.28%  132.229     32 Template:Cite_news","  7.32%  116.948     10 Template:Citation_needed","  6.88%  109.915     11 Template:Fix","  5.50%   87.837      7 Template:Wikidata"]},"scribunto":{"limitreport-timeusage":{"value":"0.799","limit":"10.000"},"limitreport-memusage":{"value":12469809,"limit":52428800}},"cachereport":{"origin":"mw1354","timestamp":"20200417051808","ttl":86400,"transientcontent":true}}});});</script>
<script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Eli Lilly and Company","url":"https:\/\/en.wikipedia.org\/wiki\/Eli_Lilly_and_Company","sameAs":"http:\/\/www.wikidata.org\/entity\/Q632240","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q632240","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2004-06-27T20:28:27Z","dateModified":"2020-04-09T05:39:24Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/2\/2b\/Eli_Lilly_and_Company.svg","headline":"American global pharmaceutical company"}</script><script>(window.NORLQ=window.NORLQ||[]).push(function(){var ns,i,p,img;ns=document.getElementsByTagName('noscript');for(i=0;i<ns.length;i++){p=ns[i].nextSibling;if(p&&p.className&&p.className.indexOf('lazy-image-placeholder')>-1){img=document.createElement('img');img.setAttribute('src',p.getAttribute('data-src'));img.setAttribute('width',p.getAttribute('data-width'));img.setAttribute('height',p.getAttribute('data-height'));img.setAttribute('alt',p.getAttribute('data-alt'));p.parentNode.replaceChild(img,p);}}});</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgBackendResponseTime":342,"wgHostname":"mw1373"});});</script>		</body>
		</html>
		